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CHAPTER 1 
General introduction 
Adapted from: Klein Gunnewiek, J.M.T., van de Putte, L.B.A., and van Venrooij, 
W.J. (1997) 
Clinical and Experimental Rheumatology, in press 

General introduction 
GENERAL INTRODUCTION 
Introduction 
In addition to ribosomal, transfer and messenger RNAs, all eucaryotic cells contain a 
number of distinct small RNAs. These RNAs are usually complexed with several 
proteins in ribonucleoprotein (RNP) particles. A specified class of these complexes 
are the small nuclear ribonucleoprotein (snRNP) particles of which several have been 
identified by now. The most abundant snRNPs are U1, U2, U4/U6 and U5. U4 and 
U6 snRNP usually reside together in the same snRNP particle. These snRNPs are 
also called spliceosomal snRNPs since they constitute a substantial part of the 
spliceosome, the complex in which splicing takes place. During splicing non-coding 
sequences are removed from the precursor messenger RNA (pre-mRNA) in order to 
obtain functional mRNA (for a review see Krämer, 1996). 
Components of snRNP particles are also major targets of autoantibodies in sera 
from patients with systemic lupus erythematosus (SLE) and mixed connective 
tissue disease (MCTD). 
In this introduction an overview of the structure and function of the spliceosomal 
snRNPs, with emphasis on U1 snRNP, will be given. 
Composition of the major snRNPs 
The spliceosomal snRNPs U1, U2, U4/U6 and U5 consist of an RNA backbone 
molecule with several associated proteins (reviewed in Will et al., 1993). The 
spliceosomal snRNAs are metabolically stable, small RNAs which primary sequence 
is highly conserved among higher eucaryotes. The proteins associated with these 
RNAs can be distinguished into two classes: i) the so-called common or Sm 
proteins, which are present in the four spliceosomal snRNP particles; ii) the particle 
specific proteins. See Figure 1 for the schematic two and three-dimensional 
structures of the U1 snRNP particle. 
Common proteins 
The common or Sm proteins (see Table 1) include a group of at least eight tightly 
associated polypeptides, denoted B' (29 kDa), В (28 kDa), D1 (16 kDa), D2 (16.5 
kDa), D3 (18 kDa), E (12 kDa), F (11 kDa) and G (9 kDa) (reviewed in Will et al.. 
1993; see Figure 2A for structural features of the Sm proteins). Sm-D3 has an 
overall sequence identity of 29% with Sm-D1. The C-terminal part of D2 shows 
significant amino acid identity with the N-terminal region of Sm-B/B'. Sm-B and B' 
are encoded by the same gene via alternative splicing and contain identical 
sequences except for nine additional C-terminal amino acids in B' (Van Dam et al., 
1989). In addition, a protein denoted N, which is structurally highly related to B/B', 
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Figure 1. Structure of the U1 snRNP particle. (A) 
Secondary structure of the human U1 snRNA with the 
associated common (Sm) proteins and particle-specific 
proteins, U1-70K, U1A and U1C. Stemloop structures 
are numbered I through IV. U1A and U1-70K bind 
directly to the U1 snRNA while U1C binds the particle 
via protein-protein interactions. The Sm proteins bind 
to the highly conserved Sm site or A domain 
(reviewed by Klein Gunnewiek and Van Venrooij, 
1994). The U1 snRNA contains a characteristic 
trimethyl cap structure at its 5' end. (B) Schematic 
representation of a model of the three dimensional 
structure of the U1 snRNP particle (adapted from 
Nelissen et al., 1994). m3G: trimethyl (m2'27GpppN) 
cap structure. 
has been identif ied in snRNPs f r o m neural t issues (McAll ister et al., 1 9 8 8 ) . In the 
f irst steps of snRNP assembly, occuring in the c y t o p l a s m , the c o m m o n proteins 
bind the snRNA w h i c h results in the format ion of the so-called snRNP core complex 
(see also be low). Recently, a 6 9 kDa protein, w h i c h also binds t o the snRNP core 
and may therefore be considered an additional c o m m o n protein, has been identif ied. 
However, this 6 9 kDa protein is more loosely bound and appears t o interact 
transiently w i t h snRNPs (Hackl et al., 1994). 
Recently it has been s h o w n t h a t the c o m m o n proteins f r o m organisms as diverse as 
yeast, nematodes, insects, plants and higher vertebrates contain t w o sequence 
mot i fs , denoted Sm m o t i f s 1 and 2 w h i c h are 3 2 and 14 amino acids long, 
respectively (Hermann et al., 1 9 9 5 ; Séraphin, 1995 ; Cooper et al., 1995) . These 
mot i fs are at least in part involved in the protein-protein interactions between the 
Sm proteins (Hermann et al., 1995 ; Raker et al., 1996) . It has also been suggested 
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that, due to the presence of these Sm motifs, the Sm proteins may have very 
similar secondary structures (Hermann et al., 1995; Séraphin, 1995). 
The common proteins bind to a highly conserved sequence of the U1, U2, U4 and 
U5 snRNAs, the so-called A domain or Sm site. The Sm site consists of a single 
stranded region, PuA(U)nGPu with n > 3 , usually flanked by hairpin loops (see Figure 
1 and Will ef al., 1993 for a review). The assembly of the common proteins onto 
the Sm site appears to occur in a stepwise fashion as will be discussed below. 
Particle-specific proteins 
U1 snRNP particle 
The U1 snRNP particle has been isolated as a 12S particle which contains, along 
with the common proteins three specific proteins denoted U1-70K, U1A and U1C 
(Table 1; see Figure 1 for the U1 snRNP particle and Figure 2B for the structural 
features of the U1 snRNP-specific proteins). The U1-70K protein contains a 
conserved domain at the N-terminal half of the protein referred to as RNP motif, 
RNA binding domain (RBD) or RNA recognition motif (RRM) which is found in many 
other RNA binding proteins. This RNP motif is together with some N- and C-terminal 
flanking amino acid residues necessary and sufficient for binding of stemloop I of 
U1 snRNA (Query et al., 1989; Surowy et al., 1989). The U1A protein has two 
RNP motifs at each end of the protein. The N-terminal RNP motif together with 
some N- and C-terminal flanking amino acids is involved in the binding of stemloop II 
of U1 snRNA (Scherly er al., 1989), while the C-terminal RNP motif does not seem 
to have any affinity for RNA (Lu and Hall, 1995). The crystal structure of the N-
terminal RNP motif (aa 2-95) of U1A forms a βαββαβ structure with the highly 
conserved RNP1 and RNP2 consensus sequences located in the two central β 
strands (Nagai et al., 1990). An additional α helix (helix C) is present when a longer 
fragment of the U1A protein is analyzed (aa 2-102; Howe et al., 1994). In the 
crystal structure of a U1A fragment containing amino acids 2-98 in a complex with 
the U1 loop II sequence the RNA loop lies across the β sheet, fitting into a groove 
formed between loop 3 (situated between β2 and β3) and the C-terminal region of 
the RNP motif (Oubridge ef al., 1994). In a recent NMR study using an even longer 
fragment of U1A (aa 2-117) in solution it was shown that helix С extends across 
the β sheet thereby covering part of the RNA binding site defined by the crystal 
suggesting that RNA binding is accompanied by a re-orientation of helix С (Avis et 
al., 1996). 
The UIA protein is also able to bind its own pre-mRNA. The 3' untranslated region 
(3' UTR) of U1A pre-mRNA contains a conserved region encompassing two 
stretches of seven nucleotides similar to those found in the second stemloop of U1 
snRNA (Boelens et al., 1993). This conserved region can be bound by two U1A 
proteins (Van Gelder et al., 1993). 
The U1C protein contains an N-terminal zinc finger-like region which is necessary 
and sufficient for binding of the U1 snRNP particle via protein-protein interactions 
(Nelissen et al., 1991a). For this interaction it needs at least the presence of the 
11 
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Figure 2. Structural features of the Sm proteins G, F, E, D I , 02, D3, В/В' and 69 kDa (A) and 
the U1 snRNP-specific proteins 70K, A and С (В). 
(A) Sm-G (76 aa; Hermann et al., 1995) contains many hydrophobic amino acids (34%) which 
are mainly located in the C-terminal half of the protein. Sm-F (86 aa; Hermann et al., 1995) 
contains many acidic residues at the C-terminal end of the protein. Furthermore, the protein is 
enriched in aromatic amino acid residues, which are mainly concentrated just before the middle 
of the protein sequence. Sm-E (92 aa; Stanford et al., 1988) does not contain any characteristic 
domains. Two features of Sm-D1 (119 aa; Rokeach et al., 1988) can be discerned: i) a nine-fold 
repeated glycine-arginine motif between amino acid residues 97 and 114; ii) a lysine-rich 
hydrophilic region between residues 82 and 93. Sm-D2 (118 aa; Lehmeier et al., 1994) has a 
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В 
Arg/Ser Arg/Ser 
RNP motif 
U1A 
RNP2 RNP1 
/ 
Pro/Met RNP2 RNP1 
RNP motif RNP motif 
U1C 
Zn Pro/Met 
highly hydrophilic cluster (aa 8-25) that contains most of the glutamic acid residues of the 
protein while the C-terminal one third of the protein is rich in hydrophobic amino acids A cluster 
of basic amino acids is located between residues 79 and 88 Sm-D3 (126 aa, Lehmeier et al, 
1994) has a repeated arginme-glycine domain (four repeats) which is located at the C-terminal 
end of the protein Furthermore, Sm-D3 has an uneven distribution of charged amino acids, with 
all of the glutamic acid residues located in the N terminus Sm-B/B' (231 and 240 aa, 
respectively, Van Dam et al., 1989) are rich in prolines and glycines with the prolines 
concentrated in the C-terminus of the proteins in a repetitive manner The unit PPPGMRPP is 
three times present in Sm-B' and twice in Sm-B Similar motifs are also found in U1A and U1C 
(Habets et al., 1989) The 69 kDa protein (518 aa, Hackl and Luhrmann, 1996) contains an RNP 
motif which is found in many RNA binding proteins and three arginine glycine rich regions 
Furthermore, it contains a single putative Cys2/Cys2 zinc finger domain 
(B) U1-70K (437 aa, Theissen ef al., 1986) contains an RNP motif at the N-termmal half of the 
protein The C-terminal end of the protein contains arginine-senne rich regions The U1A protein 
(282 aa, Sillekens et al, 1987) has two RNP motifs The region in between the two RNP motifs 
is rich in the ammo acids proline and methionine The U1C protein (159 aa, Sillekens et al., 
1988) contains a zinc finger-like region at its N-terminus The C-terminal end of the protein is 
rich in the ammo acids proline and methionine 
The conserved Sm motifs 1 and 2 are indicated Lys lysine rich hydrophilic region, Arg/Gly 
arginme-glycine rich region, glu glutamic acid rich region, RNP motif RNP motif or RNA binding 
domain or RNA recognition motif, RNP1 and RNP2 most highly conserved sequences within the 
RNP motif, Pro/Met proline-methionine rich region, Arg/Ser arginine serine rich region, p30 
p30**" sequence similarity, Zn zinc finger(-like) region Numbers refer to ammo acids N is the 
amino terminus, С the carboxy terminus. 
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TABLE 1 
Protein 
G 
F 
E 
DI 
D2 
D3 
В 
В' 
Ν
1
' 
С 
А 
70К 
Β­
Α' 
: Protein composition of HeLa sri 
Mol. mass 
(kDa) 
9 
11 
12 
16 
16.5 
18 
28 
29 
29
,, 692 ' 
22 
34 
70 
28.5 
31 
35 
53 
60 
66 
92 
110 
120 
150 
160 
15 
40 
52 
100 
102 
110 
116 
200 
220 
15.5 
20 
27 
61 
63 
60 
90 
12SU1 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
12SU2 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
RNPs 
17SU2 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
? 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
' 
20S U5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
25S 
U4/U6.U5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
? 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
12S 
U4/U6 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Adapted from Will et al., 1993 
1 1N is predominantly expressed in brain tissue 
21
 69 kDa is more loosely bound to snRNPs 
U1-70K protein and the Sm proteins B/B' (Nelissen et al., 1994). Recently, it has 
been shown that the N-terminal region of U1C indeed is able to bind Z n 2 + (S. 
Muller, pers. communication). 
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The U1-70K is not only able to bind the U1 snRNP particle via an interaction with 
the RNA but also via protein-protein interactions with the Sm proteins (Nelissen ef 
al., 1994; Hilleren et al., 1995). The U1A protein is also able to bind the U1 snRNP 
particle via protein-protein interactions although the exact nature of these 
interactions is not known (Hamm et al., 1987). 
U2, U4/U6 and U5 snRNP particles 
The U2 snRNP particle has been isolated in two distinct forms, the 12S and the 17S 
U2 snRNP (see Table 1 and Will ef al., 1993 for a review). The 17S form which 
appears to represent the functional form of the particle contains at least 11 distinct 
particle-specific proteins with molecular masses ranging from 28 5 to 160 kDa 
Nine of these U2 snRNP-specific proteins can be removed by a 300 mM salt wash 
(Behrens et al., 1993). The resulting 12S U2 snRNP particle contains only two 
specific proteins, the U2A' and U2B" proteins. The U2B" protein which is highly 
similar to U1A, does not bind directly to U2 snRNA but needs the presence of U2A' 
to bind specifically to stemloop IV (Boelens et al., 1991). 
The association of U4/U6 with the U5 snRNP particle resulting in the formation of 
U4/U6.U5 tn-snRNP is a dynamic process in which different subsets of snRNP 
specific proteins are involved. U4/U6 has been isolated as a 12S particle which 
contains along with the common proteins two additional proteins (see Table 1; 
Gozani et al., 1994). The 20S U5 snRNP particle contains at least nine specific 
proteins (reviewed by Will ef al., 1993). The cDNA encoding the U5-200 kD has 
been isolated (Lauber ef al., 1996). The 25S [U4/U6.U5] tn-snRNP complex 
contains along with the proteins present in 12S U4/U6 and 20S U5 snRNP particles, 
five additional proteins (see Table 1; Will et al., 1993 for a review). 
Evolutionary conservation 
Common proteins 
Apart from the human Sm proteins the murine and Drosophi/a Sm-B (one ammo acid 
substitution and 65% identity, respectively; Griffith ef al., 1992; Brunei ef al., 
1993), murine and yeast Sm-D1 (99% and 35% identity, respectively; Mitsuda ef 
al., 1992, Rymond et al., 1993), yeast Sm-D3 (51% identity; Roy et al., 1995) and 
the chicken Sm-E (100% identity; Fautsch et al., 1992) have been characterized. 
Due to the finding that Sm proteins contain two evolutionary conserved sequence 
motifs, additional putative homologues of the human Sm proteins have been 
identified in the sequence databases (Hermann ef al., 1995; Séraphin, 1995). The 
Sm proteins show extensive conservation. Alignment of putative homologues of 
human Sm-F and Sm-G from various species revealed that the percentage of 
identical amino acid residues in Sm-F homologues from organisms as diverse as 
man, worm, insect and plant ranges between 72 and 78% while this value ranges 
between 50 and 60% for the various Sm-G homologues (Hermann et al., 1995). 
15 
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UI snRNA and UI snRNP-specific proteins 
Sequencing of U1 snRNAs isolated from various cells and organisms has revealed 
extensive conservation of the RNA sequence and, in particular, of its secondary 
structure. Although the yeast U1 snRNA is several times larger than its metazoan 
counterpart (569 nts compared to 165 nts), the structure of several of the 
functionally most important regions are still conserved between yeast and man 
(reviewed by Lührmann et al., 1990). The region in yeast U1 snRNA likely to be 
involved in binding of the yeast U1A protein has been defined. This site is very 
different from the vertebrate U1A binding site but its location within the yeast U1 
snRNA suggests a conserved structural relationship to other U1 snRNP components 
(Tang and Rosbash, 1996). 
cDNAs encoding the U1 snRNP-specific proteins in several organisms have been 
isolated (see Table 2 for an overview). The characterized counterparts of the human 
U1-70K protein all contain an RNP motif but do not always contain the arginine-
serine rich regions. In addition, all the known U1-70K proteins are encoded by a 
single gene except for the Xenopus U1-70K which is presumed to be encoded by at 
least two, and possibly more, different genes. Multiple (sub)classes of mRNAs have 
been found in human (Spritz et al., 1987), mouse (Hornig et al., 1989), Drosophila 
(Mancebo er al., 1990) and Arabidopsis (Golovkin and Reddy, 1996) probably as 
the result of alternative splicing. These results indicate that multiple forms of U1-
70K, possibly with different functions in vivo, may exist. We isolated a human U1-
70K cDNA encoding a 70K protein that lacks 9 amino acid residues 
(223PGPSPLPHR232, a region with four alternating prolines), which are encoded by 
exon 11 (our unpublished results). 
Several counterparts of the human U1A protein have been characterized (see Table 
2). It has been shown that the human, potato and Arabidopsis U1A proteins are 
encoded by single-copy genes (Nelissen et al., 1991b; Simpson et al., 1995). Most 
of the U1A proteins are conserved with respect to the two RNP motifs. However, 
the N-terminal RNP motif of yeast U1A is not very well conserved (24% identity 
and 47% similarity), although this region is much more conserved when amino acids 
involved in the binding of U1 snRNA are examined (Liao et al., 1993). Most 
interestingly, the Drosophila U1A protein, SNF/D25, contains motifs of both human 
U1A and human U2B", a U2 snRNP-specific protein that is highy similar to U1A 
(Sillekens et al., 1987; Harper et al., 1992). It has been shown that Drosophila 
SNF/D25 is a component of both U1 and U2 snRNPs: in vitro it binds U1 snRNA on 
its own and U2 snRNA in the presence of either human U2A' or Drosophila nuclear 
extract suggesting that in Drosophila one protein fulfills the role of both human U1A 
and U2B" (Polycarpou-Schwarz et al., 1996). 
The U1C proteins from a few species have been characterized (see Table 2). In 
mice and Xenopus laevis the zinc finger-like region is conserved and only minor 
differences are observed in the C-terminal end of the protein (Jantsch and Gall, 
1992; Nelissen et al., 1997). In yeast, the protein is less well conserved although 
the cysteines and histidines of the zinc finger-like region are conserved (Rosbash, 
16 
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TABLE 2- UI snRNP-specific proteins characterized in other species 
Protein Species Characteristics Reference 
U1-70K Mouse 
Xenopus laevis 
Drosophila 
Arabidopsis thaliania 
Yeast 
94% amino acid identity with human U1-
70K IRNP motif is 100% conservedl 
88% amino acid identity with human U1-
70K The N-termmal two thirds of the 
protein, encompassing the RNP motif is 
more conserved (97%) than the C-
terminal one third (75%) 
68% amino acid identity in the N-
termmal 214 residues (46% overall 
identity) C-terminal end is less well 
conserved but is highly charged and 
contains RS domains 
64% sequence similarity (41% identity) 
with human U1-70K The C-terminal end 
has an arginme-rich region but has no 
strong sequence similarity with the 
human U1-70K 
30% ammo acid identity with human U1-
70K. Most conserved residues are 
present in the N-terminus encompassing 
the RNP motif The C-termmus is much 
shorter and is only moderately charged 
Hornig et al., 1989 
Etzerodt et al., 1988 
Mancebo étal., 1990 
Golovkin and Reddy, 
1996 
Smith and Barrel), 
1991 
U1A Mouse 96% identity with human UIA. 
Xenopus laevis 82% identity with human U1A· 94% 
identity in both RNP motifs 
Drosophila Mixture of regions from U1A and U2B". 
77% identity with human U1A and 72% 
identity with human U2B" (N-terminal 
RNP motif 82% identity with U1A and 
77% identity with U2B", C-terminal RNP 
motif: 83% identity with both U1A and 
U2B") 
57% identity (74% similarity) with 
human U1A Most conservation resides 
in the RNP motifs 
Highly related to potato U1A (77% 
identity and 89% similarity, 52% identity 
with human U1A) 
The second RNP motif is the most highly 
conserved portion 36% identity and 
64% similarity with human U1A (22% 
overall identity) The first RNP motif 
contains a substantial insertion in the 
loop 2 region compared to human U1A 
U1C Mouse 99% identity with human UIC No 
differences in the zinc finger-like region. 
Xenopus laevis 92% identity with human U1C No 
differences in the zinc finger-like region 
Yeast 25% identity and 43% similarity with 
human U1C The zinc finger-like region is 
the most conserved part (50% identity in 
the N-terminal 30 amino acid residues) 
Potato 
Arabidopsis thaliania 
Yeast 
Bennet et al., 1993 
Scherly et al., 1991 
Harper étal., 1992 
Simpson et al., 1995 
Simpson étal., 1995 
Liao et ai, 1993 
Nelissen et al., 1997 
Jantsch and Gall, 
1992 
Rosbash, pers 
communication. 
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pers. communication). It has been suggested that the U1C gene belongs to a 
multigene family (Sillekens et al., 1988) which is supported by the finding of two 
putative murine pseudogenes (Nehssen et al., 1997). 
Assembly and nucleocytoplasmic transport of U1 snRNP 
Nucleocytoplasmic transport of RNAs and proteins proceeds through the nuclear 
pore complex (NPC). Some small proteins (up to 40 kD) have been shown to diffuse 
into the nucleus (Breeuwer and Goldfarb, 1990; Klein Gunnewiek et al., 1997). 
However, most proteins can enter the nucleus only via an energy-dependent, signal-
dependent and saturable process (reviewed by Górlich and Mattaj, 1996; Koepp and 
Silver, 1996). The signals involved in protein import, the so-called nuclear 
localization signals (NLS), do not have a strict consensus although two prototypical 
NLSs can be discerned. One of these contains two clusters of basic ammo acids 
separated by about 10 residues (the so-called bipartite NLS) while the other one is 
composed of one short stretch of basic amino acids (like the SV40 large Τ antigen 
NLS) (reviewed by Gorhch and Mattaj, 1996). The NLS-containing protein is bound 
in the cytoplasm by the importin α/β heterodimer The α subunit provides the NLS 
binding site. Subsequently, this complex is docked at the NPC via importin β after 
which translocation of the NLS-bearing protein and importin α takes place. This step 
needs the presence of Ran, a small GTP binding protein (reviewed by Gorlich and 
Mattaj, 1996; Koepp and Silver, 1996). 
The spliceosomal snRNAs, except for the RNA polymerase III encoded U6 snRNA, 
are RNA polymerase II products that are transcribed in the nucleus and initially 
acquire a monomethyl (m7GpppN) cap structure which has been shown to be 
important for export from the nucleus to the cytoplasm (see Figure 3; reviewed by 
Mattaj et al., 1993). A nuclear cap binding complex (CBC) consisting of two 
proteins, CBP80 and CBP20, is involved in the export (Izaurralde et al., 1995). CBC 
also binds to cap-bearing mRNAs in the nucleus and is translocated with them 
through the NPC (Visa et al., 1996). Interestingly, Gorlich and co-workers (1996) 
suggested that importin a, one of the proteins that are mediating protein import, is 
permanently bound to CBC. After export of the U1 snRNA-CBC-importm α complex, 
importin β might bind this complex in the cytoplasm resulting in release of the U1 
snRNA The CBC-importin α/β complex is presumed to return subsequently to the 
nucleus where importin α is supposed to remain associated with CBC. Importin β, 
which does not accumulate in the nucleus, separates from the complex and returns 
to the cytoplasm. After export of the newly transcribed snRNA to the cytoplasm, 
the common proteins associate with the Sm site resulting in the so-called snRNP 
core complex This assembly process involves the stepwise formation of several 
protein hetero-oligomers which do not contain RNA (Figure 3). Recent studies have 
shown that the ordered snRNP core assembly involves the initial formation of D1-
D2, E-F-G, D1-D2-E-F-G and B/B'-D3 complexes Subsequently, the U1 snRNA 
18 
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associates with the D1-D2-E-F-G complex in order to form an snRNP subcore 
particle. Finally, the binding of B/B'-D3 to the subcore generates a functional snRNP 
core particle (Lehmeier er al., 1994; Raker et al., 1996). It is not known what the 
nature is of the various protein-protein interactions in the snRNP core, although 
recently it has been suggested that the conserved motifs of the Sm proteins, Sm1 
and Sm2, are essential for complex formation between Sm-B and D3 in vitro 
(Hermann et al., 1995). It is also not known how the common proteins interact with 
NUCLEUS 
CBC 
m7G 
2,2,7mQ 
Sm-E, F, G 
O O O Sm-D1, DÍ 
Sm-B/B', D3 
OOO 
cap hypermethytation 
Figure 3. Transport and assembly of the U1 snRNP particle. 
After transcription in the nucleus the U1 snRNA is exported to the cytoplasm where the 
common proteins associate with the Sm site, thereby providing a binding site for a cytoplasmic 
methylase that subsequently hypermethylates the cap structure (Plessel et al., 1994) before the 
core snRNP particle returns to the nucleus. 
The assembly of the common proteins in the cytoplasm onto the Sm site appears to occur in 
several steps and involves the formation of various protein hetero-oligomers which do not 
contain RNA. It is thought that the association of the U1 snRNP-specific proteins with the U1 
core takes place in the nucleus. 
m7G: monomethyl (m7GpppN) cap structure; 2,2,7mG: trimethyl (m2-2'7GpppN) cap structure; 
Sm: Sm site; CBC: cap binding complex. 
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the Sm sites of U 1 , U2, U4 and U5 snRNAs although crosslinkmg studies have 
demonstrated that the G protein is directly bound to the Sm site of U1 snRNA 
(Heinrichs et al., 1992). After binding of the common proteins, the core snRNP is 
hypermethylated at the 5' end of the RNA and returns to the nucleus. In Xenopus 
laevis oocytes the re-import of the U1 snRNP complex into the nucleus depends on 
the presence of both the common proteins and the trimethyl cap structure. 
However, the importance of the cap structure in transport is different for different 
snRNPs and for the same snRNPs in different cells (reviewed by Mattaj et al., 
1993). 
It has been shown that snRNPs do not compete with karyophihc proteins for nuclear 
import suggesting that different receptors are used (reviewed by Gorlich and Mattaj, 
1996). Recently, it has been suggested that GTP-hydrolysis or Ran-GDP/GTP 
cycling is not essential for U1 snRNP nuclear import in somatic cells (Marshallsay et 
al., 1996). In contrast, Palacios and co-workers (1996) found that GTPase activity 
is involved in nuclear import of snRNPs These discrepancies might be explained by 
the fact that different systems were used. 
It is presumed that the association with the snRNP-specific proteins takes place in 
the nucleus since the U1 snRNP specific proteins are able to enter the nucleus 
independently of the U1 snRNA (Kambach and Mattaj, 1992; Jantsch and Gall, 
1992; Romac et al., 1994). Furthermore, it has been shown that both U1-70K and 
U1A are actively transported into the nucleus (Romac et al., 1994; Kambach and 
Mattaj, 1992). The NLSs of these proteins have been mapped. Two regions that are 
involved in the nuclear localization of U1-70K have been identified: one region (aa 
92-199) contains the RNP motif and the other one contains the C-terminal end of 
the protein (aa 183-437) (Romac et al., 1994). The NLS of U1A has been located 
between amino acids 94 and 204 (Kambach and Mattaj, 1992). This region 
encompasses the amino acid sequence in between the two RNP motifs. The U1C 
protein, however, enters the nucleus via diffusion and is retained in the nucleus by 
binding to the U1 snRNP particle (Klein Gunnewiek et al., 1997). 
The RNA polymerase III product U6 snRNA, which carries a γ-monomethyl cap does 
not leave the nuclear compartment after being synthesized (reviewed by Mattaj et 
al., 1993) and associates with U4 snRNP in the nucleus to form the U4/U6 snRNP 
particle (Wersig era/., 1992). 
Function of U1 snRNP 
The snRNPs U 1 , U2, U4/U6 and U5 play, as mentioned before, an essential role in 
splicing, a nuclear process in which the non-coding sequences of the pre-mRNA are 
removed in two successive transestenfication reactions. The catalysis of this 
process occurs in a large complex known as the sphceosome. This multicomponent 
complex consists of U 1 , U2, U4/U6 and U5 snRNPs and a large number of non-
snRNP splicing factors including members of the so-called SR protein family. These 
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proteins contain an arginine-senne rich (RS) domain in addition to an N-terminal RNP 
motif and a domain with limited but significant homology to the RNP motif 
(reviewed by Fu, 1995, Kramer, 1996; Reed, 1996). In the first step of 
sphceosome assembly the U1 snRNP binds the 5' splice site, which is 
complementary to the 5' end of the U1 snRNA (see Figure 4A). It has been shown 
that one of the SR proteins, the protein heterodimer ASF/SF2, is able to enhance 
the interaction of the U1 snRNP particle with the 5' splice site. This enhancement 
appears to be achieved via an interaction between the RS-domains of ASF/SF2 and 
the U1-70K protein. Association of U1 with the pre-mRNA promotes the 
subsequent binding of the U2 snRNP to the branchpoint. The stable binding of U2 
snRNP critically depends on U2AF, that binds to the polypynmidine tract (reviewed 
by Krämer, 1996; Fu, 1995). In the final step the tn-snRNP U4/U6 U5 binds to the 
pre-sphceosome as a 25S particle. This complex is converted into a catalytically 
active complex after some rearrangements of intermolecular RNA-RNA interactions 
which include the destabilization of the extensive basepairing between U4 and U6 
snRNAs and disruption of the U1 snRNA basepairing with the 5' splice site, which is 
replaced by U5 snRNP. U5 snRNA basepairs with exon sequences around the 5' and 
3' splice sites (Figure 4B). In addition, it has been shown that the U5 snRNP-
specific protein p220 interacts with the invariant GU dinucleotide at the 5' end of 
the intron (Reyes et al., 1996). Duplexes between U2 and U6 snRNA are formed 
and U6 snRNA basepairs with sequences at the 5' end of the intron. The catalytic 
core of the sphceosome is formed by contacts of U2, U5 and U6 snRNAs with the 
pre-mRNA and with one another (Figure 4B; reviewed by Krämer, 1996). Most 
likely, ATP-dependent RNA helicases are involved in the disruption of RNA-RNA 
duplexes. In humans, two putative RNA helicases have been identified: HRH1 (Ono 
et al., 1994) and the 200 kD U5 snRNP-specific protein (Lauber et al., 1996). 
Recently, it has been shown that splicing can occur in the absence of U1 snRNP if 
an excess of SR proteins is present (Crispino et al., 1994; Tarn and Steitz, 1994). It 
has been suggested that in U1 snRNP depleted extracts SR proteins promote the 
association of U2 snRNP with the branch site in a manner independent of the 
sequence at the 5' splice site. The subsequent recognition of the 5' splice site by 
U6 snRNP then becomes the rate-limiting step (Crispino er al., 1995) Follow-up 
studies indicate that some pre-mRNA substrates can also be efficiently processed in 
the absence of U1 snRNP without the addition of an excess of SR proteins. These 
results suggest that U1 snRNP independent splicing might not be uncommon 
(Crispino et al., 1996). 
The splicing model described above (Figure 4A) is the so-called intron-definition 
model in which introns are the primary targets to be recognized by the splicing 
factors However, an exon-definition model has also been proposed (reviewed by 
Kramer, 1996; Reed, 1996). In this model the U1 snRNP binds to the 5' splice site 
located at the downstream side of the exon and directs the binding of splicing 
factors to the 3' splice site located upstream, followed by interactions across the 
upstream intron and intron removal (Figure 4C). 
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Figure 4. Assembly of the spliceosome and the subsequent splicing of pre-mRNA. 
(A) In the first step of spliceosome assembly the U1 snRNP binds the 5' splice site, which is 
complementary to the 5' end of the U1 snRNA, in an ATP-independent manner. Association of 
U1 with the pre-mRNA promotes the subsequent ATP-dependent binding of the U2 snRNP to the 
branchpoint. Finally, the tri-snRNP U4/U6.U5 binds to the pre-spliceosome as a 25S particle. (B) 
(opposite page) Interactions between pre-mRNA and the spliceosomal RNAs U2, U5 and U6 
forming the catalytically active centre of the spliceosome (adapted from Kramer, 1996). (C) 
(opposite page) Interactions between splice sites in an intron-definition model versus an exon-
definition model. 
The pre-mRNA is shown with exons as boxes and the intron as a line. 5' splice site conforms to 
the consensus sequence AG|GURAGU: 3' splice site is characterized by the sequence YAG| and 
is preceded by a stretch of pyrimidine residues (Py) (splice site is denoted by a vertical bar and 
invariant nucleotides are underlined; R = purine; Y = pyrimidine) ); A: branch point. 
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In addition to the described ma|or class of introns with 5'-GU-AG-3' boundaries 
(Figure 4A) a minor class of metazoan introns has been indicated with well 
conserved splice sites with 5'-AU-AC-3' boundaries (Hall and Padgett, 1994; 
Mount, 1996). Excision of these AU-AC introns follows a two-step pathway akin to 
that characterized for splicing of the major class of pre-mRNA introns. The low 
abundant snRNAs U11, U12, U4atac and U6atac are together with U5 involved in 
the formation of the AU-AC spliceosome. U12, U4atac and U6atac appear to be 
functionally analogous to U2, U4 and U6 snRNAs, respectively. A direct role of U11 
has not yet been identified and U5 apparently functions identically in both types of 
sphceosomes Similarities in the predicted secondary structures of U11, U12 and 
U4atac/U6atac compared to U1, U2 and U4/U6, respectively, has been observed 
(Tarn and Steitz, 1996a and 1996b; Hall and Padgett, 1996). Recently, it was 
shown that the AU-AC splicing reaction was markedly stimulated by the presence 
of intact U1 snRNA, and this stimulation was entirely dependent on the presence of 
a conventional downstream 5' splice site suggesting that U1-mediated exon 
definition interactions can coordinate the activities of major and minor spliceosomes 
(Wu and Kramer, 1996). 
The function of the Sm proteins and the U1 snRNP particle-specific proteins in 
spliceosome assembly and splicing is not precisely known. It has been established 
that the UIC protein can augment the interaction of the U1 snRNP particle with the 
5' splice site (Heinrichs er al, 1990, Jamison et al., 1995). Recently, it has been 
shown that the presence of the UIC protein is essential for the formation of the 
early spliceosome (Will et al., 1996) and, when the protein is present in the U1 
snRNP particle, it can be crosshnked to the 5' splice site (Rossi er al., 1996). 
Furthermore, it has been suggested that both phosphorylation and 
dephosphorylation steps play important roles in splicing (reviewed by Fu, 1995). 
The U1-70K protein is strongly phosphorylated in higher organisms. Experimental 
evidence indicates that the state of phosphorylation of U1-70K is critical for the 
participation of the U1 snRNP particle in splicing (Mermoud ef al., 1992; Tazi et al., 
1993). Little is known about the function of the U1A protein in splicing When the 
U1A protein is selectively removed, splicing In vitro can still take place. 
Nevertheless, it has been suggested that the C-terminal RNP motif of the U1A 
protein has a function in splicing in yeast (Tang and Rosbash, 1996). 
An unexpected function of the U1A protein has been described in vertebrates 
where U1A regulates its own expression level by regulating the polyadenylation of 
its own pre-mRNA Two U1A proteins can bind to a conserved region in the 3' UTR 
of its own pre-mRNA, as has been discussed above, resulting in inhibition of 
polyadenylation (Boelens ef al., 1993; Van Gelder et al., 1993; Gunderson er al., 
1994). However, no such conserved region is present in the U1A pre-mRNA of 
either plants, Drosophila or yeast indicating that this autoregulation of the U1A 
protein is not a general phenomenon. 
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Outline of this thesis 
The U1 snRNP particle, the most abundant spliceosomal snRNP, consists of an RNA 
molecule and several proteins associated with it, among which the particle-specific 
proteins U1-70K, U1A and U1C. The work described in this thesis is primarily 
focussed on the U1C protein, the smallest of the U1 snRNP-specific proteins. 
Chapter 2 describes the characterization of the murine U1C protein and two 
possible murine U1C pseudogenes. The murine and human U1C proteins are 
identical except for a single residue (position 65) indicating that U1C is 
evolutionary highly conserved. The presence of two putative pseudogenes 
supports the hypothesis that the U1C gene belongs to a multigene family. The 
studies described in chapter 3 and 4 show that both the U1A and the U1C protein 
are able to form homodimers and although the functional implications of these 
dimerizations are still unknown, it is indicated that two U1C proteins might be 
present in the U1 snRNP particle. 
Chapter 5 describes the finding that the nuclear accumulation of the UIC protein 
proceeds via diffusion and subsequent binding to the U1 snRNP particle in the 
nucleus. This contrasts with the U1-70K and U1A proteins which have been shown 
to be imported into the nucleus via an energy-dependent mechanism. In Chapter 6 
studies are performed with human autoantibodies and rabbit antibodies raised 
against synthetic peptides derived from the UIC protein. The antibody recognition 
of free UIC, U1C bound to the U1 snRNP particle, and U1C synthetic peptides is 
investigated. 
Finally, the data presented in this thesis are discussed in Chapter 7. 
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ABSTRACT 
Genes for the snRNP proteins U1-70K, U1A, Sm-B/B', Sm-D1 and Sm-E have been 
isolated from various metazoan species. The genes for Sm-D1 and Sm-E, which were 
isolated from a murine and human source respectively, appear to belong to a multigene 
family. It has been suggested that also for the mammalian U1C protein such a 
multigene family exists With the human UIC cDNA as a probe, two genes containing 
sequences homologous to the probe sequence, were isolated from a mouse genomic 
library. Simultaneously, a murine U1C cDNA was isolated from a mouse cDNA library. 
This 0.74 kb cDNA contains an open reading frame of 477 bp encoding a polypeptide 
of 159 ammo acids which differs at only one position (pos. 65) from the human UIC 
protein One of the isolated U1C genes contains an open reading frame as well and 
shares 92% nucleotide sequence identity with the mouse U1C cDNA. The features of 
this gene, in particular the absence of introns, the acquisition of a 3' poly (A) tail and 
flanking direct repeats, indicate that it represents a processed pseudogene. At the 
predicted amino acid sequence level, substitutions of conserved residues at functionally 
important positions are observed, strongly suggesting that expression of this gene 
would not lead to a functional polypeptide. The second UIC gene appeared to be a 
pseudogene as well because it is also mtronless and contains a frame shift mutation 
compared to the open reading frame in the mouse UIC cDNA The characterization of 
these two pseudogenes points to the existence of a U1C multigene family in mice 
Furthermore, comparison of amino acid sequences of the murine, human and Xenopus 
U1C shows that the protein is highly conserved through evolution. Since the Xenopus 
U1C differs from the two mammalian counterparts solely at a number of positions in 
the C-termmal region, it can be concluded that amino acid changes are less well 
tolerated in the N-terminal region of U1C than in the rest of the protein. 
Abbreviations: kb, kilo bases; Myr, million years; nt, nucleotide(s); ORF, open reading 
frame, bp, basepair. 
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INTRODUCTION 
The U1 small nuclear ribonucleoprotem (snRNP) particle is one of the abundant U 
snRNPs (U1, U2, U4-6) in the nucleoplasm of eukaryotic cells and has been shown to 
function as an essential factor in the early steps of pre-mRNA splicing (Sharp, 1994). 
The U1 snRNP complex contains a 165 nt long U1 RNA molecule and a set of at least 
eleven proteins which are associated with the U1 RNA, either directly or via protein-
protein interactions (Will era/., 1993). Eight of the proteins associated with U1 snRNP 
are common to most U snRNPs and therefore named common or Sm proteins, but the 
three proteins U1-70K, U1A, and U1C are exclusively associated with U1 snRNP 
(reviewed in Will er al., 1993). The 159 residues long U1C protein depends for its 
association with U1 snRNP on protein-protein interactions. The U1C ammo-terminal 
domain, which contains a zinc finger-like sequence of the CC-HH type, is required and 
sufficient for the binding to U1 snRNP (Nehssen et al., 1991a). The U1C protein is 
probably functionally active in the early steps of the splicing process. Recently, U1C 
was shown to be required for proper 5' splice site recognition by U1 snRNP (Jamison ef 
a!.. 1995). 
For a few metazoan U snRNP proteins the corresponding, probably functional gene has 
been described the human, murine, Xenopus, and Drosophila U1-70K protein (Spritz er 
al., 1990; Hornig et al., 1989; Etzerodt et al., 1988; Mancebo et al., 1990, 
respectively), the human UIA protein (Nehssen et al. 1991b), and the human Sm 
proteins B/B' (Chu and Elkon, 1991) and E (Stanford er al., 1988). In addition to the 
intron containing Sm-E gene a processed pseudogene for Sm-E exists (Stanford et al., 
1987). For Sm-D1 the isolation of an mtronless murine gene was reported, which may 
represent a processed pseudogene as well (Mitsuda et al., 1992). 
With regard to the UIC protein only cDNAs have been reported, from human and 
Xenopus origin (Sillekens er al., 1988; Jantsch and Gall, 1992), but no genomic 
sequences. Based on hybridization of a human UIC cDNA probe on a Southern zoo 
blot, Sillekens et al. (1988) suggested the existence of a UIC multigene family in 
mammals. The present paper demonstrates the existence of such a UIC multigene 
family in mice by describing the cloning and characterization of two murine 
pseudogenes related to this protein. The features of these UIC genes are typical for 
processed retropseudogenes. In addition, the amino acid sequence deduced from the 
mouse U1C cDNA that we have isolated, is compared to the sequence of the human 
and Xenopus U1C proteins. 
EXPERIMENTAL AND DISCUSSION 
(a) Indications for the existence of a murine UIC multigene family 
The presence of multiple genes related to the mammalian U1C protein was suggested 
by Sillekens et al. (1988) based on Southern blot hybridization data obtained with fcoRI 
digested genomic DNA of a number of species and human UIC cDNA as a probe. In 
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that study the hybridization signal with the mouse genomic DNA in particular was very 
weak Since we were interested in murine U1C related genomic sequences, a Southern 
blot was prepared with mouse genomic DNA digested with six different restriction 
enzymes. With human UIC cDNA as a probe, multiple bands were detected in all lanes 
(data not shown). Although some of the bands might represent fragments of a 
functional U1C gene it is plausible that most bands correspond to distinct U1C genes, 
functional or non-functional. 
Because retroposition is most commonly found in mammals, many mammalian 
multigene families contain processed pseudogenes (Werner et al., 1986). A typical 
feature of these pseudogenes is the lack of intervening sequences as they are derived 
from mature mRNAs. In order to detect U1C related sequences within the mouse 
genome a PCR was performed with mouse genomic DNA and primers derived from the 
5' and 3' ends of the coding sequence of human U1C cDNA Analysis of the PCR 
products by agarose gel electrophoresis revealed only one band, approximately 500 bp 
in length (not shown). When the gel was blotted and probed with a UIC oligonucleotide 
a prominent band at about 500 bp position was found hybridizing with the U1C probe. 
Since the UIC coding sequence (477 bp) is highly conserved between man and 
Xenopus (Sillekens era/., 1988; Jantsch and Gall, 1992), the amplified fragments from 
the mouse genomic DNA most likely contain mtronless U1C gene sequences Although 
it cannot be excluded that U1C is encoded by an mtronless gene, the Southern 
hybridization and PCR data on mouse genomic DNA are in agreement with the 
suggested existence of a UIC multigene family in mammals in general and in mice in 
particular. It is conceivable that such a gene family includes UIC processed 
pseudogenes. 
(b) Isolation of two UIC processed pseudogenes and the mouse UIC cDNA 
In parallel, a mouse lymphocyte cDNA library and a mouse genomic library (from cell 
line CCE from strain 129) were screened with 32P-labeled human UIC cDNA as a probe 
(for methods see legend of Figures 1). Four positive cDNA clones were sequenced and 
each appeared to contain a complete or almost complete coding region homologous to 
the human UIC cDNA. These analyses resulted in the murine U1C cDNA sequence as 
given in Figure 1. The sequences of the murine and human U1C cDNAs share about 
86% overall sequence identity, and show 90% homology in their coding regions 
Most differences in the coding region appeared to be wobble substitutions 
From the screening of the genomic library two positive clones with inserts of 
approximately 20 kb (clones 15 and 22) were further analyzed. Fragments of these 
clones, hybridizing with the U1C cDNA probe, were subcloned in pGEM-3Zf(+) and 
sequenced. The results of sequence analyses of the subclones [тС-у/ІЪ and mC-y/22) 
were consistent with the hypothesis that the mouse genome does contain mtronless 
UIC genes. The 874 nt sequence of mC-ψλ 5 is 92% identical to the murine UIC cDNA 
(Figure 1), has no introns and contains an ORF of 471 nt, which is 6 nt shorter than the 
ORF in the murine cDNA In addition, тС-у/УЬ contains a canonical polyadenylation 
signal (AAUAAA) and a poly(A) stretch at the same position as in the 
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murine UIC cDNA. The UIC related sequence of mC-y/\b is flanked by 14 nt long 
direct repeats (AAAAGATACCTTTA) (positions 9-22 and 742-755). Features of the 
murine gene тС-у/УЪ including the absence of introns, the acquisition of a poly(A) tail, 
and the presence of flanking direct repeats, lead to the conclusion that this gene has 
originated from reverse transcription of a mature U1C mRNA followed by integration 
into the mouse genome. This insertion process resulted in the formation of a processed 
pseudogene flanked by a duplicated target site (Maestre et al., 1995). Since the mC-
ψ*\5 direct repeat of nt 9-22 flanks the U1C related sequence exactly at the position 
were the murine cDNA begins, it is conceivable that position 1 of the cDNA represents 
the transcriptional start of the functional murine UIC gene. 
The 579 nt sequence of clone mC-ip22 is for 88% identical to the murine UIC cDNA, 
contains no introns as well, and has a frame shift compared with the ORF in the murine 
UIC cDNA due to deletion of a single nucleotide (Figure 1). Because the downstream 
flanking region of the mouse genomic clone mC-y/22 is not available, the presence of a 
poly(A) stretch and direct repeats cannot be established. However, it is conceivable 
that the Α-rich region in mC-y/22 at position 9-22 corresponds with a repeat similar to 
that in тС-у/УЬ (compare Maestre et al., 1995) Based on the observed absence of 
introns, and the occurrence of a frame shift mutation as well as a number of 
insertions/deletions compared with the murine UIC cDNA we conclude that also mC-
y/22 is a processed pseudogene. 
te) Calculations of evolutionary divergences 
With the divergence of primates and rodents set on 80 Myr ago the rate for 
nonsynonymous substitutions in the human and murine U1C coding regions was 
calculated at 0.02x10 9 substitutions/site/year (method of Li and Graur, 1991) Since 
the average rate in mammalian genes is 0 85x10 9 the UIC gene can be considered as 
extremely conservative in these mammals. Likewise, the rate for synonymous 
substitution in UIC coding sequences was calculated at 4 3 x 1 0 9 which is near the 
average rate of 4.6x10 9 . Similarly large relative differences between the rates for 
synonymous and nonsynonymous substitutions are also described for other highly 
conserved genes, e.g. the human and rodent histon (3/4) and actin (α/β) genes (Li and 
Graur, 1991) 
The approximate time of origin for the pseudogenes тС-цЛЪ and mC-y/22 can be 
estimated with the rate of 5 x 1 0 9 substrtutions/site/year for non-functional sequences 
(Miyata and Yasunaga, 1981). Since pseudogene тС-хуЛЬ differs at 50/705 positions 
[poly(A) excluded] from the murine UIC cDNA sequence, the time of retroposition of 
this pseudogene can be calculated at (50/705)/5x109 « 14 Myr ago The creation time 
for pseudogene тС-ц/22 was estimated at about 25 Myr ago. 
(d) Amino acid sequence comparison of the human, mouse and Xenopus UIC proteins 
and the hypothetical mC-ψΊ 5 and mC-y/22 derived polypeptides 
The U1C protein can be considered evolutionary highly conserved, since the human 
and Xenopus U1C polypeptides share almost 9 1 % sequence identity (Jantsch and Gall, 
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1992; see also Figure 2). The human and Xenopus U1C proteins differ at 15 amino acid 
positions, all located in the C-termmal region of the protein (residues 61-159) The N-
termmal region, i.e. amino acids 1-60, which has been shown to be essential and 
sufficient for U1C to bind to U1 snRNP (Nelissen et al., 1991a) is completely conserved 
between the two species The sequence conservation between human and murine U1C 
is even higher. Although the U1C cDNAs differ at about 10% of the nucleotides, U1C 
proteins of these mammals are identical except for a single residue (position 65, Figure 
2). Almost all nucleotide differences between the murine and human cDNAs (48/49) 
were synonymous substitutions. At all positions where the human and Xenopus U1C 
differ, the human and murine UIC polypeptides are identical. Considering the 
observation that the Xenopus U1C and the U1C proteins from human or murine origin 
solely differ at a number of positions in their C-termmal regions we conclude that during 
evolution selection has taken place against changes in the functionally important N-
terminal region Apparently, the structural requirements of this region are very rigid. The 
functional implications of the C-termmal differences cannot be judged since no function 
has been assigned to the C-terminal region of the protein yet. 
human UIC 
10 20 30 40 50 
MPKFYCDYCDTYLTHDSPSVRKTHCSGRKhKENVKDYYQKVMEEQAQS-LIDKTTAAFQQG 60 
Xenop.UIC MPKFYCDYCDTYLTHDSPSVRKTHCSGRKHKENVKDYYQKWMEEQAQS-LIDKTTAAFQQG 60 
mouse UIC MPKFYCDYCDTYLTHDSPSVRKTHCSGRKHKENVKDYYQKWMEEQAQS-LIDKTTAAFQQG 60 
mC-\yl5 MPKFYCDYCDTYLTHNSIAVRRTNCSGRKHKENVKDCYQKWMEEQAQS-LNDKTTAAFHR- 59 
πΛ-ψ22 MLKFHCDYCDTYLTHDPPSV5KIHCSGRKHKENVKDY5REWMIAQAQTKQIDKTTAAFQQG 60 
human UIC 
70 80 90 100 110 
KIPPTPFSAPPPAGAMIPPPPSLPGPPRPGMMPAPHMGGPPMMPMMGPPP-PGMMPVGPAP 120 
Xenop UIC KIPPTPFAAPPAGSAMIPPPPSLGGPPRPGMMPAPPMAGPPMMPMMGPPP-PGMMPVGHGP 120 
mouse UIC KIPPAPFSAPPPAGAMIPPPPSLPGPPRPGMMPAPHMGGPPMMPMMGPPP-PGMMPVGPAP 120 
mC-\)/15 KIPPAPFSVPPPAGAMIPPP—TMGPPRPGMTPVPHMGGPPMMPMMDTPLLPGMVPVGPAP 118 
mC-4/22 KIPTARFSAPLPAGAMIPPTPSLPSPPQPGMMPASLMEGPPVMPMLGPPP-PGMMDVGPAP 120 
human UIC 
130 140 150 
GMRPPMGGHMPMMPGPPMMRPPARPMMVPTRPGMTRPDR 159 
GMRPPMGAHMPMMPGPPMMRPPTRPMMLQSRPGMARPDR 159 
GMRPPMGGHMPMMPGPPMMRPPARPMMVPTRPGMTRPDR 159 
Xenop. U 1С 
mouse UIC 
ΙΓ€-ψ15 GMRLPMGGHMPMMPGPPMMRPPACPMMVPTWPGMTRPDR 157 
тС-ц/22 GMRQSTGGHMPMMLGPPMMRPPACPKMVPTWP RPDR 156 
Figure 2. Comparison of the ammo acid sequences deduced from the Xenopus UIC cDNA, the 
mouse UIC cDNA and pseudogenes /nC-(/15 and mC-y/ll with the sequence of the human UIC 
cDNA encoded polypeptide All residues in the aligned sequences which are identical to the human 
U1C sequence are underlined The position of a frame shift in mC-ψΙΖ is indicated by a club sign The 
numbers above the sequences correspond to amino acid positions in the cDNA deduced sequences 
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It should be noted that in one of the murine UIC cDNA clones a nucleotide substitution 
was observed at position 6 1 . The thymidine that was found in the other three cDNA 
clones (Figure 1) was substituted by an adenosine, which leads to a replacement of a D 
by an E residue at position 10 of the deduced polypeptide. Although we cannot judge 
whether this substitution is the result of allelic variation or of a rare polymerase error 
during cDNA synthesis, we favor the former possibility since a rather subtle ammo acid 
change from D to E conceivably would not influence the function of the U1C N-terminal 
domain. Nevertheless, such a substitution is an interesting observation in a region of 
UIC that appears evolutionary so highly conserved. 
The ammo acid sequences deduced from pseudogenes тС-іу15 and mC-y/22 are 
respectively 2 and 3 residues shorter than the murine U1C protein. In addition, both of 
the deduced polypeptides differ at more than 20 positions from U1C (Figure 2) due to a 
number of mutations at the nucleotide level. Since σιΟ-ψ22 contains a frame shift 
mutation at codon 42 of the U1C related ORF, this gene will not be the source of 
transcripts for functional UIC polypeptides In contrast, mC-i/15 does contain an ORF 
corresponding to the ORF in the murine UIC cDNA. This raises the question whether 
the coding sequence of mC-i//'\5 could lead to the synthesis of a functional mouse U1C 
protein For two reasons this is highly unlikely: a) insertion of a retroposon derived from 
a correctly initiated mRNA will almost always lead to the generation of an inactive 
pseudogene, since essential promoter elements for RNA polymerase II transcription are 
located upstream from the transcriptional initiation site; b) in the rare case that the 
sequence of mC-y/'\5 would have been inserted into the mouse genome downstream of 
a functional promoter of another gene, synthesis of a polypeptide derived from its 
coding sequence would be feasible. However, the putative mC-i|/15 translation product 
is not expected to bind to U1 snRNP, due to the substitution of the essential histidme 
residue at position 24 (Nehssen et al., 1991). Binding to U1 snRNP might not only be 
required for U1C activity in splicing, but also for translocation to the nucleus as 
suggested by Jantsch and Gall (1992). 
(e) Conclusions 
(1) For the murine U1 snRNP-specific С protein at least two mtronless pseudogenes 
exist, i.e. тС-уЛЪ and mC-y/Z2, in addition to one or more yet unidentified, functional 
genes. This demonstrates the existence of a murine UIC multigene family and supports 
the suggested existence of such a genomic organization for the mammalian U1C in 
general. Retroposition of the processed pseudogenes тС-уАЪ and mC-y/Zl from 
functional UIC transcripts has taken place about 14 an 25 Myr ago, respectively. 
(2) The calculated rate for nonsynonymous substitutions in the UIC coding region 
(comparison man/mouse) points to a very high conservation of the gene during 
evolution. 
(3) The human, murine, and Xenopus U1C proteins share a completely conserved N-
termmal region which indicates that the structure/function of this domain is not tolerant 
to amino acid substitutions. 
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(4) As a result of the substitution of histidme-24 in the hypothetical mC-vj/15 
polypeptide, expression of pseudogene тС-уАЪ, if transcribed at all, is not expected to 
lead to functional U1C protein 
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ABSTRACT 
The U1 snRNP-specific protein С contains an N-terminal zinc finger-like CH motif which 
is required for the binding of the U1C protein to the U1 snRNP particle. Recently a 
similar motif was reported to be essential for in vivo homodimerization of the yeast 
splicing factor PRP9. In the present study we demonstrate that the human U1C protein 
is able to form homodimers as well U1C homodimers are found when i) the human 
UIC protein is expressed in E. coli, ti) immunoprecipitations with anti-U1C antibodies are 
performed on in vitro translated U1C, and when Hi) the yeast two hybrid system is 
used. Analyses of mutant U1C proteins in an in vitro dimenzation assay and the yeast 
two hybrid system revealed that ammo acids within the CH motif, i.e. between 
positions 22 and 30, are required for homodimerization. 
INTRODUCTION 
During the process of pre-mRNA splicing, the U1 snRNP particle binds to the 5' splice 
site of the pre-mRNA resulting in the formation of a commitment complex (1). In 
addition to the so-called common or Sm proteins (2) which are also present in the U2, 
U4 and U5 snRNPs, U1 snRNP contains three specific proteins denoted U1-70K, U1A 
and U1C (2, 3). For its activity in splicing both the U1 RNA and protein components are 
known to be needed but the precise function in the splicing process of the latter is only 
poorly understood (1-5). Recently rt was shown by in vitro studies that the U1-70K 
protein plays an essential role in splicing, a role in which the phosphorylation state of 
the protein appears to be crucial (6) 
With regard to the U1C protein Heinrichs and coworkers (7) performed a functional 
study in which the pre-mRNA binding capacity of U1 snRNP particles containing or 
lacking the U1C protein was compared in an in vitro assay. U1 snRNPs lacking the U1C 
protein bound to the pre-mRNA 5' splice site with only 40% efficiency as compared 
with complete U1 snRNPs. Binding efficiency could be restored to wild type levels by 
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adding purified HeLa U1C protein. These results suggested that the U1C protein is 
involved in the binding of the U1 snRNP particle to the 5' splice site. 
In contrast to the U1-70K and U1A protein, the U1C protein does not contain an RNP or 
RNA recognition motif (8). Lacking such a motif, the U1C protein can only bind to the 
U1 snRNP particle when the U1-70K and common proteins are already associated with 
the U1 RNA (9). The N-terminal region of U1C, containing a zinc finger-like sequence 
which resembles the CC-HH zinc fingers of the TFIIIa type, is required and sufficient for 
this interaction (10). Similar CH motifs have been observed in the yeast splicing proteins 
PRP6, PRP9, and PRP11 (11, 12). Neither one of the proteins UIC, PRP6, PRP9, or 
PRP11, however, has actually been shown to bind zinc. Recently, Legrain and 
coworkers (13) demonstrated in the yeast two hybrid system that the two CH motifs in 
the PRP9 protein are required for the formation of PRP9 homodimers. 
In the present study we show that the human U1C protein is able to form homodimers 
as well. U1C dimers were detected in preparations of human U1C protein expressed in 
£ coli and dimerization could be induced with in vitro translated U1C. In both an in vitro 
dimerization assay and the yeast two hybrid system it could be demonstrated that 
amino acid residues between positions 22 and 30 are required for dimerization. 
MATERIALS AND METHODS 
Expression and purification of (his)e-tagged human U1C protein in E. cot 
Using site directed mutagenesis an /Vtfel site was introduced at the translational start 
codon of the human U1C cDNA, which was cloned into pGEM-3Zf( + ). By PCR the 
translational stop codon of the (Λ/tfeDUIC cDNA was replaced by the codons of six 
histidine residues, followed by a stop codon and a BamYW site. Subsequently the 
U1C(his)e cDNA was recloned as an NdeUBamHl fragment into the expression vector 
pET-3b (14) and with this construct E coli strain BL21(DE3)pLysS (15) was 
transformed. The human U1C(his)e protein was overexpressed (16), followed by freeze-
thawing and sonication of the cells in 10 ml PBS with 0.5 mM PMSF, 10 mM MgCI2 
and 0.5 mg DNase I. After centrifugation all U1C(his)e was present in the non-soluble 
fraction which could be dissolved in 8M urea. In the text the solubilized U1C(his)e 
fraction is referred to as U1C(his)e bacterial extract. A control extract was prepared 
from BL21 (DE3)pLysS transformed with pET-3b lacking the UIC cDNA. 
The U1C(his)e protein was purified from the bacterial extract following the procedures 
described by Janknecht et al. (17) and Schmitt et al. (18). U1C(his)e bacterial extract 
was incubated batchwise at 20°C with Ni-NTA-agarose beads (Qiagen) and IPP10o И0 
mM Tris-HCI pH 8.0; 100 mM NaCI; 0.05% NP-40). Proteins bound to the Ni-groups 
were eluted batchwise by incubating the beads two times during 5 min with elution 
buffer D (10 mM HEPES pH 7.9; 5 mM MgCI2; 0.1 mM EDTA; 50 mM NaCI; 17% 
glycerol (v/v); 1 mM DTE; 1 mM PMSF; 10 mM NaF) containing increasing 
concentrations of imidazole: 40 mM, 60 mM, 200 mM, 500 mM. When the purification 
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was performed under non-reducing conditions, DTE was omrtted from the elution 
buffer. 
Site directed mutagenesis 
Single stranded DNA of the U1C cDNA cloned into pGEM-3Zf( + ) was produced with 
the helper phage M13K07 Point mutations were introduced into the cDNA using the 
oligo-directed mutagenesis system kit from Amersham and checked by sequencing. 
In vitro transcription and translation 
To produce T7-U1C mRNA for translation, 1 цд of linearized template was transcribed 
in essentially the same manner as described by Scherly et al. (19). The cDNA encoding 
U1C was recloned in pGEM-3Zf( + ) (Promega) lacking a functional BamH\ site, as 
described previously (10). To produce 35S-labeled U1C protein or derivatives thereof, 
200 ng (2 μΙ) of the corresponding T7-mRNA were incubated with wheat germ extract 
(Amersham) and 35S-methionme (Amersham) in essentially the same manner as 
described by Scherly et al. (19). 
Truncated С proteins 
To produce templates for the truncated human U1C proteins containing amino acids 23-
159, and 30-159, the codons for residues 21/22 or 28/29 in the U1C cDNA were 
replaced by a BamH\ site (contains codons for Gly and Ser) using the site directed 
mutagenesis technique. The U1C sequences coding for residues 23-159 and 30-159, 
respectively, were subcloned as BamH\IHind\\\ fragments directly behind the start codon 
of the mutant U1A (2/3) construct, in which codons for residues 2 and 3 were replaced 
by a BamH\ site (20). Except for the U1A start codon the new U1C constructs do not 
contain any other U1A codons. 
In vitro U1C dimerization assay 
U1C(his)e containing bacterial extract (15 μΙ) was incubated for 1 h at 20°C with 20 μΙ 
Ni-NTA-agarose (50% slurry) and 30 μΙ ΙΡΡ150· The beads were washed three times 
with 0.5 ml IPP1S0, resuspended in 20 μΙ ΙΡΡ,50 and incubated for 1 h at 20°C with 2 μΙ 
in vitro translated 35S-labeled U1C protein, or mutants thereof. Non-bound protein was 
removed by extensive washing with IPP150- All 35S-labeled U1C associated with 
U1C(his)e protein bound to Ni-groups was eluted by incubating the beads with 20 μΙ 
elution buffer D containing 200 mM imidazole, but lacking DTE. The U1C(his)6 was 
present in excess over the 35S-labeled U1C protein, because when more 35S-labeled 
U1C was added to the assay also more 35S-labeled U1C could be precipitated (data not 
shown). The elution fractions were separated on an SDS-polyacrylamide gel. When 
separation was performed under non-reducing conditions the ß-mercaptoethanol (5%) 
was omitted from the sample buffer. 
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Immunodetection of UI snRNP proteins on Western blot 
U1 snRNP proteins transferred to nitrocellulose were detected by immunostaining with 
monoclonal (mouse) and monospecific (rabbit) antibodies specifically directed against 
U1 snRNP proteins, and with phosphatase-conjugated second antibodies as described 
by Lehmeier et al. (21). The monoclonal mouse antibodies used were directed against 
the U1-70K (H111) (22), U1A (9A9) (23), B/B' (KSm5) and D1 (KSm2) (24) proteins. 
Monospecific rabbit antibodies specifically raised against a peptide or recombinant 
fragment of the respective antigen, were used to detect the U1C, D3, D2, F and G (25) 
protein. Anti-(his)e antibodies were raised by immunizing a rabbit with (his)e coupled to 
BSA (Euro-Diagnostica B.V., Apeldoorn, The Netherlands). The anti-(his)e-tag antibodies 
do recognize U1C(his)e protein but not U1C protein lacking the (his)e-tag. 
Detection of U1C homodimers using the yeast two hybrid system 
Cloning of the U1C fusion proteins. A cloned human U1C cDNA (26) was used as a 
template for PCR amplification with different primers The resulting DNA fragments 
encode the wild type U1C protein or various N-termma! deletion mutants (corresponding 
to U1C(63-159), U1C(23-159) and U1C(30-159), see figure 4A). These DNAs were 
cloned in the pAS2 plasmid, allowing synthesis of corresponding fusion proteins with 
the Gal4 DNA binding domain (Gal4BD). The wild type amplified DNA fragment was 
also cloned in the pACTII plasmid for production of fusion protein with the Gal4 
activator domain (Gal4AD, 27, 28). Sequences of PCR amplified fragments were 
verified. 
Yeast manipulations. Yeast cells were grown and transformed according to standard 
procedures The Y526 yeast strain [MATa, his3-, ade2-, Iys2-, trp1-, Ieu2-, canR, gal4-, 
gal80-, URA"GAL1-lacZ) was transformed with the two plasmids and transformants 
were selected on minimal medium lacking leucine and tryptophan and assayed for ß-
galactosidase activity using a filter assay with X-gal Several colonies were streaked 
and cells were grown in liquid cultures to perform quantitative ß-galactosidase assays 
(13). 
RESULTS 
Expression and functionality of recombinant U1C(his)6 protein 
To investigate whether U1C is able to form homodimers, the human UIC protein with a 
C-terminal tag of six histidine residues, was expressed in E coli. The expressed 
U1C(his)6 protein was detected on a Coomassie Brilliant Blue stained SDS-
polyacrylamide gel as a prominent 21 kD band, which was not present in a control 
extract of bacteria lacking U1C(his)e. This 21 kD band corresponds with the expected 
mobility of the U1C protein from HeLa cells (26) and is immunologically recognized on a 
Western blot by anti-U1C monospecific antibodies directed to the CH motif of the 
protein and by anti-(his)e polyclonal antibodies (data not shown) Both antibodies did not 
crossreact with bacterial proteins Interestingly, a band of approximately 42 kD was 
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also detected with both antibodies. The characterization of this band will be discussed 
below. 
The U1C(his)e protein was purified from the extract with Ni-NTA-agarose. Proteins 
bound to the Ni-NTA-groups were specifically eluted with increasing imidazole 
concentrations. The U1C(his)e protein was eluted most efficiently at a concentration of 
200 mM imidazole (data not shown). The purified U1C(his)e protein seems to be 
functional since it is capable of competing with in vitro translated 35S-labeled U1C 
protein for binding to U1 snRNPs (data not shown) m an S100 reconstitution assay as 
described previously (10). 
Recombinant human UIC protein is able to forni homodimers 
Based on the immunostaining of a 42 kD band as described above, we hypothesized 
that the 42 kD complex might represent a U1C(his)e homodimer. To detect the putative 
U1C(his)6 dimer band on a Coomassie stained gel as well, the purification with Ni-NTA-
agarose was repeated under non-reducing conditions, i.e. without DTE in the bacterial 
extract and elution buffers. Subsequently, samples of the elution fractions were 
separated under non-reducing conditions, ι e ß-mercaptoethanol was omitted from the 
sample buffer, on an SDS-polyacrylamide gel (Figure 1A). Following this procedure 
about 90% of the U1C(his)e in the bacterial extract was retained on the Ni-NTA-
agarose beads (compare lanes 2 and 3) Most of the eluted U1C(his)e is present in the 
200 mM imidazole elution fraction (lane 6) but at 500 mM imidazole a considerable 
amount of U1C(his)e was eluted as well (lane 7). The bands which migrate at about 12 
kD and 16 kD most likely represent distinct U1C degradation products. Figure 1A (lanes 
5-7) demonstrates that under non-reducing conditions the putative U1C(his)e 
homodimer of 42 kD indeed can be detected on a Coomassie stained gel. The finding 
that this band is only present in the imidazole eluted protein preparation under non-
reducing conditions suggests that the 42 kD band corresponds to a complex of proteins 
held together by one or more disulfide bridges. 
To provide more evidence for the presence of the U1C(his)e protein in the 42 kD 
complex, U1C(his)e bacterial extract was separated on an SDS-polyacrylamide gel 
under non-reducing conditions As a control, bacterial extract lacking U1C(his)6 was 
separated on the same gel. With reference to the markers a gel piece from the lanes of 
both extracts was cut out of the gel at the position of the 42 kD band and extracted 
with standard reducing SDS sample buffer. Both samples were separated on an SDS-
polyacrylamide gel and Western blotted. Figure 1B shows the Western blot 
immunostamed with monospecific antibodies directed to the U1C protein. With 
antibodies directed to the (his)e-tag similar results were obtained (not shown). In the 
control lane (lane 1) no proteins were detected with anti-UIC antibodies The 42 kD 
complex from the U1C(his)e bacterial extract, however, could partly be reduced to 
U1C(his)e monomers, migrating at 21 kD (Figure IB, lane 2) A similar result was 
obtained when purified, non-reduced U1C(his)e (200 mM imidazole elution fraction; 
Figure 1A, lane 6) was pre-incubated with 25 mM DTE and separated by SDS-PAGE in 
the presence of DTE (data not shown). These results indicate that the U1C(his)6 protein 
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Figure 1. Detection of U1C(his)6 homodimers. 
(A) Purification under non-reducing conditions of recombinant U1C(his)6. Coomassie Brilliant Blue 
stained 10% SDS-polyacrylamide gel: Lane 1: Protein molecular weight markers. Lane 2: 1 μΙ 
U1C(his)6 bacterial extract, of which 2.5 ml were used for purification of U1C(his)6. Lane 3: 3 μΙ of 
the supernatant containing the proteins which did not bind to the Ni-NTA-agarose. The U1C(his)6 
protein was eluted batchwise with increasing concentration of imidazole. Of the elution fractions (2 
ml in volume each) 10 μΙ was separated on gel: Lane 4: 40 mM imidazole fraction; lane 5: 60 mM 
imidazole fraction; lane 6: 200 mM imidazole fraction; lane 7: 500 mM imidazole fraction; lane 8: 1 % 
of the proteins which were still associated with the Ni-NTA-agarose beads after the elution procedure, 
dissolved in SDS sample buffer. (B) Immunostaining of Western blot with the excised, non-reduced 
42 kD band (band I) after separation under reducing conditions. U1C(his)6 containing bacterial extract 
(20 μΙ) and bacterial extract lacking U1C(his)6 (20 μΙ) were separated by non-reducing SDS-PAGE. 
From the lanes of both extracts a gel piece was excised at the position of 42 kD (band I) which was 
crushed and analyzed on a reducing 15% SDS-polyacrylamide gel. Proteins were transferred to 
nitrocellulose and immunostained with monospecific anti-U1C antibodies. Lane 1: Proteins from 
bacterial extract lacking U1C(his)6 at a position that corresponds with band I [l(be)1. Lane 2: band I 
from bacterial extract containing U1C(his)6 [l(be + C)]. 
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expressed ¡η E coli indeed is able to form homodimers, which might be stabilized by 
one ore more disulfide bridges. Apparently not all of the U1C(his)e dimers were reduced 
in the experiment of Figure 1B since the 4 2 kD band still could be detected. This may 
be due to the relatively high concentration of the recombinant U1C protein or limited 
accessibility of a disulfide bridge. 
In vitro translated UIC forms homodimers as well 
In order to test whether U1C homodimers also can be detected when the protein is 
synthesized in vitro w e ¡mmunoprecipitated 35S-labeled U1C translated in wheat germ 
extract using polyclonal anti-U1C antibodies. Figure 2, lane 3 indicates that indeed a 
complex at the dimer position is precipitated. As a control the U1C dinner obtained in 
our in vitro dimerization assay (see below) was used (Figure 2, lane 4). The dimer from 
the in vitro U1C translation migrates somewhat faster than the dimer generated in the 
dimerization assay (Figure 2, compare lanes 3 and 4) because the in vitro translated 
protein lacks a (his)6-tag. 
No dimers were observed when the U1C translation mixture was separated by non-
reducing SDS-PAGE (Figure 2, lane 2). 
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Figure 2. Immunoprecipitation of in vitro translated U1C. 
In vitro translated U1C (2 μΙ) was incubated for 90 min at 20°C with polyclonal anti-U1C antibodies 
coupled to protein-Α agarose beads (Biozym) in a final volume of 40 μΙ ΙΡΡι50· T h e beads were 
washed three times with IPP150 and resuspended in non-reducing SDS sample buffer. The 
supernatants were separated on a 10% SDS-polyacrylamide gel. Lane 1: Protein molecular weight 
markers; lane 2: 10% of the input of in vitro translated 35S-labeled U1C; lane 3: immunoprecipitation 
of 2 μΙ in vitro translated U1C via polyclonal anti-U1C antibodies; lane 4: control lane with the dimer 
obtained from the in vitro dimerization assay (see Figure 3). 
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The dimerization assay 
An in vitro dimerization assay was developed in which the dimerization between 
U1C(his)e expressed in £ coli and in vitro translated 35S-labeled U1C could be analyzed 
in more detail (Figure ЗА). 
In this assay, U1C(his)e from a bacterial extract was coupled to Ni-NTA-agarose beads. 
All non-bound proteins were removed by extensive washing of the beads. Based on the 
results obtained by SDS-PAGE analyses shown above we can assume that U1C(his)e is 
present on the Ni-beads as a mixture of monomers and dimers The U1C(his)e-Ni-beads 
were then incubated with in vitro translated ^S-labeled human U1C protein lacking a 
(his)6-tag. Following several wash steps the bound U1C(his)e and the 35S-labeled U1C 
associated with it, were specifically eluted with 200 mM imidazole. As a negative 
control the 35S-labeled U1C was added to Ni-NTA-agarose beads pre-mcubated with 
bacterial extract lacking U1C(his)e. 
One sample of each elution fraction was analyzed on a standard reducing SDS-
polyacrylamide gel, another sample on a non-reducing gel, i.e. in the absence of ß-
mercaptoethanol Figure 3B, lane 2 demonstrates that a 35S-labeled protein(complex) of 
approximately 41 kD is eluted in the absence of a reducing agent. Since the 41 kD band 
was never observed in the control assays (lanes 3 and 5) it is most likely to conclude 
that the 41 kD complex corresponds to a dimer formed by U1C(his)e and 35S-labeled 
U1C (this dimer thus migrates somewhat faster than the 42 kD U1C(his)e homodimer). 
As expected the 35S-labeled 41 kD complex is destabilized under reducing SDS-PAGE 
conditions and only U1C monomers can be detected (lane 4) The eluted 35S-labeled 
U1C monomers seen in lanes 2 and 4 are probably generated by background binding of 
3SS-labeled U1C to Ni-agarose associated bacterial proteins (see background lanes 3 and 
5) and by destabilization of eluted dimers. 
Amino acids between positions 22 and 30 are required for homodimerizatíon 
To determine which part of the U1C protein is involved in dimer formation 35S-labeled 
U1C mutant proteins (Figure 4A) were tested in the in vitro dimerization assay. The 
mutant U1C, «, is known to bind to U1 snRNP with comparable efficiency as the wild 
type protein (9). The U1C substitution mutants (s24) and (s30), in which a histidme 
residue is substituted by a glutamme, were previously reported to have lost their ability 
to bind to U1 snRNP. In contrast, substitution of the Cys-25 by Ser-25 (mutant s25) did 
not affect binding to U1 snRNP (10). Additionally, a double point mutant was made in 
which the codons for the residues Arg-21/Lys-22 were substituted by a BamH\ site, 
which codes for glycine/serine This mutant U1C(s21/22) cannot bind to U1 snRNP 
(data not shown). Following the incubation of an 35S-labeled mutant U1C protein in the 
dimerization assay the 200 mM imidazole elution fraction was analyzed on an SDS-
polyacrylamide gel under non-reducing conditions. Wild type U1C protein was included 
as a positive control (Figure 4B). 
The U1C i e o protein seems to dimenze with U1C(his)6 almost as efficient as the wild 
type protein. The N-termmal domain, containing the zinc finger-like region thus appears 
to be sufficient for in vitro dimerization Further analyses of N-terminal deletion mutants 
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Figure 3. The dimenzation assay. 
(A) Scheme of the in vitro U1C dimerization 
assay. U1C(his)6 from bacterial extract was 
coupled to Ni-NTA-agarose beads. The 
U1C(his)6-beads were incubated with in vitro 
translated 35S-labeled U1C protein or 
mutants thereof and precipitated 35S-labeled 
protein was eluted from the beads with 200 
mM imidazole containing elution buffers. The 
eluted 35S-labeled protein was visualized by 
SDS-PAGE followed by autoradiography. (B) 
Dimerization of 35S-labeled U1C and 
recombinant U1C(his)6. Lane 1: 10% of the 
input of in vitro translated 35S-labeled U1C 
protein. Lanes 2 and 3: Non-reductive 
separation of 35S-labeled U1C eluted from 
beads containing or lacking U1C(his)6, 
respectively; lanes 4 and 5: as lanes 2 and 
3, but analyzed by SDS-PAGE with sample 
buffer containing 5% ß-mercaptoethanol. 
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Figure 4 (opposite page). In vitro dimenzation of S-labeled UIC or mutants thereof and U1C(his)6 
immobilized on Ni-NTA-agarose 
As a control the 3SS-labeled proteins were tested with Ni-beads which were preincubated with 
bacterial extract lacking U1C(his)6 (A) Schematic representation of the mutant proteins derived from 
the wild type human UIC protein The ammo acid numbers are indicated The shaded box represents 
the proline and methionine rich C-termmal domain, starting at residue 61 Dark-grey boxes indicate 
the position at which an ammo acid is substituted by another residue (UIC mutants (s25) 
substitution of cysteine by serine, (s24) and (s30) substitution of histidine by glutamme, (s21/22) 
substitution of arginine/lysine by glycine/senne) (B) 200 mM imidazole elution fractions of 35S-labeled 
U1C (wild type) and U1C mutants tested in the dimenzation assay and separated by non-reducing 
SDS-PAGE Lanes 1: 10% of the 2 μΙ input of in vitro translated 35S-labeled U1С protein (wild type or 
mutant), lanes 2 and 3. 35S-labeled U1C (wild type or mutant) eluted from beads containing ( + C) or 
lacking U1C(his)e (-C), respectively The assay was performed with the mutant proteins U1C1 6 0, 
U1C23_159, U1C30.,59, U1C(s21/22), U1C(s24), U1C(s25), and U1C(s30), respectively. 
show that the first 22 amino acids, which encompass the two conserved cysteines of 
the zinc finger-like region, are not essential for dimenzation. The mutant protein 
U1C 2 3 1 5 9 still is able to dimenze with U1C(his)e whereas U1C 3 0 1 5 9 has completely lost 
its ability to interact with U1C(his)„ [Figure 4B, lanes 2 of (23-159) and (30-159)]. All 
the mutations which previously were shown to abolish binding to U1 snRNP hardly or 
only moderately interfered with dimenzation in this assay [Figure 4B, lanes 2 of 
(s21/22), (s24), (s30)]. When Cys-25 is substituted, no stable dimers can be detected 
after SDS-PAGE (Figure 4B, lane 2 of s25), indicating that Cys-25 is most likely the 
residue responsible for disulfide bridge formation between two U1C proteins. However, 
as for all dimenzing UIC dérivâtes, incubation of mutant s25 leads to a specific 
monomenc signal (Figure 4B, lanes 2). These results suggest that s25 is able to form 
homodimers purely as a result of non-covalent interactions which are disrupted during 
SDS-PAGE. 
The N-termmal deletion mutant U1C23159 for some reason gives a higher monomer 
background in the dimenzation assay. At the moment we have no explanation for this 
phenomenon. 
Similar results were obtained when in vitro translated 3SS-labeled mutant U1C proteins 
were immunoprecipitated via polyclonal anti-U1C antibodies, as in the experiment of 
Figure 2 (data not shown). 
UIC homodimers are detected in the yeast two hybrid assay 
To verify the results of our in vitro assays, we used the two hybrid assay in yeast 
which allows the detection of protein-protein interactions in vivo (29). When the two 
U1C wild type fusion proteins were expressed in yeast, ß-galactosidase activity was 
detected using a qualitative X-gal conversion assay (data not shown). This was specific 
since the production of any of the two fusion proteins in combination with an irrelevant 
protein did not induce ß-galactosidase synthesis. However, transformants grew slowly 
and, when primary transformants were streaked on plates, fast growing variants were 
often recovered which were systematically negative in an X-gal conversion assay. 
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Figure 5 Analysis of U1С dimers in the yeast two hybnd assay. 
Fusion proteins expressed by the cells are indicated below the histograms (Gal4AD fusion 
protein/Gal4BD fusion protein) Five independent transformants were streaked for each expenment 
PRP21 is a yeast splicing factor (28) Assays were done in duplicate for each transformant and the 
values were within a 1 0 % variation range 
To analyze in more detail the formation of U1C protein homodimers, several versions of 
the U1C protein fused to the Gal4 DNA binding domain were assayed in combination 
with the wild type U1C partner fused to the Gal4 activation domain. In Figure 5 it is 
shown that dimers are formed between wild type and U1C2 3 1 59 proteins and resulting 
ß-galactosidase activities are comparable or even higher than those detected for the 
wild type homodimer. The various clones exhibited different activities, probably 
reflecting a variable amount of negative variants arising during the liquid culture When 
the wild type U1C fused to the GAL4 activation domain was replaced by an irrelevant 
protein such as PRP21, no ß-galactosidase activity was observed indicating that the 
activity measured for the combination of the wild type U1C and the U1C23159 proteins 
very likely reflects the formation of a dimer. Similarly, the co-expression of the wild 
type UIC protein in combination with и іСзо 1 5 9 , U1Ce 3 1 69 or an irrelevant protein did 
not lead to any detectable ß-galactosidase activity. A number of U1C point mutants 
(s6, s9, s24, s25 and s30) were tested in the yeast two hybrid assay as well These 
mutants also showed dimer formation in vivo (data not shown). Our results suggest 
that in the yeast two hybrid system non-covalent interactions are sufficient for UIC 
dimerization. We conclude that in the two hybrid assay U1C homodimers are detected 
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and that their assembly points t o a functional region between the amino acid residues 
22 and 3 0 , which is in agreement w i t h the results obtained w i t h our dimerization assay. 
Are UIC homodimers present in HeLa U1 snRNPs? 
Assuming that dimerization of the human U1C protein has functional implications, it 
would be interesting to investigate whether U1C dimers are present in U1 snRNP 
particles as wel l . For the detection of U1C homodimers in U1 snRNPs, U1 particles 
were purified from HeLa cells as described by Bach et al. (30) and its protein 
components were separated on a reducing and a non-reducing SDS-polyacrylamide gel 
followed by Western blotting (Figure 6). 
REDUCING 
67 kD 
43 
•30 
2 0 
14 
i 
: 
• 
1 . 
i 
г з 4 . 
ι 
ι 
: 
3 
1 
1 
1 
1 
5 7 8 9 
70K 
A 
B
'B 
С 
)3p 
F 
G 
NON-REDUCING 
i : 
I 
í 
• 
Ί 
I 
, I 
* 
I 
ί 
ι 
ι . 
І 
•j! 
1 2 3 4 5 6 7 £ 
. 
ê 
• 
• 
, 
i 9 
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Figure 6. Detection of U1C dimers in U1 snRNPs by immunostaining. 
Native U1 snRNPs were isolated from HeLa cells by ¡mmunoaffinity chromatography followed by 
Mono Q chromatography as described by Bach et al. (30) (generous gift of С Will and R. Lührmann, 
Marburg). 
Approximately 50 μg U1 snRNPs (protein weight) were separated on a 10% SDS/high TEMED-
polyacrylamide gel under reducing or non-reducing conditions and transferred to nitrocellulose. The 
nitrocellulose lanes were cut into strips and each strip was ¡mmunostained with a monoclonal or 
monospecific antibody directed to the U1 snRNP proteins U1-70K (lanes 1), U1A (lanes 2), Sm-B/B' 
(lanes 3), U1C (lanes 4), Sm-D3 (lanes 5), Sm-D2 (lanes 6), Sm-D1 (lanes 7), Sm-F (lanes 8), and 
Sm-G (lanes 9), respectively. Left panel: U1 snRNP proteins separated under reducing conditions; 
right panel: U1 snRNP proteins separated under non-reducing conditions. The arrowhead indicates the 
position of the U1C homodimer. 
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Individual U1 snRNP proteins were visualized on the blot by immunostainmg with 
monoclonal or monospecific antibodies specifically raised against particular U1 snRNP 
proteins, except for Sm-E, as described previously (9). Under reducing conditions the 
U1C protein was detected as a monomer migrating at a position of 21 kD However, 
under non-reducing conditions not only U1C monomers were detected with 
monospecific anti-U1C antibodies, but also a band of approximately 42 kD which 
corresponds to the expected molecular weight of U1C homodimers (Figure 6, lane 4). 
Since none of the other antibodies stained a protem(complex) at the same position, 
these results suggest that U1C homodimers indeed are present in HeLa U1 snRNPs 
Because the experiment was performed under conditions which are not favourable to 
interparticle interactions (22) the possibility of such interactions involving the UIC 
protein seems unlikely We were not able to detect dimers in U1 snRNP particles 
purified from HeLa S100 extract using sucrose gradient centrifugation (data not 
shown) We do not know whether U1C dimers are not present in this U1 snRNP 
population or that dimers have already been reduced to monomers due to the isolation 
and separation procedures. 
DISCUSSION 
Our results demonstrate that the human U1 snRNP-specific protein С is able to form 
homodimers. The finding that the residues between positions 22 and 30 within the CH-
motif are necessary for dimenzation, as shown in an in vitro dimenzation assay and in 
the yeast two hybrid system, is in principle in agreement with the reported involvement 
of the two zinc finger-like motifs in the homodimenzation of the yeast splicing factor 
PRP9 (13). Legram and coworkers observed in the yeast two hybrid system that 
homodimenzation of PRP9, mutated in the conserved cysteine and histidme residues of 
the CH motif, was reduced with at least one order of magnitude Our mutational 
analysis of the U1C zinc finger-like region in both our dimenzation assay and the yeast 
two hybrid system showed that the amino acids between positions 22 and 30 are 
important for homodimenzation. The conserved cysteines at positions 6 and 9 seem 
less important since deletion of the N-terminal 22 ammo acids did not affect 
dimenzation in the in vitro dimenzation assay (Figure 4) and the yeast two hybrid 
system (Figure 5). Further analyses of point mutants within the region between amino 
acids 22 and 30 of the U1C protein showed that the residues which previously had 
been indicated to be important for binding of the U1 snRNP particle (10), seem less 
important for homodimenzation Substitution of the conserved histidme residues in the 
CH motif (amino acids 24 and 30) hardly or only moderately affected the dimenzation 
efficiency in our dimenzation assay (Figure 4B) Based on these observations and the 
finding that dimers are stable under non-reducing SDS-PAGE conditions, we conclude 
that in vitro residue Cys-25 is likely to be involved in the formation of a disulfide bridge 
between two UIC molecules. This conclusion is in concert with data reported by 
Benezra (31) who showed that E2A proteins, a subfamily of the basic hehx-loop-helix 
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family of DNA-binding proteins, form homodimers that are linked via a disulfide bond. 
However, the appearance of relatively high monomer signals in our dimenzation assay 
(Figure 4B) do indicate that non-covalent interactions are involved in dimer formation as 
well. 
We were also able to show the formation of UIC dimers with in vitro translated U1C. 
When a UIC translation mixture was separated by non-reducing SDS-PAGE no dimers 
were observed (Figure 2, lane 2). However, U1C dimers could be detected after 
immunoprecipitation with anti-U1C antibodies (Figure 2, lane 3). Since formation of 
dimers most likely depends on the concentration of the monomer protein, dimenzation 
might be facilitated by binding of U1C to the bivalent antibodies. Alternatively, the 
binding of the antibodies could stimulate the UIC protein to adopt its native structure 
Such antibody assisted protein folding has been demonstrated by Carlson and Yarmush 
for the ribonuclease A S-protem (32). A third possibility is that the cell-free translation 
system contains a component that prevents dimer formation, as indeed has been 
suggested by Benezra (31). By immunoprecipitation of U1C this component might be 
separated efficiently from the U1C protein. 
Our data indicate that the U1C protein can form homodimers in vivo as well. This was 
shown in the yeast two hybrid assay (Figure 5). Using this system the importance of 
the amino acids 23-29 of the U1C protein for dimer formation was corroborated. 
Indeed, the absolute values of ß-galactosidase activity are low compared to those found 
for other homodimers detected with the yeast two hybrid assay, such as PRP9 (40 
units, reference 28). Nevertheless, the positive results with the U1C protein were 
reproducibly found. It should be stressed that in the case of homodimerizatìon, an 
inhibition of productive interactions may occur due to the formation of true homodimers 
between identical fusion proteins. The exact nature of the link between the two UIC 
monomers in vivo is not precisely known. In our in vitro experiments the formation of a 
disulfide bridge in addition to non-covalent interactions is necessary for the detection of 
U1C dimers after SDS-PAGE, as has been discussed above. In the yeast two hybrid 
system probably only non-covalent interactions between the two monomers exist as 
has been suggested by the positive results obtained with the U1C point mutants. But 
also in vivo such non-covalent interactions are primarily mediated by ammo acid 
residues between positions 22 and 30. 
The data shown in Figure 6 suggest that at least a considerable portion of the UIC 
protein from purified HeLa U1 snRNPs is present in dimers stabilized by a disulfide 
bridge. Part of the putative U1C dimers from HeLa Ul snRNPs may have been reduced 
during the preparation of the particles for which DTT-contaming buffers were used (30) 
which may lead to an underrepresentation of dimers. We do not know whether the 
disulfide bridges are actually present in U1 snRNP particles or that they are formed 
during the snRNP isolation procedure. It is likely that the dimers are formed by non-
covalent interactions which subsequently might facilitate the formation of a disulfide 
bridge Our data are in agreement with the estimated stoichiometry for U1 snRNPs as 
proposed by Feeney et al. (33) who predicted the presence of two U1C molecules per 
U1 snRNP particle. 
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Since the U1C homodimer might be present in U1 snRNP particles in vivo, as suggested 
by the results of Figure 6, an important question concerns the function of these U1C 
dimers. Data reported by Heinrichs et al. (7) indicated that the UIC protein is involved 
in the binding of the U1 snRNP particle to the pre-mRNA 5' splice site. Possibly, stable 
binding to the 5' splice site requires the presence of a U1C dimer on the U1 snRNP 
particle. Within such a model it can be speculated that U1C dimers are responsible for a 
direct contact with the pre-mRNA. Our present studies are directed to test this 
hypothesis. 
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Dimerization of Ui A 
DIMERIZATION OF THE U1 snRNP SPECIFIC PROTEIN A IS STIMULATED BY RNA 
Jacqueline M.T. Klein Gunnewiek, Yvonne van Aarssen, Rob de Jong, Marcel van 
den Heuvel, Wilbert Boelens and Walther J . van Venrooij 
Department of Biochemistry, University of Nijmegen, P.O. Box 9101, 6500 HB 
Nijmegen, the Netherlands. 
ABSTRACT 
The human U1A protein, one of the three U1 snRNP particle-specific proteins, has 
been shown to affect polyadenylation of U1A pre-mRNA, thereby controlling its 
own expression level. The autoregulation is achieved by the binding of two U1A 
proteins to a conserved structure in the 3' untranslated region (UTR) of the U1A 
pre-mRNA resulting in an interaction with the poly(A) polymerase (PAP) and the 
subsequent inhibition of polyadenylation. The two U1A binding sites are in close 
vicinity of each other and the involvement of protein-protein interactions in the 
binding of two U1A molecules to the 3' UTR has been suggested. 
Here we show that the U1A protein is able to dimerize in the yeast two hybrid 
system and in an in vitro dimerization assay when RNA, that can be specifically 
bound by U1A (i.e. stemloop II of U1 snRNA or the 3' UTR of U1A pre-mRNA), is 
absent. However, dimer formation in the in vitro assay decreased drastically by 
RNase A treatment suggesting that dimerization is dependent on the presence of 
RNA non-specifically bound by U1A. Based on these results we hypothesize that 
one U1A molecule bound to RNA, either specifically or non-specifically, stimulates 
the association of a second U1A molecule next to the already bound U1A molecule. 
Analysis of mutant U1A proteins in both the yeast two hybrid system and the in 
vitro dimerization assay indicate that the N-terminal 117 amino acids of U1A are 
essential for dimer formation. 
INTRODUCTION 
The U1 small nuclear ribonucleoprotein (snRNP) particle is the most abundant snRNP 
in the group of so-called spliceosomal snRNPs. These snRNPs play an essential role 
in splicing, a process in which non-coding sequences are removed from the 
precursor messenger RNA (pre-mRNA) in order to obtain functional mRNA (reviewed 
by Krämer, 1996). The U1 snRNP particle consists of an RNA backbone with 
several proteins associated to it. These proteins can be subdivided in the so-called 
common or Sm proteins, which are also present in the other spliceosomal snRNPs 
and three particle-specific proteins, U1-70K, U1A and U1C. The U1A protein 
contains two evolutionary conserved RNP motifs, also called RNA recognition motif 
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(RRM) or RNA binding domain (RBD), which are also present in other RNA binding 
proteins (reviewed by Will et al., 1993) The N-terminal RNP motif is together with 
some N- and C-terminal flanking amino acids necessary and sufficient for binding to 
the loop sequence AUUGCAC found in stemloop II of the U1 snRNA (Scherly et al, 
1989, 1990, Lutz-Freyermuth et al., 1990) while the C-terminal RNP motif does not 
seem to have any affinity for RNA at all (Lu and Hall, 1995) The N-terminal RNP 
motif of the U1A protein (aa 2-95) forms a βαββαβ structure with the highly 
conserved RNP1 and RNP2 consensus sequences located in the two central β 
strands (Nagai et al, 1990). An additional α helix (helix C) is present when a longer 
fragment of the U1A protein is analyzed (aa 2-102, Howe et al., 1994). Also the 
crystal structure of amino acids 2-98 in the presence of the loop II sequence of U1 
snRNA has been solved (Oubridge et al., 1994). In this structure the RNA loop lies 
across the β sheet fitting into a groove formed between loop 3 (situated between 
β2 and β3) and the C-terminal region of the RNP motif. Although U1A specifically 
recognizes the U1 snRNA loop II sequence it has been shown that the N-terminal 
101 amino acids of U1A are able to bind RNA non-specifically at low salt conditions 
(Lu and Hall, 1995). 
The U1 snRNP particle is involved in the first step of spliceosome formation in 
which it binds to the 5' splice site of the pre-mRNA (reviewed by Kramer, 1996). 
The function of the U1A protein in the U1 snRNP particle is not known When the 
U1A protein is absent splicing can still take place. Nevertheless, it has been 
suggested that the U1A protein might be important for 5' and 3' splice site 
communication (Tarn and Steitz, 1995). 
In vertebrates, the U1A protein is able to autoregulate the polyadenylation of U1A 
pre-mRNA thereby regulating its own expression level (Boelens et al., 1993) The 3' 
untranslated region (3' UTR) of the U1A pre-mRNA contains a conserved region 
encompassing two stretches of seven nucleotides similar to those found in the 
second stemloop of the U1 snRNA, Box 1 (AUUGUAC) and Box 2 (AUUGCAC), 
which can be bound by two U1A proteins (Boelens et al., 1993; Van Gelder et al., 
1993). 
Via direct binding of the U1A pre-mRNA-U1A complex to poly(A) polymerase (PAP) 
the polyadenylation is inhibited (Gunderson et al., 1994). Further analyses of the 
U1A pre-mRNA-UIA complexed with PAP showed that the C-terminal 20 amino 
acids of PAP and amino acids 103-119 of both U1A proteins are essential for the 
inhibitory effect It was also suggested that the secondary structure of the RNA is 
not highly constrained but serves to bring two U1A proteins in close proximity for 
binding to PAP (Gunderson et al., 1997; Teunissen et al., 1997). 
The structure of the N-terminal RNP motif of U1A bound to one of the U1A binding 
sites present in the 3' UTR has been solved (Allain et al., 1996) and models for 
binding of two U1A proteins to the two U1A binding sites in the 3' UTR have been 
proposed (Adam et al., 1996, Avis et al., 1996, Jovine et al., 1996; Teunissen et 
al, 1997). 
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Here we show by using the yeast two hybrid system and an in vitro dimerization 
assay that U1A is able to dimenze. Mutational studies strongly suggest that both 
the N-termmal RNP motif and the highly charged region flanking the RNP motif at 
the C-terminal border (residues 1-117) are important for dimer formation. We also 
show that in vitro dimer formation is mainly achieved via non-specific binding of 
U1A to RNA. The results obtained in both assays suggest that dimerization of U1A 
is accomplished by binding of one U1A molecule to RNA, either specifically or non-
specifically, resulting in the subsequent binding of the second U1A molecule next to 
the one that is already bound. 
MATERIALS AND METHODS 
cDNAs and plasmids 
All U1A proteins used in this study were encoded by cDNAs of which Box 1 and 2 
in the 3' UTR had been mutated. These constructs are referred to as υΐΑΔΒ1/2 and 
U1A when the cDNA or mRNA and the protein, respectively, are mentioned. 
To produce U1A(s52/53) encoded by a cDNA of which Box 1 and 2 in the 3' UTR 
had been mutated, the cDNA encoding U1A(s52/53) (Boelens et al., 1991) was 
digested with Nco\IBgl\\. Subsequently, this fragment was cloned into the NcoMBglW 
cut of the U1AAB1/2 cDNA (Boelens er al., 1993). The mutants 
U1A(s52/53,106/108) and U1A(s52/53,110/112) contain in addition to 
substitutions at positions 52/53, substitutions at positions 106-108 (Arg/Lys/Arg is 
substituted into Gly/Ser/lle) and 110-112 (Lys/Arg/Lys is substituted into 
Gly/Ser/lle). These mutant cDNAs were produced in a three step PCR using 
U1A(s52/53) as a template in essentially the same manner as described before 
(Picard er al., 1994) with the exception that 20 instead of 10 cycles of 
amplification were performed in the second and third step. The resulting fragment 
was cloned into the fcoRI site of pGEM3Zf( + ). To produce U1A(s52/53,106/108) 
and U1A(s52/53,110/112) encoded by a cDNA of which Box 1 and 2 had been 
mutated the cDNAs were subcloned as described above. To produce U1A 1 0 4 2 a 2 , a 
cDNA encoding U1A(s102/103) (Boelens et al., 1991) was digested with 
BamH\IHind\\\ and the resulting fragment was cloned into the BamH\/Hind\\\ site of 
U1A(s2/3) (Boelens et al., 1991). To produce U1A 1 0 4 2 8 2 encoded by a cDNA with 
mutated Boxes 1 and 2 the cDNA was subcloned as described above. 
Cloning of fusion proteins for the veast two hybrid assay. The UIC (Sillekens er al., 
1988), ШАДВ1/2, and U1AAB1/2(s52/53) cDNAs were digested with fcoRI (U1C) 
or Nco\IEcoR\ (U1AAB1/2(s52/53) and ШАДВ1/2) and the resulting fragments were 
subcloned into the fcoRI or Nco\/EcoRÌ site of pEG202, allowing synthesis of fusion 
proteins with the LexA DNA binding domain (BD). 
The UIC, U2B" (Habets et al., 1987), U1AAB1/2, U1AAB1/2(s52/53), U IA ,
 101 
(Boelens et al., 1991), U1AAB1/21042e2, U1AAB1/2(s52/53,106/108), 
U1AAB1/2(s52/53,110/112), U2B",
 9ΒΑΔΒ1/2, U2B", 145ΑΔΒ1/2, U1A, 1 0 1 Β " , and 
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U1A 1 2 0 2 B" cDNAs were digested with FcoRI (U1C and U2B") or Ncol/EcoRi 
(U1AAB1/2(s52/53), U1AAB1/2, U1A,
 1 0 1 , U1ΑΔΒ1/21 0 4 2 8 2, 
U1AAB1/2(s52/53,106/108), U1 AAB1/2(s52/53,110/112), U2B",
 9βΑΔΒ1/2, 
U2B",
 145ΑΔΒ1/2, U1A 1 1 0 1 B", and U1A 1 2 0 2B") and the resulting fragments were 
cloned into the fcoRI or /Vcol/fcoRI site of pJG4-5 for production of fusion protein 
with the B42 activation domain (AD). Prior to subcloning of the U2B",
 9βΑΔΒ1/2 and 
U2B",
 146ΑΔΒ1/2 cDNAs into pJG4-5 the U1AAB1/2 cDNA was digested with Sac\ 
and the resulting fragment was cloned into the Sac\ site of the U2B"1 9 BA and 
U2B",
 1 4 SA cDNAs. 
Yeast two hybrid assay 
We used the Brent yeast two hybrid system described by Guyris and coworkers 
(1993) to study protein-protein interactions. EGY48 yeast cells (trp1, his3, игаЗ) 
were grown and transformed with pEG202 (Watson et al., 1996; this vector 
encodes the DNA binding domain of Lex A and contains the HIS3 selectable 
marker), pJG4-5 (Watson era/., 1996; this vector encodes the activation domain of 
B42 and contains the TRP1 selectable marker) and pSH 18-34 (lacZ reporter 
containing the lacZ gene under the control of the lexA operator and the URA3 
selectable marker). Transformants were selected on glucose plates lacking histidme, 
uracil and tryptophane, several colonies were streaked and grown in medium lacking 
histidme, uracil and tryptophane. Exponentially growing cells were harvested (0 5-
1.0 ODeoo/ml)· 1 ml yeast cells was pelleted (1 mm, 10,000g) and resuspended in 
250 μΙ buffer Ζ (100 mM NaxP04 pH 7.2; 10 mM KCl; 1 mM MgS0 4 ; 0.36% ß-
mercaptoethanol) and 100 μΙ milliQ saturated with ether. After mixing and spinning 
(1 mm, 10,000g) the ether was evaporated (30 mm, 20°C). Subsequently, 100 μΙ 
extract was transferred to a 96-well plate, incubated during 5 mm at 30°C and 100 
μΙ ONPG (4mg/ml in buffer Z) was added to start the assay. We followed the 
activity during the course of the reaction (generally 60 mm) by determining the 
optical density at 405 nm each 60 sec m a microplate scanner (Biotek Instruments 
Ceres 900C UV). The amount of protein present in the ß-galactosidase assay was 
established by addition of 100 μΙ Bradford reagens (Biorad) to 10 μΙ of extract and 
measurement at OD5 9 5. The ß-galactosidase activity was determined using the 
equation: 1000(X*1/OD595). The linear part of the obtained absorption curve at 
OD405 was used to determine X. X is defined by the increase of the measured OD 
related to the time period in which the absorption was measured. At least three 
independent colonies were analyzed for each pair of constructs. 
In vitro dimerization assay 
Approximately 400 ng (3 to 5 μΙ) U1A(his)e in PBS with 250 mM imidazole, which 
was expressed and purified as described before (Klein Gunnewiek et al., 1995), was 
incubated with in vitro translated 35S-labeled proteins (2 to 4 μΙ of an in vitro 
translation mixture of 15 μΙ) in a final volume of 20 μΙ buffer В (20 mM HEPES-KOH, 
pH 7.9; 100 mM KCl; 1 mM MgCI2; 0.05 % Nomdet P-40). Alternatively, both 
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U1A(his)e and the S-labeled proteins were incubated for 10 min at 37°C with 
RNase A (1.5 цд/ті) prior to incubation. After 30 min of incubation at 20°C, 
polyclonal anti-(his)e antibodies (Klein Gunnewiek era/., 1995) coupled to protein-A 
agarose beads (Biozym, 20 μΙ 50% slurry) were added together with 300 μΙ IPP1W> 
(10 mM Tris-HCI, pH 8.0; 100 mM NaCI; 0.05 % Nonidet-P 40). This mixture was 
rotated during 90 min at 4°C and the beads were subsequently washed three times 
with IPP10o- The beads were finally resuspended in SDS-PAGE sample buffer, 
heated for 5 min at 95°C and separated on a 10% SDS-polyacrylamide gel. As a 
control, E. col/ proteins expressed and purified in the same manner as U1A(his)e 
were used. 
In vitro transcription and translation 
To produce U1A T7-mRNAs or mutants thereof for translation, 1 μg of linearized 
template was transcribed in essentially the same manner as described by Scherly et 
al. (1989). U1A and point mutants thereof were linearized with Bgl\\ while U1A 
deletion mutants were obtained via BamH\ digestion of point mutants 
U1A(s102/103) and U1 A(s118/119) (Boelens et al., 1991). To produce 3SS-labeled 
proteins, 200 ng (2 μΙ) of the mRNA was incubated with wheat germ extract and 
35S-methionine (ICN) in essentially the same manner as described by Scherly er al. 
(1989). 
RESULTS 
UIA dimerìzatìon in the yeast two hybrid system. 
In the crystal structure of the free U1A protein (aa 2-95) it appeared that two U1A 
molecules interact through a hydrophobic surface at the site opposite of the RNA 
binding surface (Nagai era/ . , 1990). However, dimerìzatìon of U1A in solution has 
not been detected, yet (Avis er al., 1996), although cooperative binding of the two 
U1A proteins to the 3' UTR has been suggested (Van Gelder er al., 1993) indicating 
that a direct interaction between the two U1A proteins via the 3' UTR of U1A pre-
mRNA may exist. 
To investigate if the U1A protein was able to dimerize we used the yeast two 
hybrid system which allows the detection of protein-protein interactions in vivo 
(Fields and Song, 1989). In this assay, each of two proteins is fused to either the 
LexA DNA binding domain, the so-called 'bait', or the B42 activation domain, the 
so-called 'prey'. If the two fusion proteins associate, the LacZ gene from the 
reporter plasmid is transcribed. In a quantitative ß-galactosidase assay the 
efficiency of interaction between bait and prey fusion proteins can be determined. 
To minimize a possible interaction of the U1A proteins with specific RNA in the 
yeast two hybrid system we tested two U1A constructs: i) U1A encoded by a 
cDNA of which the two U1A binding sites in the 3' UTR had been mutated resulting 
in complete loss of specific U1A binding (Boelens era/., 1993); /// U1A(s52/53) 
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Figure 1. Analysis of U1A dinners in the yeast two hybrid assay. Fusion proteins expressed by 
the cells are indicated below the histograms (BD fusion protein/AD fusion protein). Each 
histogram represents the mean value of three independent transformants and standard 
deviations are indicated. (A) Analysis of U1A and U1A(s52/53). (B) Analysis of deletion mutants 
of UIA. A and A52/53 represent U1A and U1A(s52/53); С represents the U1C protein; crys 
represents aB-crystallin. 
which contains along with the mutations in the 3' UTR an additional mutation at 
amino acid positions 52/53, which disrupts the capacity of the protein to bind to 
stemloop II of U1 snRNA (Scherly et al., 1989; Boelens et al., 1991). It should be 
noted that the region of the 3' UTR containing Box 1 and 2 is only conserved in 
vertebrates (Van Gelder et al., 1993) and that yeast U1 snRNA does not contain a 
sequence similar to the U1A binding site in human U1 snRNA. Both U1A and 
U1A(s52/53) were able to dimerize while these constructs did not interact with the 
control protein, aB-crystallin (see Figure 1A). The positive controls U1C and aB-
crystallin were able to homodimerize which is in agreement with results obtained 
before (Figure 1A; Klein Gunnewiek et al., 1995; W. Boelens, unpublished data). 
The results obtained in the yeast two hybrid system suggest that U1A is able to 
dimerize in the absence of RNA sequences specifically interacting with U1A. 
However, since the N-terminal RNP motif of U1A has been shown to be able to bind 
RNA non-specifically under low salt conditions (Lu and Hall, 1995) we cannot 
exclude the possibility that U1A dimerization is mediated by non-specific binding of 
RNA. 
The N-terminal 117 amino acid residues are involved in dimerization. 
To locate the region of the U1A protein which is involved in dimerization we cloned 
cDNAs encoding deletion mutants U1A,.101 (residues 1-101) and U1A104.282 
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(residues 104-282) into the prey vector pJG4-5. Both υ ΐΑ,.,ο, and U1A1 0 4.2 8 2 were 
not able to dimerize with U1A in the yeast two hybrid system (Figure 1B). This 
result might indicate that residues from both deletion mutants are needed for 
dimerization or that one or both of the deletion mutants were improperly folded due 
to the deletion. To investigate the latter possibility we used chimeras of U1A and 
U2B", a U2 snRNP-specific protein which is homologous to U1A (Figure 2A). The 
chimeras are swapped at corresponding positions resulting in mutants having both 
U1A and U2B" characteristics (Scherly era/., 1990). Figure 2B shows a schematic 
overview of the chimeric proteins used. We cloned the corresponding cDNAs into 
pJG4-5 and tested their ability to bind to U1A. Figure ЗА shows that U2B" was 
unable to heterodimerize with the U1A protein while chimeras A,. 1 0 1 B", which 
contains the N-terminal 101 amino acids of U1A fused to the C-terminal part of 
U1A 
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Figure 2. Structural features of U1A, U2B" and chimeras of U1A and U2B" used in the yeast 
two hybrid assay. Open boxes represent the U1A protein while filled boxes indicate U2B". (A) 
Both the U1A and the U2B" protein contain two RNP motifs (also denoted RNA recognition 
motif (RRM) or RNA binding domain (RBD)). The two most highly conserved regions of this 
motif, RNP1 and RNP2, are indicated. Regions A and С of U1A and U2B" are very similar while 
regions В of both proteins display moderate similarity (Sillekens er al., 1987; Habets ef al., 
1987). (В) Chimeras of U1A and U2B" used in the yeast two hybrid assay: mutant Α,.,ο,Β" (aa 
1-101 of U1A and aa 101-225 of U2B"); mutant A,.202B" (aa 1-202 of U1A and aa 148-225 of 
U2B"); mutant B",.98A (aa 1-98 of U2B" and aa 104-282 of U1A); mutant и2В",.,4БА (aa 1-145 
of U2B" and aa 205-282 of U1A). 
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Figure 3. Analysis of dimer formation between U1A and chimeras of U1A and U2B" (A) and 
mutant U1A proteins (B). Fusion proteins expressed by the cells are indicated below the 
histograms (BD fusion protein/AD fusion protein). Each histogram represents the mean value of 
three independent transformants and standard deviations are indicated. A: U1A; B": U2B"; 
Α,.,ο,Β": aa 1-101 of U1A fused to aa 101-225 of U2B"; A1 2 0 2B": aa 1-202 of U1A fused to aa 
148-225 of U2B"; B",.98A: aa 1-98 of U2B" fused to aa 104-282 of U1A; B",.145A: aa 1-145 of 
U2B" fused to aa 205-282 of U1A; crys: aB-crystallin. 
U2B", and Ar.Z02B", which contains the N-terminal 202 residues of U1A, were able 
to bind to U1A. However, when the N-terminal 101 amino acids of U1A, 
encompassing the N-terminal RNP motif, were replaced by the corresponding N-
terminal domain of U2B" (mutant Β'Ί.98Α) no interaction with U1A could be 
observed. The same holds true when the N-terminal 202 residues of U1A were 
replaced by the corresponding region of U2B" (mutant B",.145A). All tested mutants 
did not bind the control protein, aB-crystallin. Similar results were obtained when 
U1A(s52/53) was used as a bait instead of U1A (data not shown). The results 
obtained in the yeast t w o hybrid assay suggest that the N-terminal domain of U1A 
(aa 1-101) is essential but not sufficient for dimerization of the protein. A closer 
look at the sequences of both U1A and U2B" shows that in U1A the region 104-
117 contains a cluster of charged residues and charged residues are also clustered 
in the corresponding region of U2B" (U1A: 104RDRKREKRKPKSQE117 and U2B": 
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101KEKKKEKKKAKTVE114). Based on this observation and the fact that U1 A,.1 0 1 was 
unable to dimerize with U1A (Figure 1B) it could well be that in addition to the N-
terminal 101 amino acids of U1A the presence of this highly charged region is also 
needed for dimer formation. To investigate this possibility, we tested U1A mutants 
with substitutions at positions 52/53 and 106-108 (U1A(s52/53,106/108)) or 11Ο­
112 (U1A(s52/53,110/112)) for binding to U1A in the yeast two hybrid system. 
U1A(s52/53) was able to dimerize with U1A while the combination of both 
U1A(s52/53,106/108) and U1 A(s52/53,110/112) with U1A did not lead to 
statistically significant dimerization signals (Figure 3B). These results strongly 
suggest that the N-terminal 117 amino acids encompassing the N-terminal RNP 
motif and a highly charged region are involved in U1A dimer formation. 
In vitro dimerization of UJA is RNA mediated. 
To confirm the U1A dimerization detected in the yeast two hybrid system, we 
developed an in vitro dimerization assay. In this assay we incubated purified 
U1A(his)6, a U1A protein carrying a tag of six histidines at the C-terminus 
expressed in E coli, with in vitro translated 35S-labeled U1A obtained by translation 
of a U1A mRNA which lacks the 3' UTR. Indeed, in vitro translated U1A was able 
to bind to U1A(his)e under these conditions (see Figure 4, lane 2). However, when 
both U1A(his)e and 35S-labeled U1A were treated with RNase A prior to the 
incubation, the observed signal decreased drastically (Figure 4, lane 1), although a 
residual signal above background was reproducibly observed. When increasing 
A Ä52/53 Al-ΙΟΙ Al-117 A52/53, A52/53, 
106/108 Π0/Ι12 
Β Η 
Η - 5%I + - 5%I - 5%I - 5%I - 5%I - 5%I 
10 11 12 13 14 15 16 
Figure 4. In vitro dimerization of U1A. 
U1A(his)6 expressed in E. coli was incubated with 35S-labeled U1A (lanes 1 and 2), U1A(s52/53) (lanes 6 and 7), U1A,.,0, (lane 9), U1A,. l l7 (lane 11), U1 A(s52/53,106/108) (lane 13), and 
U1 A(s52/53,110/112) (lane 15). Lanes 1, 3, and 6 show incubations in the presence of RNase 
A ( + ) while lanes 2, 4, 7, 9, 11, 13, and 15 show incubations in the absence of RNase A (-). 
Lanes 5, 8, 10, 12, 14, and 16 represent 5% of the input of the respective 35S-labeled proteins. 
As a control, 35S-labeled U1A was incubated with E. coli proteins (BE, lanes 3 and 4). 
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concentrations of E. coli tRNA were added to the assay a similar decrease in signal 
was observed (data not shown). These results indicate that in the in vitro assay a 
substantial part of the U1A dimerization must be mediated via non-specific 
interactions with RNA. In addition, we also incubated 35S-labeled U1A(s52/53), 
υΐΑ,.,ο,, U1A,.1 1 7, U1A(s52/53,106/108) and U1A(s52/53,110/112) with 
U1A(his)e. U1 A(s52/53) was able to bind to U1A(his)e as was observed in the yeast 
two hybrid system (Figure 4, lane 7). Again, this signal decreased drastically when 
an RNase A treatment was performed prior to incubation (lane 6). Deletion mutant 
υΐΑ,.,,7 was able to bind to U1A(his)e while υΐΑ,.,ο, was not (compare lanes 9 
and 11). Finally the point mutants U1A(s52/53,106/108) and 
U1A(s52/53,110/112) were not able to bind to U1A(his)e (lanes 13 and 15). These 
results fully confirm the results obtained in the yeast two hybrid system (see Figure 
5 for an overview): the N-terminal RNP motif and some charged residues in the 
flanking region (amino acids 1-117) are essential for U1A dimer formation. In 
addition, our results strongly suggest that U1A dimerization is mediated by non­
specific binding to RNA. 
DISCUSSION 
Dimerization of the U1A protein was first suggested by Nagai and coworkers (1990) 
who showed that a dimer was present in the crystal structure of the RNP domain of 
U1A (aa 2-95) in the absence of RNA. The two RNP motifs of the dimer were 
related to each other by a non-crystallographic dyad axis and many hydrophobic 
amino acids were found in the interface which was formed by a core between helix 
A and В (aa 22-35) and the loop after helix В (aa 61-80). In contrast, U1A dimer 
formation could not be demonstrated in solution in the absence of RNA (Avis et al., 
1996). 
Our experiments show that the U1A protein is able to dimerize in the yeast two 
hybrid system and in an in vitro dimerization assay. The N-terminal 117 amino acid 
residues encompassing the N-terminal RNP motif and a highly charged region, are 
involved in dimer formation. We also show that in vitro dimerization is much more 
efficient in the presence of RNA, even when the two specific U1A binding sites in 
the 3' UTR of the U1A mRNA are absent. Apparently, U1A is able to bind RNA non-
specifically under these conditions. Non-specific RNA binding by U1A has been 
reported before by Lu and Hall (1995) who observed, in filter binding experiments, 
binding of the N-terminal 101 amino acid residues of U1A with a number of RNAs. 
The finding that in vitro dimerization of U1A is RNA-mediated and the fact that 
similar results as in the in vitro assay are obtained when U1A and U1A mutants 
were tested in the yeast two hybrid system (Figure 5) might indicate that 
dimerization of U1A in the yeast two hybrid system is also RNA-mediated. 
Cosentino and coworkers (1995) showed that the human double-stranded RNA-
dependent protein kinase (PKR) was able to dimerize in vivo in the yeast two hybrid 
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Figure 5. Overview of the U1A dimerization results obtained in the in vivo yeast two hybrid 
system and the in vitro dimerization assay. The RNP motif and the two highly conserved 
sequences RNP1 and RNP2 are indicated. An asteriks indicates double or triple point mutations. 
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system provided that two functional dsRNA binding motifs were present in the 
protein while in vitro dimenzation of PKR requires the presence of dsRNA, which 
suggests that PKR dimenzation in the yeast two hybrid system is mediated by 
dsRNA of the yeast. In a similar way, U1A dimenzation in the yeast two hybrid 
system might be RNA-mediated. The signal obtained for U1A(s52/53) in the yeast 
two hybrid system was reproducibly stronger than that observed for U1A (Figure 
1A). This result might reflect differences in non-specific RNA binding of the two 
proteins. U1A is able to bind RNA both specifically and non-specifically (Lu and Hall, 
1995), while U1A(s52/53) is unable to bind RNA specifically (Boelens et al., 1991). 
It might be possible that the non-specific RNA binding of wild type U1A is less 
efficient when compared to the non-specific RNA binding of U1 A(s52/53). 
In this study it is shown that both the N-termmal RNP motif and some charged 
residues (aa 1-117) are involved in U1A dimer formation (Figure 5). When the N-
terminal 101 amino acids of U1A are present (U1A,
 1 0 1) no dimenzation is observed 
with U1A in the yeast two hybrid system although this mutant protein is able to 
bind RNA. In addition, no dimer formation was observed between U1A104282< which 
contains the cluster of charged residues, and U1A. Similar results were obtained 
when chimeras of U1A and U2B", a U2 snRNP-specific protein homologous to U1A 
which also contains the clustering of charged residues at similar positions, were 
used. Dimer formation was observed when the first 101 amino acids of U1A were 
present together with the charged region of U2B" (mutant U1A,
 1 0 iB"). When the 
N-terminal RNP motif of U2B" was fused to the residues 104-282 of U1A (mutant 
U2B" i e 8 A) no dimer formation with U1A was observed although the charged 
residues (aa 104-117) were present. Similarly, when residues 106-108 and 11Ο­
112 were substituted (mutants U1A(s52/53,106/108) and U1A(s52/53,110/112), 
respectively) no dimenzation was observed (Figure 5). Taken together, these results 
strongly indicate that both the N-terminal RNP motif of U1A and a highly charged 
region, such as occurring in either U1A or U2B", are essential for dimenzation. In 
addition, these results indicate that U1A dimenzation is not simply the consequence 
of the binding of two U1A molecules to any region of the RNA. First, in both the 
yeast two hybrid system and the in vitro dimenzation assay the presence of the N-
terminal 101 residues of U1A (U1A,
 1 0 1) is insufficient for dimer formation Second, 
U2B" has been shown to be able to bind RNA non-specifically (Scherly er al., 
1990). If both U1A and U2B" bind non-specifically to RNA in the yeast two hybrid 
system, dimenzation between U1A and U2B" might be expected but was not 
observed (Figure ЗА). Based on these results we hypothesize that the binding of 
one U1A protein to RNA, either specifically or non-specifically, results in the 
preferential binding of a second U1A protein next to the already bound U1A protein. 
This hypothetical dimenzation mechanism seems to be specific for U1A since U2B", 
which binds RNA non-specifically and contains a highly charged region (aa 101-114 
of U2B"), was unable to enhance the binding of a second U1A molecule next to it 
when the yeast t w o hybrid system was used. 
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Our dimerization data are supported by previously published data that suggest 
cooperative binding of t w o U1A molecules to the 3' UTR of U1A pre-mRNA (Van 
Gelder et al., 1993). In that study, it was shown that two U1A proteins can bind 
the 3' UTR at 500 mM salt (this high salt concentration abolishes direct UIA-Box 1 
interaction so that only one site (Box 2) remains for direct binding of U1A) 
suggesting that protein-protein interactions contribute to formation of a stable U1A-
3' UTR-U1A complex. 
A structure model has been proposed for the complex of t w o U1A molecules 
containing residues 2-98, and the 3' UTR of U1A pre-mRNA (Jovine ef al., 1996) 
based on the crystal structure of the U1A2.98-RNA hairpin II complex. This model 
predicts protein-protein interactions between the two U1A subunits in which 
interactions of Lys96 and Lys60 of subunit 1 with Asp 24 and Gln39, respectively, 
of subunit 2 are involved. Unfortunately, no data on U1A,.1 1 7 complexed with the 3' 
UTR are available. Teunissen and coworkers (1997) performed chemical protection 
experiments of the 3' UTR complexed to two U1A molecules which suggest the 
involvement of the N-terminal RNP domain in protein-protein interactions. In their 
assay two U 1 A V 1 0 1 molecules were able to bind the 3' UTR while we were not able 
to detect dimerization in our assays when U1A,.1 0 1 was used. These contradictary 
results might be explained by differences in the assays that were used. Teunissen 
and coworkers (1997) used the 3' UTR of U1A pre-mRNA which is bound 
specifically by two U1A molecules while our data can only be the result of non­
specific RNA binding of U1A which is supposed to be much weaker. In addition, it 
has been suggested that the U1A structure changes upon specific RNA binding 
(Allain et al., 1996; Avis et al., 1996). Possibly, no or different changes of the U1A 
structure occur when RNA is bound non-specifically. 
Recently, it has been shown that amino acid residues 103-119 of the U1A protein 
are involved in binding of PAP. Two U1A molecules bind to the С-terminal 20 amino 
acids of PAP (Gunderson et al., 1997). Since these 20 residues of PAP do not 
contain any apparent sequence duplication it was suggested that the two U1A 
molecules might present a single surface for interaction with PAP (Jovine et al., 
1996; Gunderson et al., 1997). Gunderson and coworkers (1997) discussed the 
possibility that this U1A single surface might be presented to PAP via dimerization 
of residues within the region spanning amino acids 103-119 of U1A. Our findings 
support this hypothesis. 
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ABSTRACT 
The U1 snRNP particle has an important function in the early formation of the 
spliceosome, the multicomponent complex in which pre-mRNA splicing takes place. The 
nuclear localization signals of two of the three U1 snRNP-specific proteins, U1-70K and 
U1A, have been mapped. Both proteins are transported actively to the nucleus. Here 
we show by microinjection of Xenopus laevis oocytes that the third U1 snRNP-specific 
protein, U1C, passively enters the nucleus. Furthermore, we show that in both Xenopus 
laevis oocytes and cultured HeLa cells mutant U1C proteins that are not able to bind to 
the U1 snRNP particle do not accumulate in the nucleus indicating that nuclear 
accumulation of U1C is due to incorporation of the protein into the U1 snRNP particle. 
INTRODUCTION 
Small nuclear ribonucleoprotein particles (snRNPs) play an essential role in splicing, a 
process in which sequences are excised from precursor mRNAs. The catalysis of this 
process occurs in a large complex known as the spliceosome. In the first step of 
spliceosome formation the U1 snRNP particle binds to the 5' splice site [reviewed in 1]. 
The U1 snRNP particle consists of an RNA backbone with several proteins associated to 
it. These proteins can be divided into two groups: i) the common or Sm proteins B/B', 
D1, D2, D3, E, F and G which are also present in other snRNPs and ¡i) the particle 
specific proteins 70K, A and С [reviewed in 2]. The U1-70K and U1A proteins bind 
directly to the first and second stemloop structures, respectively, of the U1 snRNA [3, 
4]. The U1C protein binds to the U1 snRNP particle via protein-protein interactions [5] 
and needs the presence of the U1-70K and some of the Sm proteins [6]. The U1C 
protein contains a zinc finger-like region which encompasses the first 30 amino acid 
residues of the protein. This region is necessary and sufficient for binding to the U1 
snRNP particle [5]. Recently, it also has been shown that the U1C protein is able to 
dimerize. The region between amino acids 23 and 30, encompassing part of the zinc 
finger-like region, is involved in dimer formation [7]. 
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The function of the U1 snRNP specific proteins in splicing is not precisely known. It has 
been suggested that the state of phosphorylation is critical for the participation of U1-
70K in splicing [8-10]. The U1A protein has been suggested to be necessary for 5' 
splice site switching [11] although U1A is dispensable for binding of the U1 snRNP to 
the 5' splice site. The U1C protein can augment the interaction of the U1 snRNP 
particle with the 5' splice site [12, 13] Possibly related to this, it has been shown that 
the U1C protein is involved in the formation of the E (early) sphceosomal complex [14] 
Moreover, the U1C protein when present in the U1 snRNP particle can be crosslmked to 
an RNA oligonucleotide comprising the 5' splice site [15] 
The U1 snRNA, an RNA polymerase II product characterized by a monomethyl cap 
structure (m7GpppN) at the 5' end of the newly synthesized RNA, is exported from the 
nucleus to the cytoplasm. Both the monomethyl cap and a nuclear cap binding complex 
(CBC), composed of two proteins, CBP80 and CBP20, are involved in this process [16, 
17] In the cytoplasm the Sm proteins assemble onto the conserved Sm site of the 
RNA The assembly of the Sm proteins is a multistep process in which, prior to RNA 
binding, D1-D2, E-F-G, D1-D2-E-F-G and B/B'-D3 protein complexes are formed. 
Subsequently, the D1-D2-E-F-G complex binds to the conserved Sm site of the U1 
snRNA Finally, the binding of B/B'-D3 generates a so-called core U1 snRNP [18, 19]. 
After binding of the Sm proteins, which is essential for subsequent tnmethylation of the 
cap structure [20], the core U1 snRNP returns to the nucleus. In Xenopus laevis the 
remigration to the nucleus depends on the presence of the Sm proteins and the 
tnmethyl cap structure [21] but in somatic cells the presence of the Sm proteins alone 
is both necessary and sufficient [22, 23] It has been suggested that the association of 
the U1 snRNP-specific proteins takes place in the nucleus since it has been shown that 
all three specific proteins are able to enter the nucleus independent of the U1 snRNA 
[24-26] 
Nuclear import of proteins, which is usually mediated by nuclear localization signals 
(NLS), is a well studied process [reviewed in 27, 28] Active protein import 
encompasses the binding in the cytoplasm of the NLS-contaming protein by the importin 
α/β heterodimer where the α subunit provides the NLS binding site. Subsequently this 
complex is docked at the nuclear pore complex where translocation of the NLS-beanng 
protein and importin α takes place. This final step needs the presence of Ran, a small 
GTP binding protein [reviewed in 27, 28]. Recently the requirement of Ran in U1 snRNP 
nuclear import has been studied by two groups [29, 30]. Different results were 
obtained in both studies, which might be explained by the fact that different assays 
were used 
The NLSs of both U1-70K and U1A have been mapped [24, 26]. Two NLSs, one 
ranging from amino acids 92-199 and another one ranging from amino acids 183-437, 
have been shown to be present in the U1-70K protein. Both are independently capable 
to direct the protein to the nucleus [26]. The NLS of the U1A protein includes ammo 
acid residues 94-204 [24]. Since little is known about the nuclear import of the U1C 
protein we studied this phenomenon in both Xenopus laevis oocytes and HeLa cells. 
Here we show that the nuclear import of the U1C protein is not an energy requiring 
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process and that nuclear accumulation of this protein is primarily controlled by its 
association with U1 snRNP particles. 
MATERIALS AND METHODS 
Plasmids and cDNA constructs 
To produce templates for the in vitro translation of U1C protein [31] and mutants 
thereof we used cDNA fragments which have been described before [5-7]. 
To produce the truncated U1C protein containing amino acids 1-60 (hC, ^ ) or mutants 
thereof, the corresponding cDNA fragments [5] were amplified by PCR using a DNA 
oligonucleotide encompassing the EcoRI site at the 5' end of the cDNA and an 
oligonucleotide complementary to bases encoding ammo acid residues 54-60, which 
additionally contained three ATG codons and a BamHÌ site. A fusion protein of mutant 
hC, «J with mDHFR was subsequently constructed by cloning the EcoRi/BamHl 
fragment of the truncated U1C into the EcoR\/BamH\ sites of mDHFR in pBS(-) which 
has been described before by Kambach and Mattaj [24]. To produce hC, eolDHFR^ the 
BamHVHincflW fragment of DHFR was cloned into the ВдП НіпсЛП sites of hC, <¡oDHFR, 
which resulted in the formation of hC, eo(DHFR)2. Finally, a second BamH\IHmd\\\ 
fragment of DHFR was cloned into the Bgñ\/Hind\i\ sites of hC, eofDHFR^. 
To produce triple hC we first introduced an Nde\ site at the start position via site 
directed mutagenesis. This construct was partially digested with Nde\ at amino acid 
positions 1 and 129. The resulting fragment was fused at its 5' end to the cDNA 
encoding U1C digested with Nde\ at amino acid position 129 and at its 3' end to a U1C 
cDNA digested with Nde\ at ammo acid position 1. 
The fusion proteins, hC, «, and mutants thereof with the green fluorescent protein 
(GFP), were obtained by subclonmg a FcoRI/ßamHI fragment of the corresponding 
truncated U1C mutants into the fcoRI/ÄamHI sites of pEGFP-N3 (Clontech). The 
integrity of all constructs was subsequently checked by sequence analysis. 
To produce hA(his)e, the translational stop codon of the U1A cDNA [32] was replaced 
by the codons for six histidine residues followed by a stop codon and a BamHl site by 
PCR. The hA(his)a cDNA was subsequently cloned into the NcoMBamYW site of the 
expression vector pET-8c. 
Expression and purification of recombinant proteins 
The proteins hC(his)e, hC(s25)(his)6, hCao 1B9(his)e and hA(his)e were induced and 
purified as described before [7]. The proteins were eluted in buffer D"(10 mM HEPES-
KOH, pH 7.9; 5 mM MgCI2, 0.1 mM EDTA; 50 mM NaCI; 17% glycerol (v/v), 1 mM 
PMSF; 10mM NaF) with 200 mM imidazole except for hA(his)e which was eluted in 
PBS with 250 mM imidazole. 
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in vitro transcription and translation 
To produce hC or hC, «jDHFR T7-mRNAs or mutants of both for translation, 1 цд of 
linearized template was transcribed in essentially the same manner as described in [4]. 
To produce 35S-labeled proteins, 200 ng (2 μΙ) of the mRNA were incubated with wheat 
germ extract and 35S-methionine (ICN) in essentially the same manner as described in 
[4]. 
Oocyte injection 
Oocytes were released from the ovary by treatment with collagenase В (2.5 mg/ml) in 
Barm's medium [33] without Ca 2 + . In vitro translated proteins were injected into the 
cytoplasm (30 nl per oocyte). Oocytes were incubated in Barth's medium containing 
cycloheximide (100 цд/ті) to inhibit incorporation of 35S-methionme into endogenous 
proteins After 18 hours of incubation (or other time periods as indicated in the text) at 
18°C or 0°C the oocytes were manually dissected in J-buffer (20 mM Tris-HCI, pH 
7 5; 70 mM NH4CI; 7 mM MgCI2; 0.1 mM EDTA, 2.5 mM dithiothreitol; 10% glycerol). 
Isolated nuclei (N) were immediately precipitated in ethanol, whereas the 'total' oocyte 
(T) and cytoplasmic (C) fractions were transferred to 300 μΙ TN50E (10 mM Tris-HCI, pH 
8.0; 50 mM NaCI, 1 mM EDTA). For the protein injection experiments 6 oocytes per 
sample were used. The 'total' and cytoplasmic fractions were homogenized and spun 
for 15 mm at 10,000 g to remove yolk and insoluble components. 200 ul of the 
supernatant was precipitated with 5 volumes acetone for 1 hour at -70°C. After 
spinning for 15 mm, the samples were dried, dissolved in SDS-PAGE sample buffer, 
incubated for 5 mm at 95°C, and loaded on a 10% SDS-polyacrylamide gel. 
Immunodepletion 
After an overnight incubation at 18°C, 18 oocytes injected with 3SS-labeled U1C were 
dissected and both cytoplasmic and nuclear fractions were homogenized in 600 μΙ 
TN150E (10 mM Tris-HCI, pH 8.0; 150 mM NaCI, 1 mM EDTA) and spun for 15 mm at 
10,000 g. Subsequently 400 μΙ of the supernatant was incubated with monoclonal anti-
Sm antibodies (Y12 [34]) coupled to protein-Α agarose beads (20 μΙ of 50% slurry, 
Biozym) Nonidet P-40 was added to a final concentration of 0.05%. After 2 hours 
rotation at 4°C the supernatants were transferred to fresh tubes with monoclonal anti-
Sm antibodies (Y12) coupled to protem-A agarose beads (20 μΙ of 50% slurry). Similar 
immunoprecipitations were subsequently performed twice with anti-m3G antibodies 
(H20; Euro-Diagnostica BV, Arnhem, the Netherlands) coupled to protein-G agarose 
beads (20 μΙ 50% slurry, Pharmacia). After the final immunoprecipitation the 
supernatant was precipitated with 5 volumes acetone for 1 hour at -70°C and 
subsequently loaded on a 10% SDS-polyacrylamide gel as described above. 
Electroporation of HeLa cells 
2* 10e HeLa cells were transfected with 5 μg of the corresponding DNAs in a total 
volume of 400 μΙ Dulbecco's Modified Eagles Medium (DMEM). Electroporation was 
performed at 296 V and a capacitance of 950 μΡβ. After electroporation, cells were 
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resuspended in 10 ml DMEM, divided in two portions, and allowed to grow on a cover 
slip. Two days later, the cells were washed twice with PBS and subsequently examined 
using a fluorescence microscope (with FITC adjustment). 
In vitro reconstitution in HeLa S100 
(η vitro translated 3BS-labeled proteins (2 or 3 μΙ of an in vitro translation mixture of 15 
μΙ) were incubated in a final volume of 20 μΙ with 5 μΙ HeLa S100 extract (extract of 
5*105 cells in 25 mM Tns-HCI, pH 7.4; 0.1 mM EDTA; 0.25 mM DTE; 0.5 mM PMSF; 
0.1 M KCl; 0 . 0 1 % Nonidet P-40; 20% (v/v) glycerol as described previously [5]), 2 μΙ 
buffer В (200 mM HEPES-KOH, pH 7.9; 1M KCl; 10 mM MgCI2; 0.05% Nonidet P-40), 
and 5 μΙ BSA (10 mg/ml). After 90 mm of incubation at 20°C monoclonal anti-U1A 
antibodies (9A9; Euro-Diagnostica BV, Arnhem, the Netherlands) coupled to protein-A 
agarose beads (20 μΙ 50% slurry) were added together with 300 μΙ IPP150 (10 mM Tris-
HCI, pH 8.0; 150 mM NaCI; 0.05% Nonidet P-40). The beads were rotated during 90 
mm at 20°C and subsequently washed three times with IPP150. The beads were finally 
resuspended in SDS-PAGE sample buffer, heated for 5 mm at 95°C and separated on a 
10% SDS-polyacrylamide gel. 
RESULTS 
Nuclear import of the UIC protein 
Not much is known about the nuclear import of the U1C protein. The U1C protein does 
not contain an NLS similar to the prototype SV40 Τ antigen NLS which consists of a 
short stretch of basic amino acid residues [35] nor does it contain a so-called bipartite 
NLS consisting of two stretches of basic ammo acids separated by a spacer of 
approximately 10 random ammo acids [36] In order to investigate the mechanism of 
nuclear accumulation of U1C we first injected 35S-labeled U1C protein dn vitro 
translated in a cell-free system) into the cytoplasm of X. laevis oocytes. After various 
incubation times (2, 4, 6, 8 and 21 hours) at 18°C the oocytes were dissected and the 
presence of 35S-labeled protein in both the nuclear and the cytoplasmic fraction was 
analyzed by SDS-PAGE. The U1C protein gradually migrated into the nucleus (see 
Figure 1A). After 4 hours a substantial part of the labeled protein (Figure 1A, lane 5) 
and after 21 hours more than 50% of the injected protein had entered the nucleus (see 
Figure 1A, lanes 11-12). The U1A protein which was included as an internal control 
was also transported to the nucleus (lanes 11-12 of Figure 1A). The fraction of the 
U1A protein found in the nucleus was relatively small which is consistent with the 
results obtained by Kambach and Mattaj [24]. 
Parallel incubations of oocytes injected with 35S-labeled UIC were performed at 0°C. 
At this temperature energy-dependent transport is severely hampered, in contrast to 
passive diffusion [37, 38]. At 0°C nuclear accumulation of the U1C protein is still 
observed although the rate of nuclear entry appeared to be somewhat lower than that 
observed at 18°C (compare lanes 2-12 of Figure 1A with lanes 1-11 of Figure 1B). At 
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0 ° C no transport of the U1A protein from cytoplasm t o nucleus w a s observed which is 
consistent w i t h the idea that U1A transport is energy-dependent [ 2 4 ] . The results 
presented in Figure 1 suggest that nuclear accumulation of the U1C protein is not an 
energy-dependent process. 
l=2h t=4h t=6h t=8h t=21h 18°C 
T 0 C N C N C N C N Τ С N 
hA 
10 11 12 
В 
t=2h l=4h t=6h t=8h t=21h 0°C 
C N C N C N C N T C N 
hA 
1 2 3 4 5 6 7 8 9 10 11 
Figure 1. Nuclear accumulation of the U1 snRNP specific protein С 
A mixture of in vitro translated 35S-labeled U1C and U1A (indicated as hC and hA, respectively) were 
injected into the cytoplasm of X. laevis oocytes and after incubation at 18°C (A) or 0°C (B) oocytes 
were dissected in cytoplasmic (C) and nuclear (N) fractions and subsequently analyzed by 10% SDS-
PAGE. (A) Cytoplasmic and nuclear fractions after incubation of 2 (lanes 2-3), 4 (lanes 4-5), 6 (lanes 
6-7), 8 (lanes 8-9) and 21 hours (lanes 10-12). The amount of injected 35S-labeled proteins is shown 
in lane 1 (T0). (B) Cytoplasmic and nuclear fractions after incubation of 2 (lanes 1-2), 4 (lanes 3-4), 6 
(lanes 5-6), 8 (lanes 7-8) and 21 hours (lanes 9-11). T: total oocyte fraction. 
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The UIC protein diffuses into the nucleus 
In order to find out if the UIC protein accumulates in the nucleus via diffusion, we 
fused the first 60 amino acid residues which encompass the zinc finger-like region of 
the UIC protein to mouse DHFR (dihydrofolate reductase). Oocytes were injected with 
^S-labeled hC^eoDHFR and after an overnight incubation at 18°C the nuclear and 
cytoplasmic fractions were analyzed on a 10% SDS-polyacrylamide gel. About 50% of 
the injected hC^eoDHFR had accumulated in the nucleus (see Figure 2, lanes 5-6). In 
contrast, the injected 35S-labeled DHFR was still localized in the cytoplasm (see lanes 8-
9 of Figure 2). When oocytes injected with hC1eoDHFR were incubated at 0°C for 18 
hours the transport of the fusion protein to the nucleus was hampered but not 
completely inhibited (lanes 14-15 of Figure 2). The transport of the wild type U1C 
protein was also slowed down under these conditions (Figure 2, lanes 11-12), as was 
observed before. 
The nuclear accumulation of hC^eoDHFR both at 18°C and 0°C was less efficient as 
compared to that of the wild type U1C protein (compare lanes 2-3 with lanes 5-6 of 
Figure 2). To investigate whether this was due to the larger size of hC^eoDHFR (±33 
kD), we fused three copies of DHFR to the first 60 amino acid residues of U1C 
(hC160DHFR3: molecular weight of this polypeptide is 80-85 kD) as described in the 
Materials and Methods section. After an overnight incubation at 18°C no nuclear 
accumulation for hC^eoDHFRa could be observed (data not shown). We also made a 
construct in which almost the complete coding sequence of the U1C protein was 
repeated three times (triple hC; molecular weight of the polypeptide is 55-60 kD. See 
Materials and Methods). Also with this fusion protein no nuclear accumulation was 
observed after 18 hours incubation at 18°C (data not shown). The observation that (i) 
nuclear entry of U1C is hardly temperature dependent and (ii) the rate of nuclear entry 
is dependent on the size of the fusion protein indicates that nuclear entry of the U1C 
protein is due to diffusion of the protein. 
The nuclear accumulation of U1C and hCieoDHFR can only be explained by assuming 
that both proteins are able to bind to some nuclear components, most likely the U1 
snRNP particle. To investigate this possibility we performed an in vitro reconstitution 
assay in HeLa S100 extract. 35S-labeled U1C, hCieoDHFR and DHFR were added to 
HeLa S100 cell extract and subsequently immunoprecipitated with monoclonal 
antibodies directed to the U1A protein. The immunoprecipitated proteins, most probably 
contained in U1 snRNP particles, were analyzed by SDS-PAGE. Indeed, UIC as well as 
hC160DHFR were precipitated by the antibodies (lanes 4 and 6 of Figure 3) although 
some background binding of both proteins to the antibodies coupled to protein-A 
agarose beads was observed (lanes 5 and 7, Figure 3). DHFR was not precipitated by 
the anti-U1A antibodies (lanes 8-9, Figure 3). Similar results were obtained when 
monoclonal anti-Sm antibodies (Y12) were used. These results strongly suggest that 
both U1C and hC1e0DHFR accumulate in the nucleus due to diffusion and subsequent 
incorporation into the U1 snRNP particles. 
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Figure 2. Nuclear accumulation of hC160DHFR. 
In vitro translated 35S-labeled hC (lanes 1-3 and 10-12), hC160DHFR (lanes 4-6 and 13-15) and DHFR (lanes 7-9) were injected into the cytoplasm of X. laevis oocytes, incubated for 18 hours at 18°C 
(lanes 1-9) or 0°C (lanes 10-15). After incubation oocytes were dissected in cytoplasmic (C) and 
nuclear (N) fractions and analyzed by 10% SDS-PAGE. T: total oocyte fraction. 
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Figure 3. Reconstitution of U1 snRNP in HeLa S100. 
In vitro translated 35S-labeled hC (lanes 4-5), hC160DHFR (lanes 6-7) and DHFR (lanes 8-9) were 
incubated with ( + ) or without (-) HeLa S100 and precipitated via monoclonal anti-U1A antibodies. 
The bound proteins were analyzed on a 10% SDS-polyacrylamide gel. 10% of the inputs were 
analyzed in parallel (lanes 1-3). 
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The zinc finger-like region of UIC is involved in nuclear accumulation 
If nuclear accumulation of U1C is dependent on its binding to U1 snRNP particles, as 
has been suggested above, it would be expected that mutant U1C proteins that are not 
able to bind to the U1 snRNP particle do not accumulate in the nucleus To investigate 
this in more detail we constructed several 35S-labeled mutants of the U1C protein: a 
deletion mutant lacking the C-terminal end (hC, ^ ) ; deletion mutants lacking the N-
terminal 22, 29 or 46 ammo acids (hC23i59, hC3o159 and hC 4 7 1 5 9 , respectively), in 
which the zinc finger-like region is partially or completely deleted; amino acid 
substitution mutants in which the conserved cysteines at positions 6 and 9 and the 
cysteine at position 25 were changed into serines (mutants s6, s9 and s25), the 
conserved histidines at positions 24 and 30 were changed into glutammes (mutants s24 
and s30) or the argmines and lysines at positions 21/22 and 28/29 were changed into 
glycine-serine (mutants s21/22 and s28/29) Mutants hC2 3 1 59, hC30159, hC47159, s6, 
s9, s21/22, s24 and s30 are not able to bind to the U1 snRNP particle [5, 7]. The 3 5S-
labeled mutant U1C proteins were injected into the cytoplasm of X laevis oocytes and 
after an overnight incubation at 18°C the cytoplasmic and nuclear fractions were 
analyzed by SDS-PAGE U1C mutants that are able to bind to the U1 snRNP particle 
accumulated in the nucleus to a similar extent as observed for the wild type protein 
(data not shown). In contrast, mutant proteins that were not able to bind to the U1 
snRNP particle appeared to be quite unstable after an overnight incubation at 18°C 
(data not shown). 
If indeed energy is not required for nuclear uptake of U1C, as suggested by the data 
described above, this would allow analysis of the U1C mutants at 0°C, ι e. under 
conditions where protein degradation will be limited. Therefore, we studied the nuclear 
accumulation of the 36S-labeled wild type U1C and U1C mutants at 0°C and incubated 
the injected oocytes also for a longer period of time (up to 45 hours of incubation) to 
reach higher levels of nuclear accumulation After 45 hours of incubation at 0°C more 
than 50% of the injected wild type protein was present in the nucleus (see Figure 4B, 
lanes 8-9) As expected, the control protein U1A did not enter the nucleus at all under 
these conditions (Figure 4B). Injection of X. laevis oocytes with 35S-labeled U1C 
mutants and subsequent incubation at 0°C indicated that U1C mutants unable to bind 
to the U1 snRNP particle did not accumulate in the nucleus (see Figures 4C and 4D for 
the mutant proteins hC(s6) and hC(s24)). No or only slight degradation of these proteins 
was observed under these conditions. In contrast, U1C mutants that are able to bind to 
the U1 snRNP particle accumulated in the nucleus to the same extent as the wild type 
protein (see Figures 4E and 4F for the mutant proteins hC(s25) and hC(s28/29)). In 
Figure 5 the results obtained with all U1C mutant proteins are summarized and 
correlated with their ability to bind to the U1 snRNP particle. 
Taken together, our results indicate that the UIC protein passively enters the nucleus 
and is retained in this compartment via binding to the U1 snRNP particle. 
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Figure 4. Nuclear accumulation of mutant U1C proteins. 
In vitro translated 35S-labeled hC (A and B) and hC(s6) (C) were injected into the cytoplasm of X. 
laevis oocytes. 35S-labeled U1A was coinjected as an internal control (indicated hA in A and B). After 
incubation at 18°C (A) or 0°C (B-C) oocytes were dissected in cytoplasmic (C) and nuclear (N) 
fractions, which were subsequently analyzed by 10% SDS-PAGE. (A) Total oocyte (T), cytoplasmic 
and nuclear fractions after 7 (lanes 2-4), 21 (lanes 5-7) and 45 hours (lanes 8-10) of incubation. The 
amount of 35S-labeled protein injected is indicated in lanes 1 (T0). (B) total, cytoplasmic and nuclear 
fractions after incubations of 7 (lanes 1-3), 21 (lanes 4-6) and 45 hours (lanes 7-9). (C) Total, 
cytoplasmic and nuclear fractions after incubation of 7 (lanes 2-3), 29 (lanes 4-6) and 45 hours (lanes 
7-9). 
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Figure 4 (continued). In vitro translated 35S-labeled hC(s24) (D), hC(s25) (E) and hC(s28/29) (F) were 
injected into the cytoplasm of X. laev/'s oocytes. After incubation at 0°C oocytes were dissected in 
cytoplasmic (C) and nuclear (N) fractions, which were subsequently analyzed by 10% SDS-PAGE. 
Total oocyte (T), cytoplasmic and nuclear fractions after 7 (lanes 2-4), 21 (lanes 5-7) and 45 hours 
(lanes 8-10) of incubation. The amount of 3SS-labeled protein injected is indicated in lanes 1 (T0). 
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Figure 5. Nuclear accumulation and binding to the U1 snRNP particle of U1C and its mutants. 
Summary of the different mutants of the U1C protein used in X. laevis oocyte injection experiments 
and their ability to accumulate in the nucleus and to bind to the U1 snRNP particle. The amino acid 
numbers are indicated. The shaded box represents the proline and methionine rich C-terminal domain, 
starting at residue 6 1 . Dark-gray boxes indicate the position at which an amino acid is substituted by 
another residue (U1C mutants s6, s9 and s25: substitution of cysteine by serine; s24 and s30: 
substitution of histidine by glutamine; S21/22 and s28/29: substitution of arginine-lysine into glycine-
serine). Mutant (1-60)DHFR represents the first 60 amino acids of U1C (open box) fused to DHFR 
(crosshatched box). 
Nuclear accumulation of the U1C protein is dependent on nuclear binding sites 
Since the number of U1 snRNP particles in the nucleus that do not contain the (X. 
laevis) U1C protein is limiting, one would expect that nuclear retention of UIC as 
described above is a saturable process. Therefore, we injected 1 ng hC(his)e, 
hC(s25)(his)e, hC3o.159(his)6 or hA(his)e in the nucleus prior to cytoplasmic injection of 
35S-labeled U1C. 35S-labeled U1A protein was coinjected as an internal control. hC(his)fl, 
hC(s25)(his)e, hC30.i59(his)fl and hA(his)e were expressed and purified as described in 
the Materials and Methods section. After an overnight incubation at 18°C the oocytes 
were dissected and cytoplasmic and nuclear fractions were analyzed by SDS-PAGE. 
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Injection of hA(his)e prior to injection of the 35S-labeled U1C protein did not markedly 
affect nuclear accumulation of the U1C protein since more than 50% was found in the 
nucleus (see Figure 6, lanes 2-3). Unfortunately, U1A signals are too weak to observe a 
decrease in nuclear accumulation of 35S-labeled U1A as would be expected based on 
results obtained by Kambach and Mattaj [24]. When hC3o_159(his)e, which is unable to 
bind to the U1 snRNP particle, was injected in the nucleus again more than 50% of the 
35S-labeled U1C accumulated in the nucleus (see Figure 6, lanes 11-12). However, 
when hC(his)e or hC(s25)(his)e which both are able to bind to the U1 snRNP particle 
were injected in the nucleus the nuclear accumulation of the 35S-labeled U1C protein 
was severely reduced (compare lanes 2-3 with lanes 5-6 and lanes 8-9 of Figure 6). 
These results support the previous conclusion that nuclear accumulation of the U1C 
protein is dependent on the presence of U1C binding sites in the nucleus. 
hA(his)6 hC(his)6 hC(s25)(his)6 hC30.l59(his)6 
T C N T C N T C N T C N 
hC 
1 2 3 4 5 6 7 8 9 10 11 12 
Figure 6. Nuclear accumulation of U1C is saturable. 
Prior to cytoplasmic injection of a mixture of in vitro translated 35S-labeled U1С and U1A (indicated as 
hC and hA, respectively) the nuclei of X. laevis oocytes were microinjected with 1 ng hA(his)6 (lanes 
1-3), hC(his>6 (lanes 4-6), hC(s25)(his)6 (lanes 7-9) or hC3o.,59(his)6 (lanes 10-12). After 18 hours of 
incubation at 18°C oocytes were dissected in cytoplasmic (C) and nuclear (N) fractions and analyzed 
by 10% SDS-PAGE. T: total oocyte fraction. 
To confirm that indeed the microinjected human U1C protein associates with Xenopus 
U1 snRNP, the nuclear snRNPs were ¡mmunoprecipitated from extracts prepared from 
oocytes microinjected with the radiolabeled U1C protein. To warrant quantitative 
immunoprecipitation of snRNPs, a number of subsequent immunoprecipitations were 
performed using monoclonal anti-Sm and anti-m3G antibodies as described in the 
Materials and Methods section. These experiments showed that the majority (85-95%) 
of the detectable 35S-labeled U1C protein molecules present in the nucleus were 
associated with U1 snRNP particles (data not shown). 
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Figure 7 (opposite page). Nuclear accumulation of hC,
 e0GFP and hC, eoGFP mutants in cultured HeLa 
cells. GFP (A), hC,
 60GFP (B), hC, e0(s6)GFP (C), hC, eo(s24)GFP (D), hC, eo(s25)GFP (E) and 
hC,
 eo(s28/29)GFP (F) were transiently expressed in cultured HeLa cells Two days after transfection, 
GFP and GFP fusion protein expression were examined by fluorescence microscopy. 
Nuclear accumulation of U1C in cultured HeLa cells 
Studies of nuclear import of U1 snRNA have shown that the requirements in cultured 
human cells may be (partially) different from those in X. laevis oocytes. To study 
nuclear accumulation of UIC in HeLa cells we fused the N-terminal 60 ammo acid 
residues of the U1C protein or mutants thereof (i.e. mutants s6, s24, s25, s28/29) to 
the N-terminal end of a variant of the Green Fluorescent Protein (GFPmutD [39]. The 
fusion proteins were expressed by transfection of HeLa cells with the corresponding 
constructs. Two days after electroporation expression of GFP and GFP fusion proteins 
was examined by fluorescence microscopy. GFP alone showed an intense staining of 
both cytoplasm and nucleus (Figure 7A). However, when the N-terminal 60 amino acids 
of the U1C protein were fused to GFP, the nucleus showed a speckled pattern, 
characteristic for snRNP staining (see Figure 7B) while no fluorescence was detected in 
the cytoplasm. When we transfected hCi oo(s25)GFP and hC, eo(s28/29)GFP which are 
still able to bind to the U1 snRNP particle, a similar pattern was obtained (see Figures 
7E and 7F) However, hC, ao(s28/29)GFP showed in addition to the nuclear staining also 
a weak cytoplasmic staining (Figures 7F). This might be due to the fact that two 
charged ammo acid residues (i.e. arginine and lysine) are substituted in this mutant. 
Alternatively, the faint cytoplasmic staining might be due to the expression level of 
hC,^o(s28/29)GFP When hC, ao(s6)GFP or hC, eo(s24)GFP, in which a conserved 
cysteine and histidme, respectively, were substituted, were expressed no nuclear 
accumulation was observed (see Figure 7C and 7D). Note that the intensity of 
fluorescence obtained with the hC, eoGFP fusion protein or mutants thereof is markedly 
reduced in comparison with the GFP control. 
Taken together, these experiments suggest that also in cultured HeLa cells nuclear 
accumulation of the U1C protein is dependent on its incorporation into U1 snRNP 
complexes. 
DISCUSSION 
Jantsch and Gall [25] have shown that the X. laevis U1C protein, which has no amino 
acid differences in the zinc finger-like region compared to the human UIC, is localized 
within structures known to contain U1 snRNPs after injection of transcripts encoding a 
m/c-tagged С protein into oocytes. They suggested that the U1C protein might be able 
to enter the nucleus via diffusion and might be retained in the nucleus via binding to the 
U1 snRNP particle. 
In this study we present evidence that the U1C protein indeed enters the nucleus by 
diffusion. Nuclear accumulation of U1C is reduced but not drastically inhibited by 
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cooling to 0°C (Figure 1), excluding an energy-dependent transport mechanism. 
Furthermore, the nucleocytoplasmic distribution of 35S-labeled U1C microinjected into 
the cytoplasm of X. laevis oocytes and incubated for 45 hours at 0°C is comparable to 
that observed when oocytes injected with 35S-labeled U1C were incubated at 18°C for 
21 hours (compare Figures 4A and 4B). The diffusion rate depends on the size of the 
U1C proteins used. When larger constructs like triple hC (55-60 kD) and hC, eo(DHFR)3 
(80-85 kD) were used virtually no import into the nucleus was observed. 
We also show in this study that the nuclear accumulation of the U1C protein is 
controlled by the binding of the protein to the nuclear U1 snRNP particle since mutants 
of the U1C proteins that are able to bind to the U1 snRNP particle accumulate in the 
nucleus while mutants that are unable to bind to the U1 snRNP particle do not (results 
summarized in Figure 5). This mechanism is substantiated by the nuclear accumulation 
of hC, eoDHFR which, due to its relatively small size (±33 kD) and its ability to bind to 
the U1 snRNP particle (Figure 3) showed the same behavior as U1C. In addition, we 
showed that most of the nuclear 35S-labeled U1C protein was bound to the U1 snRNP 
particle, consistent with results obtained by Jantsch and Gall [25]. 
The presence of an excess of U1C protein in the nucleus resulted in a reduced nuclear 
accumulation of 35S-labeled U1C protein (Figure 6). Similar results have been obtained 
previously with the U1A protein. Kambach and Mattaj [24] showed that the 
nucleocytoplasmic distribution of the U1A protein at equilibrium is not determined by its 
transport rate but rather by the number of free binding sites in the two compartments. 
The U1-70K protein has been reported to contain two independent NLSs: one 
encompasses the RNA binding domain and the other one is located in the C-termmal 
region of the protein [26] The C-terminal region of the protein might represent a true 
NLS. When this part of the protein is deleted the mutant protein still contains a 
functional RNA binding domain and might be able, in view of its size (20-25 kD), to 
diffuse through the nuclear pore and bind to the U1 snRNP particle in a way similar to 
what we observed for the UIC protein. 
We also showed that expression of wild type hC, «jGFP in HeLa cells results in a 
speckled nuclear pattern, characteristic for snRNP staining (Figure 7B). Jantsch and Gall 
[25] also showed that transfection of HeLa cells with a plasmid encoding /nyc-tagged 
U1C resulted in a nuclear distribution similar to the distribution of U1 snRNP particles. It 
is very likely that hC^ eoGFP is also able to bind to the U1 snRNP particle like 
hC,
 eoDHFR since hC, eoGFP mutant proteins that are assumed not to bind to the U1 
snRNP particle do not accumulate in the nucleus of cultured HeLa cells thereby 
confirming the results we obtained in the X. laevis oocytes. However, 
hC, ^(slQIl^GfP showed a weak cytoplasmic staining in addition to the nuclear 
staining (Figure 7F). This might be due to the fact that the expression of 
hC,
 eo(s28/29)GFP is higher compared to the other hC, eoGFP constructs resulting in 
saturation of the available UIC binding sites in the nucleus. Another explanation would 
be that substitution of the arginine and lysine in this mutant has a minor effect on the 
binding to the U1 snRNP particle resulting in less efficient nuclear retention. Such a 
reduced binding affinity would be in accordance with the observation that mutant 
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hC(s28/29) is also less efficient in supporting formation of the E (early) complex of the 
spliceosome [14]. 
In conclusion, we showed that the U1C protein enters the nuclear compartment via 
diffusion and is retained in the nucleus by binding to the U1 snRNP particle. 
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ABSTRACT 
Human U1C protein expressed in £. coli (rU1C), several truncated proteins and point 
mutants thereof, as well as 15 overlapping synthetic peptides were used in 
different types of immunoassays to analyze the specificity of anti-U1C 
autoantibodies from patients suffering from systemic lupus erythematosus (SLE), 
mixed connective tissue disease (MCTD), and other rheumatic diseases. We show 
that patients' autoantibodies are primarily directed against the native form of rU1C. 
In addition, the IgG autoantibodies rarely react with overlapping synthetic peptides 
of the U1C protein (16-30 residues long). Most of the rU1C positive patients' sera 
reacted with the rU1C mutant containing amino acid residues 30-159 which does 
not contain the zinc finger-like region Using U1C peptide-induced rabbit antisera, 
almost the same linear regions have been identified at the surface of the unbound 
rU1C protein and plastic-coated rU1C. Similar results were obtained when these 
anti-peptide sera were used in immunoprecipitation studies with both in vitro 
translated U1C and U1C bound to the U1 snRNP particle in HeLa S100 extract. 
Since no structural information and information about spatial arrangement 
concerning the U1C protein is currently available these data might be very useful for 
understanding the topography of unbound U1C and U1C bound to the U1 snRNP 
particle 
INTRODUCTION 
Among antibodies directed against small nuclear nbonucleoprotein particles 
(snRNPs), those described as anti-nRNP or anti-U1 snRNP refer to autoantibodies 
that precipitate exclusively U1 snRNP from nuclear extracts and are primarily 
directed against one or more of the U1 snRNP-specific proteins U1-70K, U1A or 
U1C. In some cases the autoantibodies react with U1 snRNA as well (reviewed by 
Klein Gunnewiek et al., 1997). Autoantibodies to snRNPs, which are common in 
autoimmune disorders like systemic lupus erythematosus (SLE) and mixed 
connective tissue disease (MCTD), have been extensively studied because they can 
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be used as highly valuable probes to explore the structure and functions of 
spliceosomes (Peng and Craft, 1996; Klein Gunnewiek et al., 1997). 
The spliceosomal snRNPs, U1, U2, U4/U6, and U5, consist of one snRNA molecule 
(or two in the case of U4/U6) complexed with eight so-called Sm or common 
proteins (B, B', D1 , D2, D3, E, F, G), which are present in all four spliceosomal 
snRNPs, and several particle-specific proteins which are specifically associated with 
one of the spliceosomal snRNPs. Two of the three U1 snRNP-specific proteins, U1-
70K and U1 A, contain a highly conserved RNP motif which is also present in several 
other RNA binding proteins (reviewed by Will et al., 1993). This RNP motif is 
essential for specific binding of U1 snRNA stemloop I by U1-70K (Patton and 
Pederson, 1988; Query et al., 1989) and stemloop II by U1A (Scherly et al., 1989). 
In contrast, U1C does not contain an RNP motif and can only bind to the U1 snRNP 
particle when U1-70K and the common proteins are already associated with the U1 
snRNA (Nelissen et al., 1994). The N-terminal domain of U1C encompassing a CC-
HH zinc finger-like region, is necessary and sufficient for U1C binding to the U1 
snRNP particle (Nelissen era/ . , 1991). In addition, part of the zinc finger-like region 
(residues 23-30) is suggested to be involved in the formation of U1C homodimers 
(Klein Gunnewiek et al., 1995). 
Spliceosomal snRNPs are involved in the processing of precursor mRNA (pre-
mRNA). In the early steps of spliceosome assembly the U1 snRNP binds the 5' 
splice site of pre-mRNA. The U1C protein can augment the binding of U1 snRNP to 
the 5' splice site (Heinrichs et al., 1990; Jamison et al., 1995; Rossi et al., 1996). 
Recently it has been shown that U1C is important for the formation and/or 
stabilization of early spliceosomal complexes (Will ef al., 1996). Mutagenesis 
experiments and complementation studies have determined that the N-terminal 60 
amino acid residues of U1C are sufficient to enhance the formation of early 
spliceosomal complexes. 
Only few reports describing B-cell epitopes on U1C that are recognized by 
autoantibodies have been published. Misaki et al. (1993) have shown that all anti-
U1C positive sera tested (n=17) reacted with truncated U1C proteins containing 
residues 102-125. This region presents a sequence similarity with an amino acid 
sequence of the herpes simplex virus type 1 ICP4 protein. James and Harley (1995) 
who used octapeptides synthesized and tested according to the Pepscan method, 
showed that all Sm/RNP precipitin positive sera tested (n = 12) reacted with 
peptides spanning residues 117-125. Ten other UIC epitopes were also identified. 
Most of them were localized in the regions 15-40, 56-68 and 78-94. The 
immunodominant region 117-125 is interesting because it contains residues 
PAPGMRPP (residues 118-125). A similar region (PPPGMRPP) is repeated twice in 
Sm-B and three times in Sm-B'/N (residues 191-198 and 216-223 of SmB/B7N and 
231-238 of SmBVN). This proline-rich sequence was shown to bear a dominant 
epitope recognized by human and murine antibodies (Habets et al., 1989; James er 
al., 1995; Williams er al., 1990). In U1A, a similar sequence, PPPGMIPP, is found 
between residues 165-172. However, in our hands, the peptide 163-184 
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encompassing this sequence did not possess significant antigenic activity with 
patients' sera (Barakat et al.. 1991). This latter result was confirmed by James and 
Harley (1996) using U1A octapeptides. 
In this study, 15 overlapping synthetic peptides of U1C were tested in ELISA with 
sera from 72 unselected patients with SLE, MCTD, secondary Sjogren's syndrome 
(sSS) and rheumatoid arthritis (RA), and from healthy individuals. The reactivity of 
patients' sera was also analyzed using human U1C expressed in E. coli and several 
truncated proteins or point mutants thereof. Furthermore, we mapped the surface 
accessibility of linear antigenic sequences of both free and bound U1C using anti-
peptide antibody probes. 
MATERIALS AND METHODS 
Human U1C and mutant proteins expressed in E. coli, and synthetic peptides 
The recombinant human U1C protein used in this work was overexpressed as a C-
terminal (his)e-tagged protein in E. coli and purified as described previously (Klein 
Gunnewiek et al., 1995) and will be referred to as rU1C. The reactivity of rUIC 
was compared to that of two truncated rU1C proteins containing amino acid 
residues 1-60 (rU1C1 6 0) and 30-159 (rU1C 3 0 1 5 9 ), respectively, and to three U1C 
mutants called rU1C(s24), rU1C(s25), and rU1C(s28/29) in which a histidine is 
substituted by a glutamme, a cysteine by a serine, and arginme/lysine by 
glycine/serine, respectively. r U 1 C i e o contains the zinc finger-like region while 
rU1C3 0 1 59 lacks this region. rU1C(s24) is unable to bind to the U1 snRNP particle 
while mutants rU1C(s25) and rU1C(s28/29) are able to bind U1 snRNP. cDNAs 
encoding mutants 1-60, s24, s25 and s28/29 with an additional C-termmal (his)e-
tag were produced in a PCR and cloned into the expression vector pET-3b in 
essentially the same manner as described previously for the wild type U1C protein 
(Klein Gunnewiek et al., 1995). The truncated protein 30-159 (Klein Gunnewiek er 
al., 1995) was similarly produced m a PCR and cloned into the Nco\IBamH\ site of 
pET-8c The PCR products were checked by sequencing. 
Fifteen peptides covering the entire sequence of the human U1C protein described 
by Sillekens et al. (1988) and overlapping each other by 4 to 13 residues were 
synthesized using Fmoc chemistry as described previously (Neimark and Briand, 
1993; Halimi er al., 1996). The peptide 5-34 was synthesized because it contains 
the zinc finger-like region. All the other peptides span 15-25 amino acid residues. 
For the latter peptides, the choice of sequences was dictated in part by the 
presence of Gly-Pro and Pro-Gly sequences because it is rather difficult to start 
Fmoc-based synthesis of a peptide with these sequences at the C-terminus 
Homogeneity of all peptides was assessed by analytical HPLC on a nucleosil C18 
column, 5 μΜ (4.6x150 mm), using a triethylammomum phosphate buffer system 
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U1C peptide antisera and human sera 
In order to induce anti-peptide antibodies, rabbits were given every two weeks s.c. 
inoculations with unconjugated peptides in the presence of complete Freund's 
adjuvant for the first and subsequent injections. In the case of peptides 85-103 and 
116-133, animals were given s.c. inoculations with ovalbumin-conjugated peptides. 
Conjugation was performed using 1 % glutaraldehyde. The final yield of 
carrier/peptide was 1:17 and 1:14 for peptides 85-103 and 116-133, respectively 
The rabbits were bled on a fortnightly basis from the third injection. A prebleedmg 
of each animal was performed and used as control in each assay. 
Human sera were obtained from 39 unselected patients with active and quiescent 
SLE, 19 patients with MCTD, 7 patients with sSS and 7 patients with RA, as well 
as from 24 healthy volunteers. These sera were obtained from D.A. Isenberg 
(Bloomsbury Rheumatology Unit, University College, London, UK), M. Reichlin 
(Oklahoma Medical Research Foundation, Oklahoma City, OK, USA) and G Folléa 
(Centre Hospitalier Universitaire, Strasbourg, France). In addition, 20 SLE patients' 
sera from our collection were selected for their positivity with U1C on immunoblot 
and introduced in the study. 
ELISA 
For the test of human sera, ELISA microtitre plates (Falcon, Oxnard, CA; ref 3912) 
were coated overnight at 37°C with the following antigens diluted in 0.05 M 
carbonate buffer pH 9 6: rU1C (0.1 //g/ml), rU1C(s25) and rU1C(s28/29) (0.1 
//g/ml), rU1C(s24) (0 3 //g/ml), rU1C160 and U1C30i59 (0.2 and 0.3 //g/ml 
respectively), and UIC synthetic peptides (2 //M). In each assay, patients' sera 
were also tested in a non-coated well incubated with coating buffer as a control. 
The subsequent steps of the test were performed as described previously (Tuaillon 
ef a / , 1992) using patients' sera diluted 1.1,000 and goat anti-human IgG 
conjugated to horseradish peroxidase (HRP) diluted 1:35,000 in PBS-Tween The 
final reaction was visualized by addition of 3,3',5,5' tetramethyl benzidine in the 
presence of H202. 
The cut-off points of the assays were determined with a series of sera from healthy 
individuals (10 for rU1C and mutants thereof, 24 for each U1C peptide). The mean 
OD values were 0.10 (sd 0.03), 0 12 (sd 0.05), 0.09 (sd 0.05), 0.12 (sd 0.06), 
0.12 (sd 0.07), 0.15 (sd 0.06) for rUIC, rU1C(s24), rU1C(s25), rU1C(s28/29), 
rU1C i e o , and rU1C30159, respectively. In the case of U1C peptides, the highest 
mean OD value was obtained with peptide 25-40 (0.11, sd 0.04). When sera were 
screened with the 15 U1C peptides and with rU1C and mutants thereof, they were 
considered positive when the OD values were higher than 0.3. Using this threshold 
value, none of the normal sera was found positive (Table 1). All samples were 
systematically tested in at least two independent assays The average intra- and 
interplate coefficients of variation were 7 4 and 12 2%, respectively. For 
calculations, all OD values > 3 were considered as 3.0. 'Mean' OD values 
correspond to the arithmetic mean of all OD values, including values under the cut-
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off line of positivity. 
The binding of patients' antibodies to rU1C in solution was tested in a competition 
assay. After incubation of rUIC for I h at 37°C and subsequent overnight 
incubation at 4°C with diluted human sera, the mixture was tranferred to wells 
precoated with rU1C and incubated for 1h at 37°C. Further steps were performed 
as described above. 
The ELISA used to measure the binding of rabbit antibodies to U1C synthetic 
peptides was performed with plates coated as described above and with an anti-
rabbit immunoglobulin HRP conjugate (Jackson Labs, Bar Harbor, ME; ref. 111-035-
003) diluted 1:40,000. 
To test the surface accessibility of different regions of rU1C, another type of 
competition assay was performed: in this ELISA format, peptides were used as 
coated antigens and free rU1C was used as inhibitor of the binding of homologous 
anti-peptide rabbit antibodies. As a positive control, the homologous peptide was 
used in the fluid-phase and, as a negative control, peptide 103-135 of U1A was 
used. 
Dot immunoassay 
Dot immunoassays were performed as described previously (Muller et al., 1994) 
except that in order to measure antibodies reactive with rU1C under native 
conditions, Tween was left out of the Tris-buffered saline (TBS). 
Immunoprecipitation of in vitro translated U1C 
Antibodies present in 15 μ\ of anti-peptide rabbit sera were coupled to protein A-
agarose beads (Biozym, Landgraaf; the Netherlands, 20 μ\ of 50% slurry) and 
incubated with 1 μ\ of in vitro translated 35S-labeled U1C protein produced as 
described previously (Klein Gunnewiek et al., 1995), and 500 μΙ IPP1S0 (10 mM Tris-
HCI, pH 8.0; 150 mM NaCI; 0.05% Nonidet P-40). The beads were rotated for 2 hr 
at 18°C, washed three times with IPPi5 0, resuspended in SDS-PAGE sample buffer, 
heated for 5 min at 95°C and separated on a 10% SDS-polyacrylamide gel. As a 
control, 200//I monoclonal anti-U1A antibodies (9A9: Euro-Diagnostica BV, Arnhem, 
the Netherlands) or 200 //I monoclonal anti-Sm antibodies (Y12: Lerner er al., 1981) 
were coupled to protein Α-agarose beads and incubated in the same way. 
Immunoprecipitation of U1 snRNPs contained in HeLa S100 extract 
Antibodies present in 10 μ\ of anti-peptide rabbit sera were coupled to protein A-
agarose beads (20 μ\ of 50% slurry) and incubated with 15 μ\ HeLa S100 extract 
(extract from 1 5 Ί 0 5 cells in 25 mM Tris-HCI, pH 7.4; 0.1 mM EDTA; 0.25 mM 
DTE; 0.5 mM PMSF; 0.1 M KCl; 0 . 0 1 % Nonidet P-40; 20% v/v glycerol) and 300 
μ\ ΙΡΡΐ5ο· The beads were rotated during 90 min at 18°C, washed three times with 
IPP150, and protein/RNA complexes that were bound to the antibodies were 
dissolved in 100 μ\ IPP15O/0.5% SDS. RNA was purified by phenol/chloroform 
extraction followed by ethanol precipitation, and separated on a denaturing 10% 
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Polyacrylamide gel. Precipitated RNA was analyzed by Northern blot hybridization 
using 32P-labeled antisense human U1 snRNA as a probe. 
RESULTS 
Reactivity of patients' sera with rU1C, rU1C mutants and UIC peptides 
Sera from 39 randomly selected SLE patients were tested in direct ELISA with 
human rU1C, point mutants rU1C(s24), rU1C(s25), rU1C(s28/29), and deletion 
mutants rUICi
 6 0 and rU1C3 0 1 5 9. Sera from some patients with SLE showed strong 
IgG antibody reactivity with the tested protein and mutant proteins (Figure 1). While 
none of the healthy sera from normal individuals were positive with any of the 
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Figure 1. Reactivity of sera from SLE patients with rU1C and rU1C mutants. 
Thirty-nine SLE sera and 3 control sera from healthy individuals were diluted 1.1,000 and 
allowed to react with 0.1 ¿/g/ml rU1C, rU1C(s25) and rU1C(s28/29), 0.2 ^g/ml rU1C,
 60 or 0.3 
//g/ml rU1C(s24) and rU1C30l59 directly adsorbed on microtiter plates. Only IgG antibodies were 
tested. The cut-off line corresponds to 0.30 OD unit. The average OD unit of each serum 
population is shown. The percentages indicate the positive sera of the tested population. 
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tested rU1C proteins, 20 out of 39 (51%) SLE sera reacted with rU1C. Eighteen 
SLE sera (46%) reacted with the rU1C(s24), 25 SLE sera (64%) reacted with the 
rU1C(s25) and 19 SLE sera (49%) reacted with rU1C(s28/29). Fourteen SLE sera 
(36%) reacted with r U 1 C i e o while 23 SLE sera (59%) reacted with rU1C3 0 1s9 
Most of the sera reactive with rU1C(s25) also reacted with rU1C, and with a few 
exceptions, all sera positive with rU1C, e o and r U 1 C 3 0 1 S 9 were positive with rUIC. 
In addition, we tested sera from patients suffering from MCTD (n = 19), sSS (n = 7), 
and RA (η = 7) for their reactivity with rU1C (Table 1). The sSS and RA sera did not 
show any reactivity while 77% of the 19 MCTD sera reacted with rU1C 
To delineate the location of epitopes recognized by patients' IgG antibodies, we 
tested the same sera (SLE, MCTD, sSS, and RA sera) for their reactivity with 15 
overlapping U1C synthetic peptides (Table 1). Using a cut-off value of 0 3 OD unit, 
it was found that very few sera (less than 16%) were positive with any of the U1C 
peptides. Only a few sera reacted strongly with some of the peptides (i.e. with OD 
TABLE 1 
Reactivity (prevalence in %) in ELISA of autoimmune and normal sera with rU1C and U1C 
synthetic peptides 
Whole rU 1С 
U1C peptides 
1-17 
5-34 
25-40 
31-48 
40-55 
44-62 
57-76 
67-83 
73-88 
85-103 
97-113 
107-127 
116-133 
123 144 
139-159 
SLE 
n = 39 
% 
51 
0 
0 
0 
0 
0 
0 
3 
0 
0 
3 
0 
8 
5 
5 
5 
MCTD 
n = 19 
% 
77 
5 
5 
16 
11 
0 
0 
11 
5 
0 
0 
11 
16 
11 
16 
11 
sSS 
n = 7 
% 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
RA 
n = 7 
% 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
NHS 
n = 24 
% 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Preselected sera 
positive with U1C 
in immunoblotting 
n = 20 
% 
95 
0 
0 
5 
0 
0 
0 
0 
0 
0 
0 
0 
20 
0 
10 
10 
SLE, systemic lupus erythematosus, MCTD, mixed connective tissue disease, sSS, 
secondary Sjogren's syndrome, RA, rheumatoid arthritis, NHS, normal human sera 
The cut-off line of the assays corresponded to 0 3 OD unit Patients' sera were diluted 
1 1,000 and allowed to react with 0 1 //g/ml rU1C or 2 μΜ of each peptide 
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values above 1.5 or 2). This limited reactivity could not be improved by using higher 
amounts of peptides for coating ELISA plates or by using lower serum dilutions 
(1:500 or less; data not shown). As shown in Table 1, a similar pattern of reactivity 
was found using a series of 20 selected SLE patients' sera known to react with 
UIC on immunoblot: 19 of these sera (95%) reacted with rU1C in ELISA and only 4 
(20%) showed a slightly positive reaction (OD: 0.31-0.53) with peptide 107-127. 
These results led us to conclude that patients' antibodies preferentially recognize 
plastic-adsorbed rU1C, i.e. rU1C in a somewhat denatured form. In addition, 
antibodies from lupus patients reacted more strongly and more frequently with 
rU1C30.i59 than with rUIC,.«,, and their reactivity was not significantly affected by 
point mutations at positions 24, 25 or 28/29. 
The reactivity of SLE autoantibodies with U1C was explored further using rU1C in 
assays in which it is expected to be present in a more native form compared to the 
plastic absorbed rU1C. First, rU1C protein at different concentrations in the fluid-
phase was used in order to compete for the binding of patients' antibodies to 
coated rU1C. Six SLE sera were tested and all reacted with free rU1C present in 
the fluid phase, leading to an inhibition of antibody binding of 60-85% at a 7.5-
molar excess of free rU1C over coated rU1C (not shown). Second, randomly 
selected SLE sera diluted in TBS without Tween were tested in a dot immunoassay 
in which rU1C was spotted on nitrocellulose sheets and tested under non-
denaturing conditions (Figure 2 gives an example of 8 out of 17 SLE sera tested). 
The dot immunoassay was found previously to be a reliable method to test protein 
antigens in their 'native' form (Muller et al., 1994). Out of the 17 SLE sera tested, 
12 reacted with rU1C in this assay: 9 of the latter were also positive in ELISA with 
coated rU1C and only t w o sera negative with rUIC in dot immunoassay were 
positive with rU1C in ELISA. From the results presented above, we conclude that 
lupus sera predominantly contained antibodies that recognize conformational 
epitopes present at the surface of the native U1C protein. 
U-|C 
BSA 
Figure 2. Reaction in dot 
, , immunoassay of rU 1С with 
patient' sera. 
rU1C (240ng) and BSA (as 
k* • • > ' w . f P i negative control) were | applied to nitrocellulose 
I sheets. The test was 
performed in TBS without 
Tween with patients' sera 
diluted 1:700. All sera 
except serum 1 reacted 
with rUIC in ELISA using 
1 17 AC\ At « Ì Й 7 ОН 1П7 protein-coated plates. The 
1 17 4 0 4 3 6 0 8 7 9 5 1 0 7
 n u m b e r s r e f e r t 0 t h e 
N H S names of the SLE sera. 
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Location of domains accessible at the surface of UIC protein 
In order to localize surface-exposed regions of U1C, a series of antisera directed 
against the 15 overlapping U1C peptides were raised in rabbits. The bleedings of 
each rabbit were first tested using peptide-coated microtiter plates in a direct 
binding ELISA format (Table 2, column 2). The specificity of the anti-peptide 
antibodies was tested by using various serum dilutions and various peptides at 
different concentrations in direct ELISA, and by a competition ELISA assay using 
the homologous peptide as antigen and the same or another peptide (i.e. peptide 
103-135 of U1A) as competitor (Table 2, column 3). 
TABLE 2 
Reactivity in ELISA of rabbit anti-U1C peptide antisera with homologous peptides and rU1C 
PEPTIDES used 
for immunization 
(1) 
1-17 
5-34 
25-40 
31-48 
40-55 
44-62 
57-76 
67-83 
73-88 
85-103 
97-113 
107-127 
116-133 
123-144 
139-159 
TEST WITH: 
HOMOLOGOUS PEPTIDES 
DIRECT ELISA 
(2) 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
COMPETITIVE 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
.+ 
+ 
+ 
+ 
+ 
+ 
+ 
ELISA 
(3) 
(89.7%) 
(94.3%) 
(100%) 
(86.1%) 
(92.7%) 
(100%) 
(68.7%) 
(100%) 
(100%) 
(98.7%) 
(89.6%) 
(92.2%) 
(73.2%) 
(98.1%) 
(85.7%) 
rU1C 
DIRECT ELISA 
(4) 
-
-
+ + 
-
+ + 
-
-
+ 
+ + + 
+ 
-
+ + + 
+ + + 
+ 
COMPETITIVE 
-
-
+ 
+ 
-
-
-
-
+ 
-
+ 
+ 
+ 
-
ELISA 
(5) 
(68.2%) 
(32.8%) 
(34.7%) 
(78%) 
(48%) 
(73.7%) 
In direct ELISA, rabbit antisera diluted 1:1,000 were allowed to react with 0.5 //g/ml rUIC 
and 2 μΜ homologous peptide. Absorbance values were measured after substrate 
hydrolysis (15 min) and reactions were considered positive when OD4 E 0 was >0.3 under 
these conditions: -, OD4 5 0 < 0 . 3 ; + , 0.3-0.75; + + , 0.75-2.0; + + + , 2.0-3.0. For each 
peptide, binding of normal rabbit serum was insignificant. 
Inhibitions by homologous peptides (positive control) and rU1C are expressed as - ( < 3 0 % 
inhibition) or + (>30% inhibition). Plates were coated with 0.015-0.250 μΜ of each 
peptide (depending on each individual peptide). When used as competitors, 0.15-5 //g/ml of 
each homologous peptide and 0.125-2 //g/ml of rU1C were incubated with rabbit antisera. 
Depending on the rabbit antiserum, serum dilution was 1:1,000-1:64,000. No inhibition 
was found with peptide 103-135 of U1A protein which was used as control (not shown). 
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103-135 UIA (Hg/ml) 
Figure 3. Competition ELISA 
Inhibition of the ELISA reaction of four 
different anti-peptide rabbit sera (·,Β,Α,0) 
and homologous peptides by increasing 
concentrations of the same homologous 
peptide as positive control (A), rU1C (B) 
and peptide 103-135 of U1A used as 
negative control (C) Rabbit antisera were 
raised against peptides 25-40 (•, dilution 
1 2,000), 31-48 (O, dilution 1.2,000), 
107-127 (A, dilution 1 1,000) and 123-
144 of U1C protein ( · , dilution 1.64,000) 
Binding of Ig from normal rabbit serum was 
insignificant 
To study the accessibility of regions of the U1C protein, the 15 anti-peptide antisera 
were first tested with rU1C directly adsorbed on plastic. In this ELISA format, 
several peptide antibodies reacted with rUIC protein, namely antibodies induced 
against peptides 31-48, 44-62, 73-88, 85-103, 97-113, 116-133, 123-144 and 
139-159 (Table 2, column 4). Subsequently, the free instead of the immobilized 
rU1C protein was tested in ELISA. In this assay, rU1C was used as competitor to 
inhibit the binding of coated peptides by their cognate anti-peptide antibodies. 
Figure 3 shows an example of the reaction with some of the tested U1C peptides 
(ι e. 25-40, 31-48, 107-127, and 123-144) and the peptide 103-135 of U1A which 
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was used as control. The results demonstrate that the regions spanning residues 
31-48, 40-55, 85-103, 107-127, 116-133 and 123-144 are readily accessible at 
the surface of free rU1C (Table 2, column 5). 
To see if similar results could be obtained with in vitro translated U1C we 
performed immunoprecipitations with the anti-peptide sera and in vitro translated 
35S-labeled U1C (Figure 4). Six of the tested sera (anti-peptide sera 31-48, 44-62, 
85-103, 116-133, 123-144, and 139-159) precipitated the 35S-labeled U1C very 
efficiently (see lanes 5, 7, 11 , and 14-16 of Figure 4). These results are very similar 
to the results we obtained with rU1C in a direct and a competitive ELISA (Table 2, 
column 4 and 5). 
The same set of anti-peptide sera was also used to study the accessibhty of the 
U1C protein contained in the U1 snRNP particle in HeLa S100 extract via detection 
of precipitated U1 snRNA (Figure 5). The same antibodies that precipitated the in 
vitro translated 35S-labeled U1C efficiently also precipitated U1 snRNA from HeLa 
S100 extract suggesting that the U1C protein was recognized when it was present 
in the U1 snRNP particle (see lanes 4, 6, 10, and 13-15 for anti-peptide sera 31-48, 
44-62, 85-103, 116-133, 123-144, and 139-159, respectively) Monoclonal anti-
U1A and anti-Sm antibodies were used as positive controls (lanes 16 and 17) 
Interestingly, differences in precipitation efficiency were observed. The most 
remarkable result was obtained with anti-peptide serum 123-144 (Figure 5, lane 14) 
which precipitated small amounts of U1 snRNP. In addition, also anti-peptide serum 
139-159 (lane 15) precipitated less U1 snRNP when compared to the other positive 
sera although differences are smaller. Anti-peptide serum 44-62 precipitates more 
U1 snRNP when compared to 31-48 (compare lanes 6 and 4; in a series of similar 
experiments, the differences between the observed signals were more pronounced 
than shown here). A weak U1 snRNP precipitation was observed with anti-peptide 
serum 107-127, which also reacts with free rU1C (Table 2). Surprisingly, region 57-
76 which was not detectably accessible in the three other assays seemed to 
become poorly accessible when U1C is bound to the U1 snRNP particle since a 
weak U1 snRNP precipitation was observed with anti-peptide serum 57-76 (lane 7). 
DISCUSSION 
The data presented in this study strongly argue for the notion that the autoanti-U1C 
response in patients suffering from SLE and MCTD is mainly directed against the 
native form of U1C and that IgG autoantibodies react rarely with 16-30 residue-long 
overlapping peptides of this molecule. We have shown that antibody reactivity was 
not affected when mutations at positions 24, 25 and 28/29 were introduced in 
rU1C. This results was not unexpected since we also showed that most of the 
patients' sera which were positive with rU1C reacted also with deletion mutant 
rU1C30159 which lacks the zinc finger-like region. 
The finding that anti-U1C autoantibodies are mainly directed against native U1C is 
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Figure 4. Immunoprecipitations of in vitro translated 35S-labeled U1C with rabbit anti-U1C 
peptide antisera. 
In vitro translated 35S-labeled U1C was precipitated with anti-peptide sera as indicated above 
lanes 2-16. Lane 1: 10% of the input of 35S-labeled U1C. Precipitation of 35S-labeled U1C by 
normal rabbit serum was not observed (not shown). 
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Figure 5. Precipitation of U1 snRNA complexed in the U1 snRNP particle via rabbit anti-U1C 
peptide antisera. 
Hela S100 extract was incubated with anti-peptide sera, as indicated above lanes 1-15. The 
precipitated RNA was transferred to a membrane and probed with 32P-labeled antisense U1 
snRNA. Monoclonal anti-U1A antibody (9A9, lane 16) and monoclonal anti-Sm antibody (Y12, 
lane 17) were used as positive controls. No precipitation of U1 snRNA with normal rabbit serum 
was observed (not shown). 
consistent w i t h the recent f indings presented by Satoh et al. ( 1 9 9 6 ) . The low 
frequency of anti-U1C antibodies found in immunoblot assays by these authors w a s 
suggested t o ref lect the fact that these antibodies react w i t h SDS-sensitive U1C 
epitopes. Using a novel immunoprecipitat ion technique t o detect autoantibodies t o 
native U1C, Satoh and c o w o r k e r s showed that 75/78 human sera w i t h anti-
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Sm/RNP antibodies were anti-U1C positive. 
It is interesting to note that our results with rU1C reported in this study differ 
significantly from previous studies describing the fine antigenic structure of other U 
snRNP proteins. Autoantibodies reacting with Sm-B/B7N, Sm-D, U1-70K and U1A 
were in all cases found to react with short peptides from these proteins and several 
dominant linear epitopes were characterized (James and Harley, 1996; see also 
Klein Gunnewiek ef al., 1997). With our series of U1C-reactive human sera, short 
peptides were rarely recognized. In contrast, rabbit antibodies raised against the 
same set of overlapping synthetic peptides did not only specifically recognize the 
peptide immunogen but some of these anti-peptide sera also recognized the U1C 
protein indicating that linear regions indeed are present at the surface of U1C. 
Figure 6 gives an overview of the peptide-raised antibodies that were able to 
recognize plastic coated immobilized rU1C, free rU1C, in vitro translated 35S-labeled 
U1C and U1C contained in the U1 snRNP particle present in HeLa S100 extract. 
Residues within four regions, namely 31-48, 85-103, 116-133, and 123-144, have 
been indicated to be accessible in the four assays used although differences in the 
extent of accessibility were observed. Residues within regions 44-62 and 139-159 
were recognized by the rabbit anti-peptide antibodies in all assays except for the 
free rUIC tested in the competition ELISA In addition, residues within the region 
40-55 were only recognized in the free rU1C (Figure 6). Regions shown to be 
accessible on 35S-labeled U1C were also accessible on plastic absorbed U1C 
although epitopes within regions 73-88 and 97-113 were accessible on plastic 
absorbed rUIC but not on 35S-labeled U1C. This discrepancy can be the 
consequence of the somewhat denatured form of rU1C, the sensitivity of the used 
assays or the fact that rUIC was expressed in an in vivo system while 3SS-labeled 
U1C was expressed in an in vitro system. Finally, immunoprecipitation studies of 
U1 snRNP particles using the anti-peptide sera indicated that residues contained 
within region 123-144 were significantly less accessible when the U1C protein is 
bound to the U1 snRNP particle. A less drastic decrease in recognition was 
observed for residues within regions 31-48 and 139-159 In addition, region 107-
127 which was accessible on free rU1C but not on plastic absorbed rU1C and 35S-
labeled U1C, was weakly accessible when U1C was contained in U1 snRNP. These 
results might be caused by a conformational change of the protein upon binding to 
the U1 snRNP particle or by the fact that these regions are covered by protein when 
U1C is bound to the U1 snRNP particle. Furthermore, residues within the region 57-
76 became accessible, though weakly, to the anti-peptide antibodies when U1C 
was bound to the U1 snRNP particle which might indicate that the conformation of 
U1C changes when the protein is in a free or bound state. Although we cannot 
exclude the possibility that due to the preparation procedure free U1C is present in 
HeLa S100 extract which might compete with the bound U1C for binding of anti-
peptide antibodies, these results do point to a preferential binding of the anti-peptide 
antibodies to some regions within U1C. 
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Figure 6. Overview of the U1C regions recognized by the rabbit anti-U1C peptide antisera tested 
in four different assays Bold lines indicate regions that are accessible in all four assays Zn zinc 
finger-like region 
It is noticeable that the sequences of U1C shown to be accessible to our set of 
rabbit anti-peptide sera encompass some epitopes which have been characterized 
previously m U1C with a small number of selected sera, namely the sequences 102-
125 (Misaki et al., 1993), 35-42, 56-64, 78-85, 85-94, 108-116, 117-125, 135-
143 and 150-159 (i.e. 8 of 11 epitopes characterized by James and Harley, 1995). 
It is also noticeable that the U1C zinc finger-like region is not significantly 
recognized by patients' autoantibodies. Again, this result differs from previous ones 
showing that zinc finger structures in 52-kD and 60-kD SSA/Ro proteins as well as 
in poly(ADP-nbose) polymerase are particularly targeted by autoantibodies from 
patients with SLE and Sjogren's syndrome (Briand ef al., 1995; Muller et al., 1994; 
Ricchiuti et al., 1994) It is possible that the zinc finger-like region of U1C is not 
available for an autoimmune response because the protein might be present as a 
homodimer in vivo (Klein Gunnewiek et al., 1995). However, a more likely 
possibility is that the U1C autoantigen is only presented in the context of the U1 
snRNP particle in which the zinc finger-like region is buried in the mass of Sm 
proteins in the core body (Nelissen et al., 1991; 1994). 
In conclusion, the results described in this paper strongly suggest that the anti-U1C 
autoimmune response is driven by the native U1C protein, probably as a part of the 
U1 snRNP complex. Furthermore, in the absence of structural data concerning the 
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U1С protein (to date only a fragment of the spliceosomal U1A protein has been 
crystallized and its structure resolved (Nagai et al., 1990)) and the U1 snRNP 
particle, our results with anti-peptide antibodies provide new data regarding the 
topography of the U1C protein, free or bound to the U1 snRNP particle. 
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Introduction 
Splicing is an essential nuclear process in which non-coding sequences are removed 
from the precursor messenger RNA (pre-mRNA) in order to obtain functional mRNA 
which serves as a template for the synthesis of protein (reviewed by Kramer, 
1996). Several trans-acting protein-RNA complexes are involved in splicing among 
which the U1 small nuclear ribonucleoprotein (snRNP) particle The U1 snRNP 
particle contains along with the so-called common proteins three particle-specific 
proteins, U1-70K, U1A and U1C. In this thesis, features of the U1C and the U1A 
proteins have been studied with emphasis on the U1C protein. 
The U1C protein 
The U1C protein is the smallest of the U1 snRNP-specific proteins and contains a 
zinc finger-like region at the N-termmal end of the protein that resembles the CC-HH 
zinc fingers found in transcription factor Ilia (TFIIIa) (Sillekens et al., 1988, Nelissen 
et al, 1991) The C-terminal end of the protein is rich in proline and methionine 
residues (Sillekens et al., 1987). 
The N-terminal zinc finger-like region 
The first 30 ammo acid residues encompassing the CC-HH zinc finger-like region 
(conserved cysteines at positions 6 and 9, conserved histidines at positions 24 and 
30) are completely conserved between human and Xenopus leavis (Sillekens et al., 
1988, Jantsch and Gall, 1992, respectively). Chapter 2 describes the 
characterization of the murine UIC protein and also in this case an absolute 
conservation with respect to the CC-HH zinc finger-like region was observed 
(Nelissen et al., 1997) Furthermore, the N-terminal 30 residues of yeast U1C show 
57% identity and 70% similarity with the human protein while the overall identity is 
only 25% and the overall similarity 4 3 % The cysteines and histidines at positions 
6, 9, 24 and 30 are conserved in yeast U1C (M Rosbash, pers communication) 
Up till now, binding of zinc ions via the zinc finger-like region could not be observed 
However, very recently it was shown that the U1C protein indeed is able to bind 
Z n 2 + and when the conserved histidme at position 24 is mutated into a glutamme, 
Z n 2 + binding is abolished (S Muller, pers communication). These results suggest 
that the zinc finger-like region of U1C indeed might be able to adopt a zinc finger 
structure stabilized by zinc coordination to the С and Η residues. It is known that 
zinc finger structures predominantly mediate protein-nucleic acid interactions but 
they have been shown to be involved in protein-protein interactions as well (Berg, 
1990, Coleman, 1992) The zinc finger-like region of U1C is involved in protein-
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protein interactions since this domain is essential for binding of U1C to the U1 
snRNP particle via protein-protein interactions (Nehssen et al., 1991, 1994). 
Furthermore, it was shown that part of the zinc finger-like region (the region 
spanning amino acids 23-29) is involved in homodimenzation (Klein Gunnewiek et 
al., 1995; Chapter 3). 
Zinc finger-like regions similar to the one present in the U1C protein are also found 
in two U2 snRNP-associated proteins: splicing factor 3a e o (SF3aeo, that comigrates 
with the sphceosome-associated protein 61 (SAP 61)) and SF3ae e (SAP 62) (see 
Table 1; Kramer et al., 1994; Chiara et al., 1994; Bennett and Reed, 1993). The 
yeast counterparts of SF3aeo and SF3aee (PRP9 and PRP 1 1 , respectively) have 
been shown to be able to homodimenze and also in this case the zinc finger-like 
domains are essential (Legrain et al., 1993; P. Legrain, pers. communication, 
respectively). 
TABLE 1 : Presence of proline-rich and zinc finger regions in spliceosomal proteins 
Protein Proline-rich region Zinc finger region Reference 
Common proteins 
E 
F 
G 
D1/D2/D3 
В/В' 
Ν 
69kD 
Van Dam et al., 1989 
McAllister étal., 1988 
Hackl and Lührmann, 1996 
12SU1 snRNP 
70K 
A 
С 
Sillekens et al., 1987 
Sillekens et al., 1988 
17SU2 snRNP 
A' 
B" 
SF3ae o(SAP61) 
SF3aee (SAP 62) 
SF3a120(SAP 114) 
SF3b50 (SAP 49) 
SF3b14S (SAP 145) 
+ 
+ 
+ 
+ 
Kràmer et al., 1994 
Chiara et al., 1994 
Bennett and Reed, 1993 
Kràmer et al., 1995 
Champion-Arnaud and Reed, 1994 
Gozani et al, 1996 
20S US snRNP 
200kD 
"Putative CC-CC zinc finger 
J)CC-HH zinc finger-like region 
'Zinc finger shown to bind zinc 
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The C-terminal proline-rich region 
The C-termmal two thirds of the U1C protein (aa 62-159) is rich in prolines and 
methionines (Sillekens et al., 1988). Sequences similar to the prohne-nch sequence 
118PAPGMRPP125 are also present in U1A (165PPPGMIPP172; Sillekens et al., 1987) 
and Sm-B/B7N (PPPGMRPP which is present twice in Sm-B (aa 191-198 and 216-
223) and three times in Sm-B' and N (aa 191-198, 216-223 and 231-238, Van 
Dam et al., 1989; McAllister et al., 1988). Similar sequences are found in a few 
other proteins among which SF3b50 (SAP 49; 233PPPGMPPP240; Champion-Arnoud 
and Reed, 1994). 
Proline-rich regions, which do not correspond to the PPPGMRPP consensus, are also 
present in other U2 snRNP-associated proteins (see Table 1). Despite the wide 
distribution, the function(s) of such proline-rich regions are unclear although some 
proline-rich regions are known to be involved in protein-protein interactions 
(reviewed by Williamson, 1994) 
It can be concluded that zinc finger-like regions and proline-rich regions are 
frequently present in spliceosome-associated proteins that have been characterized 
up till now (Table 1) which implies that these regions might have an important 
function in the mtermolecular interactions in the spliceosome. It has already been 
suggested that the proline-rich regions of some U2 snRNP-associated proteins are 
involved in protein-protein interactions with other protein components of the 
spliceosome (Bennett and Reed, 1993, Champion-Arnaud and Reed, 1994; Kramer 
et al., 1995). Further research is needed to elucidate the function and the putative 
binding partners of the zinc finger-like and proline-rich regions present in many of 
these spliceosome-associated proteins 
Function of the UIC protein 
The U1C protein can augment the binding of U1 snRNP to the 5' splice site 
(Heinrichs et al., 1990; Jamison et al., 1995, Rossi er al., 1996). The regions of 
U1C necessary for the suggested RNA binding and protein-protein interactions have 
not been mapped yet. 
It has been suggested that recognition of the 5' splice site by U1 snRNP depends on 
the structure resulting from the assembly of specific proteins around the U1 snRNA, 
whereas base pairing between the 5' end of U1 snRNA and the 5' splice site serves 
to stabilize the interaction (Rossi et al., 1996). It is possible that U1C dimers are 
present in (a subpopulation of) U1 snRNP particles (Klein Gunnewiek et al., 1995, 
Chapter 3). In that case, binding of two UIC proteins to the U1 snRNP particle 
might contribute to the correct organization of the U1 snRNP particle resulting in the 
formation of a functionally active particle. One study has been performed in which 
the function of the N-terminal part of UIC in spliceosome formation was examined 
(Will et al., 1996) This study shows that the U1C protein has a function in the 
formation and/or stabilization of early (E) splicing complexes The first 60 amino 
acid residues of U1C were shown to be necessary and sufficient for this function 
Will and collaborators also showed that mutation of residues 28 and 29 (arginine 
121 
Chapter 7 
and lysine substituted by glycine and serine, respectively) abolished the ability of 
the U1C protein to enhance Ε-complex formation. Substitution of the cysteine at 
position 25 into a serine had only a minor effect on Ε-complex formation Since the 
assay used reflects the amount of functional U1 snRNP particles that is 
reconstituted and residues 28/29 reside within the region which is indicated to be 
involved in dimer formation (Klein Gunnewiek et al., 1995; Chapter 3), these results 
suggest that U1C dimenzation is important for U1C function. 
In conclusion, it has been shown that the U1C protein has an important function in 
the stable binding of the U1 snRNP particle to the 5' splice site which is possibly 
exerted via binding of U1C to other proteins and/or 5' splice site nucleotides. It is 
not known what the precise roles of the zinc finger-like and the proline-nch rich 
regions are. The finding that the U1C protein is able to homodimerize (Klein 
Gunnewiek et al., 1995, Chapter 3) might indicate that two proteins are needed for 
efficient functioning of the U1C protein. 
The U1A protein 
The U1A protein contains two conserved RNP motifs which are separated by more 
than one hundred amino acid residues containing a proline-methionine rich region 
(Sillekens et al., 1987). The function of the U1A protein in splicing is not known. 
A possible role for the U1A protein (Lutz and Alwine, 1994, Lutz era/., 1996) and 
the U1 snRNP particle (Wassarman and Steitz, 1993) in the coupling between 
splicing and polyadenylation has been postulated It has been shown that U1A is 
able to bind to the upstream efficiency element of the SV40 late polyadenylation 
signal (Lutz and Alwine, 1994) although these results could not be reproduced by 
others (Lu and Hall, 1995, Simpson et al., 1995). In vertebrates, the U1A protein is 
able to regulate its own polyadenylation. Two copies of the U1A protein bind two 
conserved boxes in the 3' UTR of U1A pre-mRNA (Boelens er al., 1993, Van Gelder 
eí al., 1993) Via direct binding of this complex to poly(A) polymerase (PAP) 
inhibition of polyadenylation is achieved (Gunderson ef al., 1994). The C-terminal 
20 amino acids of PAP and amino acids 103-119 of both U1A molecules are 
essential for the inhibitory effect (Gunderson ef al., 1997). 
The N-terminal RNP motif 
The N-terminal RNP motif of U1A is involved in the binding of U1 snRNA (Scherly et 
al., 1989, 1990a; Lutz-Freyermuth, 1990) and the 3' UTR of the U1A pre-mRNA 
(Van Gelder et al., 1993). The crystal structure of the N-terminal RNP motif forms a 
βαββαβ structure (Nagai et al., 1990) with an additional C-terminal α-helix (helix C) 
(Howe et al., 1994) Recent RNA binding studies focussed on helix С demonstrated 
that, although helix С significantly contributes to RNA binding affinity, it is not 
required for RNA binding (Zeng and Hall, 1997). Chapter 4 describes the 
dimenzation of the U1A protein in which the N-terminal 117 amino acids appear to 
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be involved The dimenzation is greatly enhanced in the presence of RNA 
suggesting that the binding of one U1A molecule to RNA, either specifically or non-
specifically, facilitates the binding of the second U1A molecule next to the one that 
is already bound The fact that dimenzation seems to be enhanced in the presence 
of RNA and the observed cooperative binding of two U1A proteins to the 3' UTR of 
U1A pre-mRNA (Van Gelder et al., 1993) suggest that dimenzation in vivo primarily 
occurs via the 3' UTR to provide a correct binding site for PAP. The 3' UTR thus 
serves as a scaffold to bring the two U1A proteins in the correct position for PAP 
binding (Gunderson et al., 1997). 
The C-terminal RNP motif and the linker region 
The C-terminal RNP motif does not seem to have any affinity for RNA, even at very 
mild conditions (Lu and Hall, 1995). The secondary structure of the C-terminal RNP 
motif has also been described (Lu and Hall, 1995). It also contains the βαββαβ fold 
but helix С is not present. When amino acids 90-102 were added to the C-terminal 
end of the C-terminal RNP motif RNA binding was not conferrred to this RNP motif 
(Lu and Hall, 1995). The finding that the C-terminal RNP motif of U1A, as an 
isolated domain, lacks any affinity for RNA suggests that this RNP motif might need 
an auxiliary protein to bind the RNA as a heterodimer or that the C-terminal RNP 
motif could be involved in protein-protein interactions. Interestingly, the N-terminal 
RNP motif of U2B" is also involved in protein-protein interactions. A complex 
between U2B" and U2A' has been observed in the absence of RNA (Scherly et al., 
1990b). The function of the proline-nch region present in the linker region is not 
known. 
It has been suggested that stable binding of U1A to the U1 snRNP particle is 
enhanced via protein-protein interactions with other U1 snRNP-associated proteins, 
as will be discussed below. Possibly, such protein-protein interactions are exerted 
via the linker and/or C-terminal RNP motif of U1A. However, a first screening with 
the U1A protein in a library using the yeast two hybrid assay for detection of 
putative partners for protein-protein interactions, was not successful (J. Klein 
Gunnewiek, unpublished data). 
Assembly of the U1 snRNP particle 
The assembly of the U1 snRNP particle is a process which proceeds in several steps 
and probably takes place in two compartments, as has been pointed out in Chapter 
1. There are various indications that the binding of the U1 snRNP-specific proteins 
to the U1 core takes place in the nucleus rather than in the cytoplasm. First, it has 
been shown that the three U1 snRNP-specific proteins are able to enter the nucleus 
independently of the U1 snRNA (Kambach and Mattaj, 1992; Jantsch and Gall, 
1992, Romac et al., 1994). Second, both the U1-70K and the U1A protein have 
been shown to be actively transported into the nucleus (Romac et al., 1994; 
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Kambach and Mattaj, 1992, respectively). The U1C protein migrates to the nucleus 
via passive diffusion followed by retention via binding to the U1 snRNP particle 
suggesting that the diffusion rate is controlled by the availability of U1C binding 
sites in the nucleus (Klein Gunnewiek et al., 1997; Chapter 5). 
It is presumed that the core particle provides the stable platform for binding of U1-
70K, U1A and U1C Using mono Q anion exchange chromatography it has been 
shown that the U1 snRNP-specific proteins can be removed rather easily from the 
particle while the common proteins remain associated, suggesting a very stable 
core structure (Bach et al., 1990). This idea is corroborated by published data on 
the involvement of the common proteins in the association of all three U1 snRNP-
specific proteins to the U1 snRNP particle (Hamm et al., 1987, 1990; Nelissen et 
al., 1994). 
Studies performed in Xenopus laevis extracts as well as oocytes showed that 
deletion of stemloop I (the U1-70K binding site) or substitution of the loop I 
sequence has a dramatic effect on binding of all of the U1 snRNP-specific proteins 
while deletion of stemloop II (the U1A binding site) or substitution of the loop II 
sequence influenced U1A binding to some extent, in contrast to the binding of U1-
70K and U1C (Hamm et al., 1987, 1990) These results suggest that the core U1 
snRNP is initially bound by U1-70K which allows the stable binding of U1A and U1C 
resulting in the formation of a functional U1 snRNP particle. In contrast, in vitro 
assembly experiments using diluted Xenopus laevis extracts implied that the order 
of binding might be Sm, U1A, and then U1-70K. Unfortunately, the interaction of 
U1C could not be investigated due to the lack of a monospecific antibody directed 
against this protein (Hamm et al., 1987). There is strong evidence that binding of 
U1C must be preceeded by the binding of U1-70K (Bach et al., 1990; Nelissen et 
al., 1994). More research needs to be done to establish the suggested ordered 
binding of the U1 snRNP-specific proteins and to establish which protein binds first. 
The results described in Chapter 3 suggest that U1 snRNP particles may contain 
U1C dimers. One can speculate about possible mechanisms concerning dimer 
formation and U1 snRNP binding: i) One U1C protein binds to the U1 snRNP particle 
which enables the binding of a second U1C protein, HI U1C dimers are formed in the 
nucleus prior to binding to the U1 snRNP, ¡il) U1C dimers are formed in the 
cytoplasm prior to nuclear accumulation and binding to the U1 snRNP particle. 
Although additional experiments are required to confirm that a U1C dimer is indeed 
present in the U1 snRNP particle and to find out how these two U1C molecules are 
bound to the particle we favor the idea that U1C dimers might be formed in the 
nucleus and bind the U1 snRNP particle immediately after dimer formation 
(mechanism ¡i), which is supported by the results obtained from studies described in 
Chapters 3 and 5. In Chapter 5 it is shown that mutant U1C proteins that were 
unable to bind to the U1 snRNP particle but still were able to dimenze did not 
accumulate in the nucleus suggesting that mechanism i) is not very likely. 
Mechanism Hi) is also less likely since the molecular weights of the U1C dimer and 
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the UlCbeoDHFR dimer are 42 and 60 kDa, respectively, which is relatively large 
for the observed diffusion through the nuclear pore complex (Chapter 5). 
Finally, the work described in Chapter 6 provides some insight in the accessibility of 
different regions of the U1C protein using rabbit antibodies raised against synthetic 
peptides derived from U1C. We showed that some regions of U1C become less 
accessible to the rabbit anti-peptide antibodies when the U1C protein was bound to 
the U1 snRNP particle. These regions include amino acids flanking the zinc finger­
like region at the C-terminus (aa 31-48) and the C-terminal end of the protein (aa 
123-144 and 139-159) suggesting that the C-terminal end of U1C, in addition to 
the zinc finger-like region, is somewhat buried in the U1 snRNP particle or is bound 
to other components present in the HeLa S100 extract. The finding that the C-
terminal end is not absolutely inaccessible when U1C is bound to U1 snRNP 
suggests that this C-terminal end might be loosely associated with other proteins. It 
might also suggest that different subsets of U1 snRNP particles are present in HeLa 
S100 extract (i.e. U1 particles lacking U1C and U1 particles containing additional 
spliceosomal complexes and/or proteins) resulting in precipitation of U1 snRNP 
particles containing U1C that is accessible for the anti-peptide antibodies while U1 
snRNP particles in which U1C is buried will not be precipitated. Putative binding 
partners of U1C can be spliceosomal proteins containing proline-rich regions. 
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Prior to translation several consecutive reactions take place resulting in the 
formation of a functional mRNA. In the first reaction, the DNA sequence is 
transcribed as a precursor mRNA (pre-mRNA), which is, in the second reaction, 
converted to a functional mRNA which finally can be translated to a protein (third 
reaction). During the second reaction splicing takes place. Splicing is a process in 
which non-coding sequences (introns) present in the pre-mRNA are removed 
followed by the ligation of the coding sequences (exons), resulting in the formation 
of a functional mRNA. This reaction takes place in a multicomponent complex, the 
sphceosome, which consists of four small nuclear ribonucleoprotein (snRNP) 
particles, the so-called spliceosomal snRNPs, and several non-snRNP proteins. Of 
the four spliceosomal snRNPs, U1, U2, U4/U6 and U5 snRNPs, the U1 snRNP is the 
most abundant. The U1 snRNP particle contains an RNA molecule and several 
proteins associated with it. These proteins can be divided into two groups- the so-
called common or Sm proteins, which are present in all four spliceosomal snRNPs, 
and the particle-specific proteins, U1-70K, U1A and U1C, which are specifically 
associated with the U1 snRNP particle Components of the U1 snRNP particle are 
also major targets of autoantibodies in sera from patients with systemic lupus 
erythematosus (SLE) and mixed connective tissue disease (MCTD). 
In this thesis two of the U1 snRNP-specific proteins, the U1A and UIC protein, 
have been examined. 
Chapter 1 provides a general introduction describing the snRNPs with respect to 
their protein composition, structure and putative functions. Special attention has 
been payed to the U1 snRNP particle. 
Chapter 2 describes the characterization of the murine U1C protein. It is shown that 
the human and murine U1C proteins are almost identical in amino acid sequence. 
The N-terminal zinc finger-like region of U1C, which has been shown to be involved 
in the binding of U1C to the U1 snRNP particle, is absolutely conserved between 
human and mouse Furthermore, two possible murine pseudogenes of U1C have 
been characterized which supports the hypothesis that the UIC gene belongs to a 
multigene family 
In Chapter 3 it is shown that the U1C protein is able to homodimenze. Amino acid 
residues between positions 22 and 30, encompassing the C-termmal end of the zinc 
finger-like region, are involved in this dimenzation. Evidence is given indicating that 
UIC dimers might be present in U1 snRNP particles in vivo. 
Chapter 4 describes the dimenzation of the U1A protein. Based on the finding that 
dimenzation is greatly enhanced in the presence of RNA it is hypothesized that this 
dimenzation is exerted via RNA. one U1A protein binds RNA, either specifically or 
non-specifically, resulting in the facilitated binding of the second U1A protein next 
to the one that is already bound. 
Chapter 5 describes the transport of the U1C protein from the cytoplasm to the 
nucleus. In contrast to U1-70K and U1A, which have been shown to be actively 
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transported into the nucleus, the U1C protein diffuses to the nucleus through the 
nuclear pores and is retained in the nucleus via binding to the U1 snRNP particle. 
Chapter 6 describes a study in which human autoantibodies and rabbit antibodies 
raised against synthetic peptides derived from the U1C protein are used. 
Experiments with the rabbit anti-peptide antibodies show that, at the surface of the 
U1C protein, at least four regions are accessible when the U1C protein is present as 
a free protein in solution, when it is bound to plastics and when it is bound to the 
U1 snRNP particle. Some regions, especially in the C-terminal end of U1C, become 
less available to the anti-peptide antibodies when the U1C protein is bound to the 
U1 snRNP particle. 
Finally, in Chapter 7 the results described in this thesis are discussed. The 
importance of both the N-terminal zinc finger-like region and the C-terminal proline-
rich region of U1C in relation to other spliceosome-associated proteins is discussed. 
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Voordat eiwitten worden gesynthetiseerd vinden er een aantal opeenvolgende 
reacties plaats die leiden tot de vorming van een functioneel mRNA, dat dienst doet 
als leesraam voor de synthese van het eiwit. Tijdens de eerste reactie wordt de 
DNA sequentie vertaald in een voorloper van het mRNA (pre-mRNA), dat vervolgens 
in een tweede reactie wordt omgezet tot een functioneel mRNA en dat op zijn beurt 
vertaald wordt in een eiwit (derde reactie). Gedurende de tweede reactie wordt de 
splicing uitgevoerd. Splicing is een proces waarbij niet-coderende sequenties 
(intronen), die aanwezig zijn in het pre-mRNA, worden verwijderd gevolgd door 
ligering van de coderende sequenties (exonen), hetgeen resulteert in de vorming van 
een functioneel mRNA. Deze reactie vindt plaats in een complex dat is 
samengesteld uit vele componenten, het spliceosoom. Het spliceosoom bestaat uit 
vier 'small nuclear ribonucleoprotein'-complexen (snRNPs), die ook wel 
spliceosomale snRNPs worden genoemd, en vele niet-snRNP eiwitten. Van de vier 
spliceosomale snRNPs, U1, U2, U4/U6 en U5, komt UI snRNP het meest voor. Het 
UI snRNP-complex bestaat uit een RNA-molekuul waaraan vele eiwitten gebonden 
zijn. Deze eiwitten kunnen worden onderverdeeld in twee groepen: de zogenaamde 
algemene of Sm-eiwitten, die voorkomen bij alle vier spliceosomale snRNPs, en de 
complex-specifieke eiwitten, U1-70K, U1A en U1C, die alleen voorkomen in het U1 
snRNP-complex. De componenten van het U1 snRNP-complex vormen tevens het 
doelwit van autoantistoffen die aanwezig zijn in sera van patiënten die lijden aan 
systemische lupus erythematoses (SLE) of 'mixed connective tissue disease' 
(MCTD). 
In dit proefschrift zijn twee van de U1 snRNP-specifieke eiwitten, het U1A- en het 
U1C-eiwit, bestudeerd. 
Hoofdstuk 1 bevat een algemene inleiding waarin de snRNPs worden beschreven 
met betrekking tot hun samenstelling, structuur en mogelijke functies. Hierbij ligt de 
nadruk sterk op het UI snRNP-complex. 
Hoofdstuk 2 beschrijft de karakterisatie van het muis-U1C-eiwit. Hier wordt 
aangetoond dat het UlC-eiwit van zowel de mens als de muis uitermate 
geconserveerd is. Met name het zinkvinger-achtige gebied dat zich aan de N-
terminus van het eiwit bevindt en waarvan is aangetoond dat het betrokken is bij de 
binding van het eiwit aan het UI snRNP-complex, is volledig identiek bij mens en 
muis. Tevens zijn er twee mogelijke pseudogenen van het muis-U1C 
gekarakteriseerd, hetgeen een ondersteuning vormt voor de hypothese dat het U1C-
gen tot een multi-gen-familie behoort. 
In hoofdstuk 3 wordt aangetoond dat U1C in staat is homodimeren te vormen. 
Aminozuren gelegen tussen de posities 22 en 30, die het C-terminale eind van het 
zinkvinger-achtige gebied vormen, zijn betrokken bij deze dimerisatie. Tevens zijn 
aanwijzingen gevonden voor het feit dat de U1C-dimeer mogelijk aanwezig is in U1 
snRNP-complexen in vivo. 
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In hoofdstuk 4 wordt aangetoond dat ook het U1 A-eiwit kan dimeriseren. 
Gebaseerd op de bevinding dat dimeervorming drastisch toeneemt in aanwezigheid 
van RNA is een hypothese opgesteld waarin U1A-dimerisatie plaatsvindt via RNA: 
één U1A-molekuul bindt aan RNA, specifiek danwei aspecifiek, dat de binding van 
een tweede U1A-molekuul direct naast het molekuul dat al gebonden is, 
vergemakkelijkt. 
In hoofdstuk 5 wordt het transport van het U1C-eiwit van het cytoplasme naar de 
kern beschreven. In tegenstelling tot de eiwitten U1-70K en U1A, die beiden actief 
naar de kern worden getransporteerd, diffundeert het U1C-eiwit door de kernporiën 
naar de kern waar het vastgehouden wordt door binding aan het U1 snRNP-
complex. 
Hoofdstuk 6 beschrijft een studie waarin gebruik is gemaakt van humane 
autoantistoffen en konijnen-antistoffen die zijn opgewekt tegen synthetische 
peptides afgeleid van het U1C-eiwit. Experimenten met de konijnen anti-peptide 
antistoffen geven aan dat aan het oppervlak van het U1C-eiwit tenminste vier 
gebieden toegankelijk zijn als het eiwit vrij in oplossing aanwezig is, als het 
gebonden is aan plastic en als het gebonden is aan het U1 snRNP-cornplex. 
Sommige gebieden, met name in de C-terminus van het eiwit, worden minder goed 
bereikbaar voor de anti-peptide antistoffen als het U1C-eiwit aan het U1 snRNP-
complex is gebonden. 
In hoofdstuk 7 worden, tot slot, de resultaten die in dit proefschrift beschreven zijn 
bediscussieerd. Het belang van zowel het N-terminale zinkvinger-achtige gebied als 
het C-terminale proline-rijke gebied van U1C wordt besproken in relatie tot andere 
eiwitten die in het spliceosoom aanwezig zijn. 
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STELLINGEN 
behorende bij het proefschrift van Jacqueline Klein Gunnewiek 
The UI snRNP-specific proteins A and С: evolutionary conservation, 
nucleocytoplasmic transport and protein-protein interactions 
I 
Het zinkvinger-achtig gebied van het U1C-eiwit is betrokken bij de 
binding aan het U1 snRNP-partikel, de dimerisatie en de vorming van 
het vroege splicing-complex (E complex). 
Nelissen et al. (1991) Nucleic Acids Res. 19: 449-464, (1994) EMBO J. 
13: 4113-4126; Will et al. (1996) Nucleic Acids Res. 24: 4614-4623; 
dit proefschrift 
II 
De bevinding dat het transport van zowel U1C als U1A afhankelijk is 
van het aantal beschikbare bindingsplaatsen en het feit dat het RNA-
bindingsdomein van U1-70K deel uitmaakt van de NLS duiden erop 
dat het transport van U1-70K ook afhankelijk is van het aantal 
bindingsplaatsen. 
Dit proefschrift 
III 
De waargenomen RNA-afhankelijke dimerisatie van U1A is belangrijk 
voor het functioneren van dit eiwit. 
Dit proefschrift 
IV 
In gist zorgt LM С mogelijk voor de juiste conformatie van de 5' arm 
van het U1 snRNA resulterend in een productieve baseparing met een 
complementair RNA. 
Tang et al. (1997) EMBO J. 16: 4082-4091 

ν 
Het bezitten van een lichte gelaatskleur duidt niet per definitie op 
vermoeidheid of ziekte. 
VI 
Het promotieonderzoek is als het beklimmen van de Oude Holle Weg: 
na elke bocht denk je dat je er wel zult zijn. Het uiteindelijk bereiken 
van de top geeft daarom veel voldoening. 
VII 
De slogan 'de auto kan best een dagje zonder u' slaat, in gebieden 
waar de openbaar vervoersmogelijkheden alsmaar minder worden, als 
een tang op een varken. 
VIII 
Hardlopers zijn doorbijters. 
IX 
De veronderstelling dat promovendi niet geïnteresseerd zijn in salaris 
en rechtspositie, maar slechts hun wetenschappelijke honger willen 
stillen, is onjuist. 
X 
Functioneringsgesprekken tussen leidinggevenden hebben geen zin als 
zij elkaar de hand boven het hoofd houden. 
XI 
De publicatie van mislukte natuurwetenschappelijke proefnemingen zal 
een wetenschappelijke doorbraak zijn. 



